Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3048816	s-ca(7.4)	mmol/l (mmol/l)	27910	106510	0.48%
3048816	s-ca(7.4)	— (—)	8450	14969	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Contact with and exposure to communicable diseases

1889

7454

2.72

318.77

3.9

3.5

1.22

1.23

mmol/l

5.02

1587

6565

Cardiovascular diseases

3311

8622

2.18

310.81

4.6

2.6

1.22

1.23

mmol/l

5.12

2969

7325

Sleep apnoea, including avohilmo

5757

21956

1.78

307.93

4.0

3.8

1.22

1.23

mmol/l

6.30

4961

19322

Any event in cancer register

5477

18252

1.86

307.65

5.1

3.2

1.23

mmol/l

0.37

5038

15674

Fever of other and unknown origin

3725

15256

2.43

307.65

6.7

3.2

1.22

1.23

mmol/l

22.76

3453

12995

Abnormalities of breathing

5534

17947

1.92

307.65

4.2

3.6

1.22

1.23

mmol/l

10.52

4861

15597

Renal tubulo-interstitial diseases

5658

22418

2.06

307.65

8.0

2.9

1.22

1.23

mmol/l

30.48

5209

19287

Other antidepressants

6360

19190

1.80

307.65

3.9

1.22

1.23

mmol/l

1.05

5460

16944

First line medication for Crohn's disease

7216

20835

1.98

307.65

5.6

2.9

1.22

1.23

mmol/l

2.07

6613

17706

Depression medications

1643

2041

4.28

307.65

3.8

1.7

1.23

mmol/l

0.69

1390

1721

Anaemias

1711

1804

7.02

307.65

8.6

1.8

1.22

1.23

mmol/l

9.19

1588

1531

Presence of other functional implants

4847

13510

2.84

307.65

4.3

3.6

1.22

1.23

mmol/l

4.34

4065

11722

Hypothyroidism (congenital or acquired)

1646

1951

5.22

307.65

4.1

1.7

1.22

1.23

mmol/l

7.36

1424

1648

Hypertensive diseases (excluding secondary)

3275

7923

2.55

307.65

5.7

2.7

1.23

mmol/l

8.15

2990

6776

Hypertensive diseases

4739

14091

2.00

307.65

5.3

3.0

1.22

1.23

mmol/l

4.65

4307

12166

Abnormal spermatozoa

1053

3027

4.27

307.65

4.5

1.21

1.22

mmol/l

0.39

899

2701

Malignant neoplasm

5492

17444

1.97

307.65

5.5

3.1

1.23

mmol/l

0.62

5099

14935

Hypothyroidism and >3 levothyroxin purchases

1630

1948

5.18

307.65

4.1

1.7

1.22

1.23

mmol/l

7.75

1411

1645

Any reimbursement code in KELA

3345

6379

2.76

307.65

4.4

1.9

1.23

mmol/l

1.33

2984

5234

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1712

6246

3.13

307.65

7.9

3.1

1.22

1.23

mmol/l

1.59

1660

5262

General symptoms and signs

6813

18855

1.89

307.65

4.7

3.2

1.22

1.23

mmol/l

14.71

6134

16138

Oral corticosteroids

7112

22367

2.03

307.65

4.7

3.5

1.23

mmol/l

1.66

6444

19265

Hypertension, essential

4752

13817

2.07

307.65

5.1

3.0

1.22

1.23

mmol/l

5.48

4332

11921

Parasetamol

4744

12790

1.97

307.65

4.3

3.2

1.22

1.23

mmol/l

2.29

4215

11061

Metabolic disorders

5820

20509

1.85

307.65

5.9

3.2

1.22

1.23

mmol/l

15.72

5297

17710

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

5356

17084

1.95

307.65

5.4

3.0

1.23

mmol/l

0.58

4973

14611

Hypertension

4738

14081

2.00

307.65

5.3

3.0

1.22

1.23

mmol/l

4.81

4307

12158

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

3119

10865

2.81

307.65

6.9

3.0

1.23

mmol/l

0.18

3016

9160

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

5355

17082

1.95

307.65

5.4

3.0

1.23

mmol/l

0.53

4972

14610

Disorders of other endocrine glands

3039

13173

2.47

307.65

8.2

3.2

1.24

1.23

mmol/l

13.70

2822

11342

Malignant neoplasm, wide definition for exclusion

5357

17088

1.95

307.65

5.4

3.0

1.23

mmol/l

0.58

4974

14615

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6646

23489

2.16

307.65

6.5

3.1

1.22

1.23

mmol/l

23.61

6076

20277

Hypothyroidism, levothyroxine purchases

1630

1948

5.18

307.65

4.1

1.7

1.22

1.23

mmol/l

7.75

1411

1645

Persons encountering health services in other circumstances, wide

9073

20436

2.47

307.65

4.7

3.4

1.23

mmol/l

2.38

8262

17454

Other symptoms and signs involving the nervous and musculoskeletal systems

2809

12938

2.35

307.65

4.0

3.7

1.23

mmol/l

1.06

2571

11229

Cardiovascular diseases (excluding rheumatic etc)

3707

9634

2.34

307.65

4.8

2.7

1.22

1.23

mmol/l

7.32

3364

8204

Renal failure

3141

12712

2.48

307.65

11.9

3.1

1.21

1.23

mmol/l

30.58

2978

10885

Other medical care

2888

12650

2.44

307.65

6.2

3.0

1.22

1.23

mmol/l

7.00

2726

10747

ILD medications: immunosuppressive drugs

3885

18702

2.12

307.65

7.0

3.1

1.23

mmol/l

0.39

3631

16073

Inflammatory bowel disease treatment related agents

7333

22849

1.91

307.65

4.7

3.5

1.22

1.23

mmol/l

1.75

6638

19658

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7819

20303

2.34

307.65

4.9

3.4

1.23

mmol/l

0.11

7305

17350

Other bacterial diseases

5685

22651

1.82

307.65

7.1

3.1

1.22

1.23

mmol/l

28.75

5263

19510

ILD medications: prednisolone, methylprednisolone, prednisone

6905

21830

1.87

307.65

5.5

3.1

1.22

1.23

mmol/l

2.66

6284

18715

Other heart diseases

2825

7874

2.51

307.65

5.5

2.7

1.22

1.23

mmol/l

21.79

2573

6725

ILD medications

7037

22065

1.83

307.65

5.5

3.1

1.22

1.23

mmol/l

2.15

6400

18902

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6032

21598

2.00

307.65

5.7

3.3

1.22

1.23

mmol/l

4.86

5312

18875

Persons encountering health services in other circumstances

3188

9915

3.63

307.65

4.4

3.3

1.22

1.23

mmol/l

8.22

2688

8423

Endocrine, nutritional and metabolic diseases

4931

12286

2.14

307.65

4.5

2.8

1.22

1.23

mmol/l

6.21

4378

10561

Chronic kidney disease

2298

8795

2.94

307.65

14.0

3.0

1.21

1.23

mmol/l

19.56

2189

7505

Persons encountering health services for specific procedures and health care

6395

23266

1.77

307.65

6.8

2.9

1.22

1.23

mmol/l

14.98

5883

19992

Used for control exclusion in common control thyroid runs

6152

18365

1.76

305.42

4.3

3.5

1.22

1.23

mmol/l

9.25

5456

15909

Malaise and fatigue

3099

12713

2.16

303.58

4.8

3.2

1.22

1.23

mmol/l

7.14

2754

10775

Hypothyroidism, drug reimbursement

831

1360

4.72

301.08

5.8

1.7

1.21

1.23

mmol/l

13.50

745

1140

Dyspnoea

5263

23699

1.78

290.25

4.5

3.7

1.22

1.23

mmol/l

22.71

4628

20668

Sleep disorders (combined)

5788

22839

1.73

283.14

4.0

3.8

1.22

1.23

mmol/l

7.42

5019

20046

Type 2 diabetes, wide definition

4813

18077

1.82

277.22

5.5

3.5

1.22

1.23

mmol/l

14.64

4342

15684

Sleep apnoea

5381

21744

1.76

276.56

4.1

3.8

1.22

1.23

mmol/l

7.57

4663

19117

Any gastric operation

4761

13509

1.83

270.07

4.8

2.4

1.22

1.23

mmol/l

14.45

4273

11458

GASTRO-related operations

4761

13509

1.83

270.07

4.8

2.4

1.22

1.23

mmol/l

14.45

4273

11458

Polyarthropathies

4144

15358

1.89

268.78

5.2

3.6

1.22

1.23

mmol/l

0.67

3774

13341

Hyperlipidaemia, other/unspecified

2622

12233

2.20

266.52

5.0

3.4

1.22

1.23

mmol/l

3.28

2371

10438

Autoimmune diseases

6364

20066

1.68

265.11

4.3

3.6

1.22

1.23

mmol/l

7.06

5636

17433

Symptoms and signs involving the nervous and musculoskeletal systems

3474

18870

1.95

263.74

4.1

3.8

1.23

mmol/l

1.20

3130

16367

Other heart diseases, wide

5200

19177

1.75

262.24

4.9

3.3

1.22

1.23

mmol/l

22.26

4661

16660

Secondary hypertension

658

1558

4.92

259.25

18.3

2.8

1.22

1.23

mmol/l

6.10

644

1298

Autoimmune diseases excluding thyroid diseases

5871

19925

1.69

259.00

4.6

3.6

1.22

1.23

mmol/l

3.18

5289

17315

Cardiac arrhythmias

3356

11651

1.99

257.25

4.2

3.1

1.22

1.23

mmol/l

22.62

2997

10040

Codes for special purposes

2670

13415

2.12

255.72

5.0

3.6

1.22

1.23

mmol/l

0.73

2471

11673

Provisional assignment of new diseases of uncertain etiology

2665

13392

2.12

255.12

5.0

3.6

1.22

1.23

mmol/l

0.68

2467

11655

Autoimmune diseases excluding thyroid diseases, strict definition

5648

19168

1.70

252.97

4.5

3.5

1.22

1.23

mmol/l

2.61

5089

16629

Diabetes mellitus

5868

21650

1.68

252.96

4.7

3.5

1.22

1.23

mmol/l

8.09

5197

18833

Diabetes, varying definitions

5845

21601

1.68

251.67

4.7

3.5

1.22

1.23

mmol/l

7.57

5175

18792

Endocrine disorders, other/unspecified

333

462

12.21

249.45

5.9

3.1

1.22

1.23

mmol/l

0.24

298

390

Disorders of the thyroid gland

5491

22030

1.69

248.66

4.0

3.7

1.22

1.23

mmol/l

6.39

4777

19220

Heart failure, not strict

4476

18056

1.80

248.18

7.7

3.2

1.21

1.23

mmol/l

56.45

4150

15511

Pain in throat and chest

4819

17389

1.76

248.14

4.0

3.6

1.22

1.23

mmol/l

4.19

4282

15143

Pneumonia, organism unspecified

5170

22863

1.70

242.68

5.9

3.3

1.22

1.23

mmol/l

24.86

4711

19727

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5137

19538

1.71

240.54

5.9

3.2

1.22

1.23

mmol/l

21.40

4697

16780

5137

19538

1.71

240.54

5.9

3.2

1.22

1.23

mmol/l

21.40

4697

16780

Hypothyroidism, other/unspecified

5152

20785

1.70

238.04

4.1

3.6

1.22

1.23

mmol/l

8.57

4452

18117

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1234

4676

2.98

234.75

6.1

3.1

1.23

mmol/l

0.32

1191

3927

Persons with potential health hazards related to communicable diseases

2072

9681

2.25

233.71

4.0

3.6

1.22

1.23

mmol/l

6.77

1757

8533

Antihypertensive medication - note that there are other indications

3185

9127

1.98

233.59

4.6

2.9

1.23

mmol/l

1.57

2812

7864

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5452

20658

1.67

233.21

4.8

3.5

1.22

1.23

mmol/l

10.46

4816

17974

Other diseases of blood and blood-forming organs, wide

1517

6415

2.63

228.51

7.3

3.7

1.22

1.23

mmol/l

2.52

1401

5605

Hypothyreosis and Thyroxine purchase for inclusion criteria

5305

21787

1.67

228.27

4.1

3.6

1.22

1.23

mmol/l

8.27

4585

19006

Benzodiazepine use

5652

25521

1.63

226.94

4.2

3.7

1.23

mmol/l

0.95

4845

22380

Other soft tissue disorders, not elsewhere classified

5270

20174

1.67

226.84

4.2

3.7

1.22

1.23

mmol/l

2.16

4662

17524

Pneumonias (Asthma/COPD co-morbidities)

5551

24394

1.63

221.91

5.9

3.3

1.22

1.23

mmol/l

21.29

5070

21074

Other disorders of fluid, electrolyte and acid-base balance

1986

9122

2.28

221.73

7.5

3.2

1.21

1.23

mmol/l

24.23

1830

7767

Diabetes, insulin treatment (Kela reimbursement)

5704

22161

1.63

221.70

4.8

3.6

1.22

1.23

mmol/l

10.51

5039

19322

All pneumoniae

5583

24489

1.63

221.19

5.9

3.3

1.22

1.23

mmol/l

21.63

5091

21171

Heart failure and antihypertensive medication

1545

4203

2.62

220.02

7.6

3.3

1.21

1.23

mmol/l

26.94

1450

3606

Type 2 diabetes

5549

20802

1.64

219.70

4.7

3.5

1.22

1.23

mmol/l

9.00

4929

18092

Hypothyroidism, strict autoimmune

4186

16376

1.76

219.18

3.7

3.5

1.23

mmol/l

1.85

3580

14148

Influenza and pneumonia

5805

24519

1.61

217.40

5.9

3.2

1.22

1.23

mmol/l

18.72

5307

21153

Episodal and paroxysmal disorders

6262

20748

1.60

215.55

3.7

3.8

1.22

1.23

mmol/l

6.16

5498

18006

Insulin medication

3442

16809

1.84

214.87

6.3

3.7

1.22

1.23

mmol/l

21.43

3069

14603

Symptoms and signs involving the circulatory and respiratory systems

5680

18014

1.63

213.03

3.9

3.6

1.22

1.23

mmol/l

6.76

5050

15656

Cerebrovascular diseases (FINNGEN)

1767

5651

2.37

212.12

4.8

2.8

1.22

1.23

mmol/l

14.55

1632

4785

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2373

7459

2.11

211.95

5.1

2.7

1.22

1.23

mmol/l

8.61

2151

6374

Atrial fibrillation and flutter

1805

5267

2.37

211.85

5.0

2.9

1.22

1.23

mmol/l

24.69

1650

4453

Condition for Implicit Sepsis (Organ dysfunction codes)

4754

21420

1.68

211.27

6.1

3.1

1.22

1.23

mmol/l

49.05

4305

18460

Transplanted organ and tissue status

729

2176

3.90

210.91

19.8

3.8

1.22

1.23

mmol/l

1.47

720

1924

Disorders of thyroid, IBD co-morbidities

1076

2780

3.02

207.99

3.9

3.0

1.22

1.23

mmol/l

2.69

944

2380

Diabetes medication

5710

22362

1.61

207.91

4.7

3.5

1.22

1.23

mmol/l

6.68

5030

19489

Implicit Sepsis

4165

19585

1.73

207.60

6.6

3.2

1.21

1.23

mmol/l

52.99

3814

16813

Opioids

5595

18751

1.62

204.66

4.7

3.1

1.22

1.23

mmol/l

3.97

5008

16152

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5392

24347

1.61

204.47

5.9

3.3

1.22

1.23

mmol/l

20.51

4917

21060

Aplastic and other anaemias

2720

14092

1.95

202.69

9.0

3.4

1.21

1.23

mmol/l

22.75

2523

12091

Intracranial trauma

3127

13103

1.86

200.21

3.9

3.7

1.22

1.23

mmol/l

9.44

2735

11367

Asthma, unspecified (mode), excluding more controls

2888

12485

1.90

199.38

3.9

3.0

1.22

1.23

mmol/l

15.57

2588

10635

Complications of surgical and medical care, not elsewhere classified

5387

25047

1.60

197.53

5.3

3.5

1.22

1.23

mmol/l

5.48

4899

21712

Constipation

4904

22323

1.64

196.78

4.6

3.7

1.22

1.23

mmol/l

3.38

4224

19522

Insulin, fast-acting

2152

11007

2.08

196.44

7.2

3.6

1.21

1.23

mmol/l

18.03

1922

9564

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

2585

8954

2.00

195.93

4.1

2.7

1.24

mmol/l

6.25

2397

7546

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

2584

8954

2.00

195.61

4.1

2.7

1.24

mmol/l

6.18

2396

7546

Depression or dysthymia

3946

13112

1.75

195.16

4.0

3.9

1.23

mmol/l

1.05

3373

11641

Spondylosis

3223

15971

1.82

194.70

3.7

3.9

1.23

mmol/l

0.51

2805

13943

Care involving dialysis

637

1849

4.09

193.85

33.9

3.0

1.20

1.23

mmol/l

16.50

630

1597

Codeine

5266

18521

1.61

192.65

4.3

3.1

1.22

1.23

mmol/l

3.72

4663

15970

Other reaction to severe stress, and adjustment disorders

1994

9978

2.11

191.90

4.8

3.5

1.23

mmol/l

1.20

1794

8797

Pain in limb

4348

19569

1.67

190.01

4.4

3.8

1.22

1.23

mmol/l

1.58

3826

17016

Drug-induced neutropenia

627

1855

4.13

187.69

10.0

3.7

1.23

mmol/l

0.05

607

1620

Disorders of parathyroid gland

1442

6415

2.45

187.63

12.3

3.2

1.26

1.23

mmol/l

26.52

1357

5465

L04AD Calcineurin inhibitors

758

2494

3.48

186.75

17.2

3.9

1.22

1.23

mmol/l

0.65

744

2205

Psychiatric diseases

6086

20216

1.55

185.86

4.1

3.7

1.23

mmol/l

1.68

5272

17766

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2037

4894

2.17

185.25

3.9

2.8

1.22

1.23

mmol/l

5.85

1779

4103

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1954

7923

2.15

185.08

4.4

2.8

1.24

mmol/l

6.36

1829

6644

Other and unspecified anaemias

2480

13167

1.94

182.93

8.5

3.4

1.21

1.23

mmol/l

19.78

2295

11302

Asthma, unspecified (mode)

2955

13347

1.83

182.44

3.9

3.1

1.22

1.23

mmol/l

13.40

2645

11409

Insulin, intermediate and long-acting

3096

17793

1.79

181.23

6.1

3.6

1.21

1.23

mmol/l

20.68

2756

15485

Other anaemias

2495

13279

1.93

180.91

8.4

3.4

1.21

1.23

mmol/l

19.87

2310

11392

Insulin, combination of fast acting with intermediate-acting or long-acting

3445

19113

1.74

180.20

6.3

3.6

1.22

1.23

mmol/l

19.59

3071

16606

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

988

3819

2.90

180.15

6.7

3.0

1.23

mmol/l

3.58

964

3229

Concussion

2650

12741

1.88

179.96

4.0

3.7

1.22

1.23

mmol/l

5.75

2317

11048

Neurological diseases, wide definition

1608

3543

2.37

179.84

3.9

2.9

1.23

mmol/l

1.52

1406

3026

Insulin, fast-acting or short human

2160

11423

2.01

178.48

7.2

3.7

1.21

1.23

mmol/l

17.29

1930

9949

Atrial fibrillation and flutter with reimbursement

1509

4324

2.39

177.23

4.3

3.0

1.22

1.24

mmol/l

19.30

1360

3630

Other endocrine disorders

435

982

5.08

175.11

6.1

3.7

1.22

1.23

mmol/l

0.70

396

844

Disorders of gallbladder, biliary tract and pancreas

5406

23144

1.56

173.96

4.5

3.7

1.22

1.23

mmol/l

7.69

4831

20139

Obesity due to excess calories

2465

13698

1.89

173.40

5.1

3.6

1.22

1.23

mmol/l

14.33

2186

11992

Neoplasms

3951

12927

1.69

173.06

4.8

2.9

1.22

mmol/l

0.14

3585

10981

Tramadol

4287

17401

1.64

172.22

5.3

3.1

1.22

1.23

mmol/l

4.51

3815

15027

Type 2 diabetes, definitions combined, including avohilmo

5168

20093

1.57

172.09

4.1

3.5

1.23

mmol/l

4.13

4570

17486

Second line medication for Crohn's disease

3069

18206

1.77

171.48

5.2

3.7

1.23

mmol/l

0.11

2842

15821

Nephropathy related operations

858

3181

3.06

170.75

28.0

3.4

1.20

1.22

mmol/l

16.59

850

2799

Codeine or tramadol medication

6269

23730

1.51

169.69

4.3

3.6

1.22

1.23

mmol/l

2.60

5543

20637

Type 2 diabetes, definitions combined

5129

20143

1.57

169.55

4.2

3.5

1.22

1.23

mmol/l

5.58

4538

17519

Dialysis, with operation codes

859

3192

3.03

169.50

27.8

3.1

1.20

1.23

mmol/l

20.50

850

2778

L04AA Selective immunosuppressants

1346

6133

2.39

169.06

10.5

3.6

1.23

mmol/l

0.58

1291

5383

Oxycodone

2140

11130

1.98

168.07

7.9

3.2

1.22

1.23

mmol/l

7.73

2018

9523

Kidney transplant status

442

1108

4.88

166.77

24.5

3.6

1.23

mmol/l

0.12

442

975

Hypothyroidism, strict autoimmune, 3 medication purchases required

4606

20389

1.60

166.63

3.7

3.6

1.23

mmol/l

1.20

3925

17779

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

733

1761

3.38

166.40

5.1

3.2

1.22

1.23

mmol/l

5.15

675

1483

Type 2 diabetes, strict (exclude DM1)

5145

20312

1.56

166.38

4.2

3.5

1.22

1.23

mmol/l

5.77

4553

17676

Neurological diseases

4785

15529

1.60

165.81

3.9

3.7

1.22

1.23

mmol/l

4.10

4214

13489

Exclusions for E4_PCOS_BROAD

1061

4408

2.64

164.56

5.6

3.8

1.22

1.23

mmol/l

2.51

990

3849

Asthma, excluding more controls

4048

13438

1.66

164.49

3.7

3.0

1.22

1.23

mmol/l

11.67

3624

11455

Headache

3298

16694

1.71

163.55

3.7

3.2

1.23

mmol/l

3.18

2926

14271

Primary_lymphoid and hematopoietic malignant neoplasms

1381

6435

2.32

163.32

10.7

3.1

1.22

1.23

mmol/l

0.60

1333

5425

Mood disorders, excluding more controls

5047

20306

1.56

163.32

4.1

3.7

1.23

mmol/l

1.98

4352

17827

L04AX Other immunosuppressants

2983

17796

1.75

163.29

5.3

3.7

1.23

mmol/l

0.10

2766

15464

Ischemic heart diseases

4343

17475

1.62

163.08

4.9

3.7

1.22

1.23

mmol/l

10.94

3875

15164

Any mental disorder

6123

20956

1.50

161.75

4.1

3.7

1.23

mmol/l

1.74

5315

18396

Autoimmune diseases related-to ILD

4497

25983

1.57

160.26

4.0

3.8

1.22

1.23

mmol/l

1.87

4010

22606

Finngen Rheumatological endpoints

5194

19729

1.54

159.69

4.1

3.6

1.23

mmol/l

0.01

4651

17097

Explicit Sepsis

2428

13207

1.86

159.13

9.5

3.2

1.21

1.23

mmol/l

29.34

2258

11283

Glomerular diseases

1142

4996

2.51

158.63

16.8

3.5

1.21

1.22

mmol/l

11.90

1082

4372

Anxiety disorders, excluding more controls

4323

18508

1.60

158.33

4.1

3.7

1.23

mmol/l

2.42

3784

16238

Agranulocytosis

802

2992

3.06

158.26

9.5

3.6

1.23

mmol/l

1.02

767

2597

Septicaemia

2327

12588

1.88

157.24

9.8

3.2

1.21

1.23

mmol/l

25.93

2165

10728

Other general symptoms and signs

405

976

4.84

156.17

3.7

2.9

1.23

mmol/l

0.19

346

826

Symptoms and signs involving the digestive system and abdomen

5542

18749

1.52

155.29

4.4

3.6

1.22

1.23

mmol/l

4.60

4912

16259

Malignant neoplasm of breast

2843

12120

1.78

154.51

4.1

3.3

1.24

mmol/l

8.14

2625

10352

Bacterial infection, other or unspecified

2911

15762

1.75

154.02

8.2

3.1

1.22

1.23

mmol/l

18.00

2727

13456

COPD/asthma related infections

5728

19557

1.51

153.22

4.6

3.2

1.22

1.23

mmol/l

11.88

5143

16797

COPD/asthma/ILD related infections

5728

19557

1.51

153.22

4.6

3.2

1.22

1.23

mmol/l

11.88

5143

16797

Asthma

4188

14391

1.61

151.65

3.7

3.1

1.22

1.23

mmol/l

8.68

3749

12315

Other septicaemia

2107

11455

1.91

150.58

10.1

3.2

1.21

1.23

mmol/l

26.72

1965

9747

Covid-19 confirmed case

1622

8271

2.10

150.09

6.2

3.7

1.22

1.23

mmol/l

4.93

1470

7172

Diseases of pulp and periapical tissues, including avohilmo

5856

20972

1.49

149.29

4.2

3.6

1.22

1.23

mmol/l

3.57

5112

18286

Dental pulpitis 1

5857

21015

1.49

147.98

4.2

3.6

1.22

1.23

mmol/l

3.46

5113

18325

Abdominal and pelvic pain

5475

18749

1.51

146.90

4.2

3.6

1.22

1.23

mmol/l

4.22

4841

16259

Dental pulpitis 4

5851

21015

1.49

146.88

4.2

3.6

1.22

1.23

mmol/l

3.45

5107

18327

Malignant neoplasm of breast, HER2-negative

2752

12055

1.77

145.35

4.1

3.3

1.24

mmol/l

7.74

2538

10296

Selective serotonin reuptake inhibitors

5363

19238

1.51

145.16

3.7

3.9

1.23

mmol/l

0.24

4560

16988

Extracorporeal dialysis

489

1451

4.05

145.01

37.9

3.5

1.19

1.22

mmol/l

16.19

483

1276

Asthma (only as main-diagnosis), excluding more controls

3594

13438

1.64

144.98

3.7

3.0

1.23

mmol/l

5.79

3210

11455

Osteoporosis

1607

7913

2.10

144.66

6.4

3.4

1.24

1.23

mmol/l

1.67

1510

6717

Schizophrenia or delusion, excluding more controls

1566

7920

2.06

142.73

3.7

3.6

1.23

mmol/l

0.47

1357

6991

Spondylopathies

4413

17751

1.56

142.63

4.0

3.8

1.23

mmol/l

0.41

3874

15508

STROKE

3105

13269

1.69

141.28

4.3

3.4

1.22

1.23

mmol/l

10.56

2855

11393

Hyperparathyroidism

1209

5620

2.33

141.28

12.4

3.2

1.28

1.23

mmol/l

47.82

1133

4796

Acute tubulo-interstitial nephritis

3257

18180

1.65

141.22

5.8

2.9

1.22

1.23

mmol/l

9.80

2946

15543

Exposure to unspecified factor

5008

26674

1.50

141.03

4.7

3.6

1.22

1.23

mmol/l

15.78

4354

23318

Other nutritional deficiencies

3227

19901

1.64

139.96

4.9

3.7

1.22

1.23

mmol/l

18.51

2863

17373

Other arrhythmias

3346

16173

1.64

139.38

3.7

3.3

1.22

1.23

mmol/l

13.59

2937

14003

Osteopathies and chondropathies

2962

17408

1.69

139.12

6.4

3.5

1.23

mmol/l

0.35

2749

15021

Recurrent or chronic depression

2005

7918

1.90

138.52

3.5

3.7

1.23

mmol/l

2.61

1698

7069

Other disorders of adrenal gland

390

1024

4.65

138.47

7.1

3.2

1.22

1.23

mmol/l

1.98

376

874

Paroxysmal tachycardia

1182

4585

2.31

138.45

4.1

2.8

1.22

1.23

mmol/l

11.64

1065

3847

Acute renal failure

1228

5864

2.28

137.46

10.8

3.1

1.20

1.23

mmol/l

29.22

1166

5033

Other (not insulin) diabetes medications

5088

21064

1.50

137.10

4.1

3.6

1.22

1.23

mmol/l

4.71

4477

18360

Asthma (mode)

4045

14470

1.58

136.89

3.6

3.1

1.23

mmol/l

6.37

3617

12385

Adrenocortical insufficiency

338

810

5.29

136.74

7.1

3.2

1.22

1.23

mmol/l

2.29

326

691

Disorders of mineral metabolism

605

2101

3.32

136.67

13.0

3.2

1.23

mmol/l

0.29

565

1809

Mood disorders

5349

24442

1.48

136.39

4.0

3.8

1.23

mmol/l

1.62

4614

21426

Bleeding

4372

21386

1.54

136.16

5.4

3.7

1.22

1.23

mmol/l

22.81

3892

18580

Nausea and vomiting

1518

7675

2.06

136.10

6.4

3.5

1.22

1.23

mmol/l

11.36

1367

6561

Mood [affective] disorders

5334

24412

1.48

135.92

4.0

3.8

1.23

mmol/l

1.67

4597

21400

COPD differential diagnosis

4362

14475

1.55

133.75

4.4

3.1

1.22

1.23

mmol/l

8.17

3925

12390

Depression

4892

23163

1.49

133.62

4.0

3.8

1.22

1.23

mmol/l

3.59

4213

20315

ILD differential diagnosis

4358

14470

1.55

133.25

4.4

3.1

1.22

1.23

mmol/l

8.08

3921

12385

Reimbursement for rheumatic diseases

3089

19532

1.64

132.78

3.6

3.8

1.23

mmol/l

1.59

2818

16912

Excluding asthma or asthma-COPD overlap

4374

14554

1.55

132.49

4.4

3.1

1.22

1.23

mmol/l

7.96

3933

12464

Anxiety disorders

4549

21926

1.51

132.22

4.1

3.7

1.23

mmol/l

2.34

3978

19171

Hypo-osmolality and hyponatraemia

1100

5109

2.35

131.70

6.2

3.2

1.21

1.23

mmol/l

16.85

1000

4319

Valvular heart disease excluding rheumatic fever

2593

11391

1.74

131.51

5.5

3.4

1.22

1.23

mmol/l

25.14

2285

9781

Non-rheumatic valve diseases

2586

11346

1.74

131.29

5.5

3.4

1.22

1.23

mmol/l

25.08

2279

9742

Kela-code for severe mental illness

1940

10911

1.87

130.95

3.6

3.8

1.23

mmol/l

3.09

1679

9583

Asthma (only as main-diagnosis)

3685

14391

1.59

130.79

3.7

3.1

1.23

mmol/l

3.58

3290

12315

740

2887

2.78

130.20

6.0

3.2

1.22

1.23

mmol/l

3.99

677

2458

Unspecified mental disorder

2109

12179

1.81

129.57

3.6

3.7

1.23

mmol/l

3.12

1833

10701

Covid-19 suspected case

1132

5327

2.27

129.49

3.7

3.5

1.23

mmol/l

3.02

1086

4631

Presbycusis

969

4311

2.48

128.92

4.2

3.8

1.22

1.23

mmol/l

0.44

764

3705

Syncope and collapse

2351

12352

1.76

128.90

4.5

3.3

1.22

1.23

mmol/l

10.51

2097

10451

Use of hypnotics and sedatives

5607

22906

1.45

128.58

4.5

3.7

1.22

1.23

mmol/l

1.41

4886

20085

Neurotic, stress-related and somatoform disorders

4478

21713

1.51

128.31

4.1

3.7

1.23

mmol/l

2.59

3910

18997

Heart failure,strict

2891

12990

1.68

128.26

6.7

3.2

1.21

1.23

mmol/l

62.04

2682

11067

Other pulmonary diagnosis

4349

14554

1.54

128.21

4.4

3.1

1.22

1.23

mmol/l

8.82

3905

12464

Diseases of arteries, arterioles and capillaries (FINNGEN)

1244

4178

2.20

124.59

7.7

3.0

1.21

1.23

mmol/l

20.36

1133

3504

Dental pulpitis 1, only avohilmo

5842

21793

1.43

122.92

3.9

3.8

1.22

1.23

mmol/l

3.49

5070

19060

Medicines for HER+ breast cancer

2016

11421

1.82

122.90

4.3

3.4

1.24

mmol/l

7.03

1884

9746

General examination and investigation of persons without complaint and reported diagnosis

3983

14098

1.55

122.78

3.8

3.7

1.23

mmol/l

3.54

3757

12022

Other disorders of urethra and urinary system

3685

18327

1.56

122.50

4.8

3.5

1.23

mmol/l

1.22

3210

15961

Other retinal disorders

3385

17812

1.59

122.21

5.4

3.7

1.22

1.23

mmol/l

11.05

2864

15527

Obesity

3016

19179

1.61

121.69

4.9

3.7

1.22

1.23

mmol/l

15.80

2676

16778

Malignant neoplasm of breast, HER-positive

1925

10953

1.84

121.08

4.4

3.4

1.24

mmol/l

6.82

1801

9335

Low back pain

3790

19544

1.54

120.86

4.1

3.8

1.23

mmol/l

0.18

3347

17043

Obesity and other hyperalimentation

3024

19262

1.61

120.71

4.9

3.7

1.22

1.23

mmol/l

16.11

2684

16848

Genitourinary diseases

3092

9731

1.64

119.54

5.3

2.7

1.22

1.23

mmol/l

4.20

2744

8448

Enlarged lymph nodes

910

4058

2.42

119.48

5.9

3.2

1.23

mmol/l

0.24

871

3485

Disorders of lens

3565

14872

1.57

117.44

5.7

3.7

1.22

1.23

mmol/l

4.41

3112

13100

Bronchitis

5468

25729

1.43

117.25

4.8

3.5

1.22

1.23

mmol/l

17.63

4890

22294

L02BG Aromatase inhibitors

1674

9388

1.91

117.00

4.5

3.4

1.25

1.24

mmol/l

7.47

1565

7993

Dental pulpitis 4, only avohilmo

5796

21783

1.42

116.70

3.9

3.8

1.22

1.23

mmol/l

3.46

5030

19050

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1798

10269

1.85

116.40

5.1

3.7

1.22

1.23

mmol/l

24.63

1635

8935

Biguanides

4940

21460

1.46

116.39

3.8

3.7

1.22

1.23

mmol/l

3.72

4342

18727

Disorders of lipoprotein metabolism and other lipidaemias

4256

18379

1.50

115.87

4.8

3.3

1.22

1.23

mmol/l

6.05

3840

15839

5989

22935

1.41

115.68

4.5

3.5

1.22

1.23

mmol/l

11.43

5313

19832

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1288

6599

2.04

115.33

4.0

3.5

1.22

1.23

mmol/l

4.13

1111

5868

Glomerular disorders in diseases classified elsewhere

726

3018

2.67

113.82

19.0

3.6

1.20

1.22

mmol/l

11.88

686

2634

Adjustment and management of implanted device

1098

5401

2.20

113.63

5.1

3.0

1.21

1.23

mmol/l

8.19

964

4533

Primary_lymphoid and hematopoietic malignant neoplasms

1381

7358

2.01

113.31

10.7

3.6

1.22

1.23

mmol/l

0.47

1333

6350

Infections, IBD-co-morbidities

808

2460

2.53

112.99

9.8

3.1

1.22

1.23

mmol/l

3.51

752

2105

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3337

20631

1.56

112.83

4.9

3.7

1.22

1.23

mmol/l

2.59

3055

17847

Certain infectious and parasitic diseases

5291

18857

1.44

112.49

5.1

2.8

1.22

1.23

mmol/l

15.00

4778

16133

Disorders of choroid and retina

4187

21120

1.49

112.38

5.1

3.7

1.22

1.23

mmol/l

7.91

3544

18485

Abnormalities of heart beat

1855

10707

1.80

110.86

3.9

3.5

1.22

1.23

mmol/l

4.71

1611

9229

Diarrhoea and gastroenteritis of presumed infectious origin

3516

21552

1.53

110.82

5.7

3.5

1.22

1.23

mmol/l

9.70

3148

18722

Invasive ventilation

508

1798

3.23

110.78

9.7

3.7

1.19

1.22

mmol/l

17.28

467

1556

Ischaemic heart disease, wide definition

4062

17483

1.50

110.60

4.9

3.7

1.22

1.23

mmol/l

13.44

3587

15214

Acute bronchitis

2158

12835

1.72

110.38

5.4

3.6

1.22

1.23

mmol/l

9.52

1914

11106

Personality disorders, excluding more controls

1188

6019

2.07

109.99

3.6

3.5

1.22

1.23

mmol/l

1.81

1009

5363

Other abnormal findings of blood chemistry

359

1045

4.14

109.84

3.9

3.6

1.23

mmol/l

0.09

340

896

Other diseases of urinary system

5299

21453

1.42

108.76

4.5

3.6

1.22

1.23

mmol/l

5.84

4603

18733

Convulsions, not elsewhere classified

1160

5784

2.08

108.56

4.7

3.2

1.21

1.23

mmol/l

18.32

1066

4968

Disorders of calcium metabolism

464

1584

3.40

108.55

15.1

3.1

1.24

1.23

mmol/l

0.57

436

1366

Type 1 diabetes, wide definition, subgroup 1

1079

5323

2.14

108.19

7.8

3.5

1.21

1.23

mmol/l

11.01

951

4640

Other acute lower respiratory infections

2690

16486

1.61

107.97

5.3

3.6

1.22

1.23

mmol/l

9.84

2415

14290

Glucagon-like peptide-1 (GLP-1) analogues

2910

15639

1.60

107.22

5.0

3.9

1.22

1.23

mmol/l

6.97

2559

13558

Dorsalgia

5167

20070

1.43

106.96

3.8

1.23

mmol/l

0.05

4529

17483

Heart failure, strict

3094

14712

1.58

106.13

6.6

3.6

1.21

1.23

mmol/l

58.34

2859

12618

Complications of procedures, not elsewhere classified

4027

24294

1.47

105.85

5.2

3.5

1.22

1.23

mmol/l

6.25

3657

21060

Intracranial injury

2889

18315

1.58

105.41

4.0

3.8

1.22

1.23

mmol/l

6.75

2522

15923

Obesity related asthma

1744

10158

1.81

105.25

4.2

3.9

1.22

1.23

mmol/l

10.11

1576

8853

Other arthritis (FG)

1629

9295

1.84

105.22

4.8

3.6

1.23

mmol/l

0.33

1474

7997

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

528

1955

3.02

104.81

7.4

2.9

1.21

1.23

mmol/l

12.86

496

1625

Anxiety (asthma-related co-morbidities)

2735

13880

1.60

104.52

3.4

3.7

1.23

mmol/l

2.10

2338

12224

Other diseases of intestines

5388

22768

1.41

104.39

4.4

3.6

1.22

1.23

mmol/l

5.62

4790

19768

All-cause Heart Failure

3051

14538

1.58

104.25

6.6

3.6

1.21

1.23

mmol/l

58.22

2818

12461

Chronic lower respiratory diseases

6148

24642

1.38

104.20

3.9

3.8

1.22

1.23

mmol/l

4.06

5467

21410

Cholelithiasis, broad definition with cholecystitis

4473

21739

1.45

104.11

4.1

3.6

1.22

1.23

mmol/l

3.47

3948

18849

Senile cataract

3279

13560

1.55

103.85

5.4

3.7

1.22

1.23

mmol/l

3.96

2841

11919

Hard cardiovascular diseases

4080

18274

1.48

103.25

4.5

3.8

1.22

1.23

mmol/l

11.99

3731

15780

Nutritional anaemias

2535

15832

1.62

103.18

5.8

3.6

1.22

1.23

mmol/l

15.16

2284

13675

Venous thromboembolism

2831

18092

1.58

102.83

5.7

3.6

1.22

1.23

mmol/l

1.76

2560

15637

Systemic connective tissue disorders

1916

11530

1.75

102.79

4.2

3.6

1.23

mmol/l

1.93

1731

9951

Other metabolic disorders

775

3454

2.44

102.78

6.6

3.0

1.21

1.23

mmol/l

26.39

704

2972

Oedema, not elsewhere classified

1606

9144

1.84

102.56

5.2

3.2

1.22

1.23

mmol/l

5.18

1452

7762

Other disorders of bladder

746

3288

2.50

102.50

4.2

4.0

1.22

mmol/l

0.71

599

2877

Problems related to lifestyle

546

2068

2.86

101.79

4.5

3.3

1.21

1.22

mmol/l

5.06

498

1779

Iron deficiency anaemia

2170

13382

1.68

101.00

6.0

3.6

1.22

1.23

mmol/l

12.98

1968

11534

Cholelithiasis

4317

21479

1.45

100.68

4.1

3.6

1.23

mmol/l

2.99

3801

18621

Injuries to the head

5464

26247

1.39

98.92

4.2

3.7

1.22

1.23

mmol/l

10.70

4793

22870

Type 1 diabetes

1274

6853

1.95

98.89

7.5

3.5

1.21

1.23

mmol/l

12.37

1124

5983

Other specified/unspecified arthritis

1443

8106

1.88

98.55

4.7

3.6

1.23

mmol/l

0.37

1312

6992

Certain disorders involving the immune mechanism

1063

5437

2.10

98.20

7.0

3.9

1.23

mmol/l

0.04

994

4770

Other disorders of kidney and ureter

777

3561

2.40

97.41

14.4

3.8

1.22

1.23

mmol/l

1.01

726

3117

Drug-induced adrenocortical insufficiency

192

387

6.83

97.36

6.6

3.6

1.22

1.23

mmol/l

0.83

184

336

Other diseases of pleura

2348

13285

1.64

96.98

6.0

3.8

1.21

1.23

mmol/l

17.61

2156

11463

Postprocedural endocrine and metabolic disorders, not elsewhere classified

716

3169

2.46

96.63

6.7

3.0

1.20

1.23

mmol/l

26.64

651

2724

Substance abuse, excluding more controls

2598

14806

1.58

96.16

4.2

3.8

1.21

1.22

mmol/l

14.45

2291

13081

Schizophrenia, schizotypal and delusional disorders

1576

9130

1.80

96.09

3.7

3.8

1.23

mmol/l

0.97

1367

8045

Schizophrenia or delusion

1566

9079

1.80

95.22

3.7

3.8

1.23

mmol/l

1.04

1357

8006

Acute upper respiratory infections of multiple and unspecified sites

3609

18791

1.48

94.66

4.8

3.6

1.22

1.23

mmol/l

8.86

3248

16334

Fall on same level

5801

24180

1.37

94.58

4.3

3.6

1.22

1.23

mmol/l

5.82

5058

21113

Symptoms and signs involving cognition, perception, emotional state and behaviour

4826

24749

1.40

93.34

3.9

3.8

1.22

1.23

mmol/l

2.55

4214

21626

All anxiety disorders

2775

14817

1.55

92.86

3.4

3.6

1.23

mmol/l

1.04

2370

13000

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1536

8953

1.80

92.16

4.5

3.8

1.23

mmol/l

0.22

1406

7808

Diagnoses used for exclusion with ILD

1385

7860

1.86

91.99

5.0

3.9

1.22

1.23

mmol/l

0.50

1277

6847

Type 1 diabetes, wide definition

1103

5801

2.00

91.92

7.8

3.5

1.21

1.23

mmol/l

11.05

972

5055

Implicit viral Sepsis

1051

5484

2.05

91.46

9.5

3.1

1.21

1.23

mmol/l

16.73

992

4666

Viral Sepsis

1051

5499

2.04

90.72

9.5

3.1

1.21

1.23

mmol/l

16.75

992

4679

Symptoms and signs involving the urinary system

3852

21164

1.45

90.53

5.1

3.7

1.22

1.23

mmol/l

6.88

3384

18416

Non-selective monoamine reuptake inhibitors

2013

12240

1.66

90.53

3.7

3.8

1.23

mmol/l

0.95

1756

10775

Pulmonary heart disease, diseases of pulmonary circulation

1690

10183

1.75

90.32

6.2

3.8

1.22

1.23

mmol/l

4.10

1576

8750

Bacterial Sepsis

2284

13098

1.61

90.22

8.6

3.2

1.21

1.23

mmol/l

33.19

2117

11179

Other anxiety disorders

2023

11203

1.65

89.85

3.3

3.5

1.22

1.23

mmol/l

1.77

1734

9830

Other systemic involvement of connective tissue (FG)

1409

8030

1.84

89.81

3.8

3.5

1.23

mmol/l

0.62

1254

6834

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2106

10413

1.64

87.38

5.0

3.1

1.22

1.23

mmol/l

5.92

1948

8785

Vocal cord dysfunction

652

2650

2.41

87.11

4.7

2.9

1.22

1.23

mmol/l

8.24

576

2286

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

506

2025

2.80

86.56

15.0

3.0

1.22

1.23

mmol/l

1.98

487

1712

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

459

1746

2.93

86.50

7.6

2.8

1.20

1.23

mmol/l

14.55

428

1451

DVT of lower extremities and pulmonary embolism

2147

13814

1.62

86.00

5.8

3.7

1.22

1.23

mmol/l

1.71

1961

11920

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

734

3445

2.31

85.96

9.4

3.1

1.23

mmol/l

1.21

711

2912

Thrombocytopenia, unspecified

457

1752

2.94

85.49

10.8

3.7

1.22

mmol/l

1.84

427

1511

Asthma (diagnoses ohter than nonallergic)

4217

26341

1.40

84.94

3.7

3.8

1.22

1.23

mmol/l

3.42

3785

22854

Other and unspecified iron deficiency

1666

10153

1.72

84.84

5.8

3.5

1.22

1.23

mmol/l

9.87

1512

8759

Extreme obesity with alveolar hypoventilation

310

972

3.78

84.33

5.5

3.4

1.20

1.23

mmol/l

7.22

258

841

Cardiodefibrillation

1910

12076

1.66

84.01

4.4

4.1

1.21

1.23

mmol/l

15.40

1691

10458

Type of accident

1418

8299

1.79

83.98

4.5

3.7

1.23

mmol/l

0.06

1294

7239

Angina pectoris

3088

14402

1.50

83.91

4.7

3.7

1.22

1.23

mmol/l

7.66

2740

12421

Dental pulpitis 2

3702

13364

1.45

83.83

4.4

3.5

1.23

mmol/l

1.41

3208

11662

Gout

1424

7598

1.80

83.44

8.4

3.8

1.21

1.22

mmol/l

4.53

1303

6538

Pain (limb, back, neck, head abdominally)

3811

13517

1.44

83.40

4.1

3.7

1.22

1.23

mmol/l

1.42

3350

11733

Pain, not elsewhere classified

1293

7374

1.83

83.28

4.3

3.1

1.23

mmol/l

1.75

1160

6302

Lower back pain or/and sciatica

5045

26243

1.36

82.98

3.9

3.8

1.23

mmol/l

0.33

4446

22873

Dental caries 3 and operation codes

4651

17524

1.39

82.90

4.2

3.6

1.23

mmol/l

0.41

4044

15356

Care involving use of rehabilitation procedures

3038

20058

1.48

82.69

3.9

3.0

1.22

1.23

mmol/l

5.54

2710

17226

Pacemaker

1756

10624

1.69

82.65

4.9

3.9

1.22

1.23

mmol/l

8.26

1555

9137

Factors influencing health status and contact with health services

1662

4904

1.75

82.56

4.4

2.8

1.22

1.23

mmol/l

2.23

1466

4121

Glomerulonephritis

589

2575

2.51

82.29

14.7

3.8

1.22

mmol/l

1.49

563

2247

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1210

6821

1.87

82.09

4.1

3.9

1.22

1.23

mmol/l

5.33

1063

6006

Dental caries 1 and operation codes

4483

16831

1.40

81.67

4.3

3.6

1.23

mmol/l

0.52

3906

14758

Gastrointestinal diseases

3064

10469

1.50

81.57

4.2

2.9

1.23

mmol/l

3.83

2713

8889

Hydronephrosis

651

2981

2.38

81.24

8.1

3.0

1.22

1.23

mmol/l

2.61

602

2552

Other CVD (FINNGEN)

613

2104

2.47

81.08

6.3

2.9

1.22

1.23

mmol/l

8.27

549

1723

Other cataract

2178

10962

1.60

81.03

5.2

3.6

1.22

1.23

mmol/l

2.68

1868

9621

Pulmonary embolism

1533

9274

1.74

80.78

6.1

3.8

1.22

1.23

mmol/l

2.73

1429

7991

Implicit bacterial Sepsis

1996

11757

1.62

80.64

8.8

3.2

1.21

1.23

mmol/l

33.28

1850

10027

Dental pulpitis 2, only avohilmo

3773

13761

1.44

80.49

4.3

3.6

1.23

mmol/l

1.45

3266

12030

Pulmonary heart disease

1533

9292

1.74

80.19

6.1

3.8

1.22

1.23

mmol/l

2.63

1429

8013

Diseases of the skin and subcutaneous tissue

5253

19826

1.35

79.09

4.7

3.3

1.22

1.23

mmol/l

1.60

4624

17217

Other functional intestinal disorders

2296

14545

1.56

78.96

4.8

3.6

1.22

1.23

mmol/l

2.99

2019

12526

Dental operations

3401

12252

1.46

78.94

4.4

3.4

1.23

mmol/l

0.12

2965

10679

Diseases of liver

1674

10410

1.68

78.68

4.7

3.9

1.22

1.23

mmol/l

7.42

1540

9087

Fibromyalgia

507

2111

2.62

78.62

2.8

3.4

1.23

1.24

mmol/l

2.13

443

1824

In situ neoplasms

1653

9754

1.68

78.37

4.7

2.9

1.23

mmol/l

0.82

1420

8196

Erysipelas

2680

16792

1.50

78.03

5.6

3.2

1.22

1.23

mmol/l

16.26

2429

14411

Asthma, hospital admission 2, infections

2782

18947

1.49

78.03

4.1

3.8

1.22

1.23

mmol/l

6.92

2522

16404

Asthma-related infections

2782

18947

1.49

78.03

4.1

3.8

1.22

1.23

mmol/l

6.92

2522

16404

Hypopituitarism

389

1428

3.01

78.00

5.2

3.6

1.22

mmol/l

1.04

364

1252

2076

13462

1.58

77.48

4.1

3.7

1.22

1.23

mmol/l

6.00

1870

11647

Special screening examination for infectious and parasitic diseases

192

5083

0.27

77.45

3.7

3.3

1.22

mmol/l

0.08

160

4398

Mental and behavioural disorders due to psychoactive substance use

2756

17981

1.49

77.24

4.2

3.9

1.21

1.22

mmol/l

15.04

2430

15812

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

799

4011

2.11

76.90

4.4

3.6

1.21

1.23

mmol/l

6.26

699

3522

Diseases of oesophagus, stomach and duodenum

5262

24305

1.34

76.89

4.6

3.6

1.22

1.23

mmol/l

5.98

4731

21108

Anaemia in chronic diseases classified elsewhere

210

545

4.81

76.58

20.3

3.2

1.20

1.22

mmol/l

4.92

205

476

Asthma, including avohilmo

5770

25813

1.32

76.16

3.5

3.9

1.23

mmol/l

0.79

5117

22446

Other and unspecified nonorganic psychotic disorders

903

4744

2.00

75.87

3.7

3.8

1.23

mmol/l

0.10

793

4168

Benign neoplasms

3391

13587

1.44

75.72

4.5

2.9

1.22

mmol/l

0.19

3027

11551

Heart failure and bmi 25plus

1825

7964

1.66

75.60

6.4

3.8

1.21

1.23

mmol/l

34.43

1671

6882

Coagulation defects, purpura and other haemorrhagic conditions

988

5375

1.95

75.58

7.9

3.7

1.22

1.23

mmol/l

4.22

914

4697

Intestinal infectious diseases

4493

26232

1.36

74.97

5.7

3.5

1.22

1.23

mmol/l

13.33

4016

22771

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4736

23232

1.36

74.93

4.7

3.7

1.22

1.23

mmol/l

2.44

4208

20279

Dental caries 1

4065

15179

1.40

74.92

4.2

3.6

1.23

mmol/l

0.93

3523

13287

Dental caries, including avohilmo

4060

15166

1.40

74.74

4.2

3.6

1.23

mmol/l

0.91

3520

13276

Malignant neoplasm of endocrine gland

455

1858

2.73

74.71

7.7

3.6

1.21

1.23

mmol/l

11.52

426

1611

Complications of medical and surgical care

3519

24286

1.41

74.60

5.6

3.6

1.22

1.23

mmol/l

6.23

3224

21054

Any operation in hilmo

193

183

5.58

74.54

3.2

1.5

1.22

1.24

mmol/l

1.96

171

153

Noninfective enteritis and colitis

2192

14617

1.55

74.27

4.8

3.7

1.22

1.23

mmol/l

4.72

1977

12734

Dental caries 3

4245

15985

1.39

74.20

4.2

3.6

1.23

mmol/l

0.77

3675

13986

Diseases of the musculoskeletal system and connective tissue

2696

9172

1.51

73.75

4.0

3.3

1.22

mmol/l

0.03

2352

7927

Diseases of the digestive system

2252

15135

1.54

73.51

5.8

3.7

1.22

1.23

mmol/l

6.78

2034

13101

Dermatitis

2924

20685

1.45

73.32

4.9

3.7

1.23

mmol/l

0.14

2592

18017

Dental caries 3, only avohilmo

4311

16327

1.38

72.90

4.1

3.8

1.23

mmol/l

0.73

3722

14305

Haemorrhage from respiratory passages

1722

10170

1.63

72.25

4.9

3.7

1.22

1.23

mmol/l

8.38

1527

8758

Retention of urine

1694

9080

1.64

71.62

5.1

3.8

1.22

mmol/l

2.47

1485

7877

ILD medications: azathioprine

737

3694

2.11

71.41

7.6

3.1

1.22

1.23

mmol/l

1.22

695

3180

Sequelae with surgical and medical care as external cause

1061

6022

1.87

71.16

5.6

3.9

1.22

1.23

mmol/l

1.70

952

5244

Soft tissue disorders

5161

20461

1.33

70.97

3.9

3.7

1.22

1.23

mmol/l

2.46

4558

17757

Azathioprine

737

3708

2.10

70.67

7.6

3.5

1.22

1.23

mmol/l

0.99

695

3200

Coronary atherosclerosis

3331

15502

1.43

70.03

5.3

3.7

1.22

1.23

mmol/l

14.41

2930

13395

Hernia of abdominal wall, postoperative

888

4775

1.96

70.00

6.5

2.5

1.22

1.23

mmol/l

6.78

786

4026

Other systemic involvement of connective tissue

1438

8885

1.70

69.83

3.9

3.7

1.23

mmol/l

0.78

1281

7655

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

376

1448

2.88

69.19

7.8

2.8

1.20

1.23

mmol/l

12.58

350

1203

Purpura and other haemorrhagic conditions

716

3611

2.13

69.18

9.0

3.7

1.22

1.23

mmol/l

2.40

666

3151

2784

17620

1.45

68.88

4.5

3.9

1.21

1.22

mmol/l

16.87

2489

15481

Hypokalaemia

652

3191

2.21

68.68

5.7

3.2

1.22

1.23

mmol/l

6.68

610

2722

Cholecystectomy

3440

22302

1.40

68.60

3.9

3.7

1.23

mmol/l

1.90

3033

19405

Dental caries 1, only avohilmo

4097

15548

1.38

68.46

4.1

3.8

1.23

mmol/l

0.89

3546

13635

Diseases of pulp and periapical tissues

1640

10492

1.62

67.76

8.2

3.5

1.22

1.23

mmol/l

2.75

1526

9157

Poisoning by drugs, medicaments and biological substances

1084

6238

1.81

67.76

4.3

3.6

1.22

1.23

mmol/l

5.68

963

5493

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1401

5160

1.72

67.63

5.1

3.4

1.22

1.21

mmol/l

1.73

1233

4450

Exclusions for E4_PCOS_CONSORTIUM

3424

15611

1.41

67.59

3.9

3.4

1.23

mmol/l

0.11

2979

13615

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1288

7767

1.72

67.57

4.0

3.6

1.22

1.23

mmol/l

3.68

1111

6862

2652

17131

1.46

67.56

4.5

3.9

1.21

1.22

mmol/l

17.15

2365

15056

Emotional disorders starting during childhood or adolecense, excluding more controls

203

528

4.05

67.53

3.7

3.1

1.22

mmol/l

0.08

167

448

Arthropathies

4439

16991

1.35

67.26

3.9

3.6

1.23

mmol/l

0.09

3936

14727

Diseases of oral cavity, salivary glands and jaws

4624

17969

1.35

67.12

4.4

3.4

1.23

mmol/l

0.17

4077

15624

Poisoning by medicine

992

5582

1.86

67.08

4.2

3.6

1.22

1.23

mmol/l

6.45

878

4918

Disorders of adult personality and behaviour

1236

7402

1.73

66.54

3.6

1.22

1.23

mmol/l

2.77

1045

6537

ILD, hospital admission 2, with pulmonary infections

542

2504

2.36

66.53

5.7

3.4

1.21

1.23

mmol/l

4.57

509

2144

Personality disorders

1188

7047

1.75

66.38

3.6

3.7

1.22

1.23

mmol/l

1.64

1009

6236

Gout, FINNGEN

1424

8912

1.67

65.60

8.4

3.8

1.21

1.22

mmol/l

3.73

1303

7671

ILD, hospital admissions

802

4306

2.00

64.88

5.0

4.0

1.22

mmol/l

2.54

731

3749

Chronic periapical parodontitis

1025

5900

1.83

64.70

9.7

3.5

1.22

1.23

mmol/l

3.82

960

5150

Hypoparathyroidism

270

916

3.47

64.57

11.9

3.3

1.18

1.23

mmol/l

15.44

261

776

Diseases of the eye and adnexa

3904

14503

1.37

64.54

4.4

3.4

1.22

1.23

mmol/l

1.92

3436

12812

Mental and behavioural disorders due to alcohol

2316

15653

1.48

63.90

4.3

4.0

1.21

1.22

mmol/l

14.88

2054

13784

Examination and observation for other reasons

1467

13972

0.62

63.86

4.6

3.7

1.22

1.23

mmol/l

0.55

1341

11919

Other interstitial pulmonary diseases

810

4386

1.98

63.78

5.0

3.9

1.22

1.23

mmol/l

2.87

739

3816

Diseases of the respiratory system

3393

12369

1.40

63.71

4.2

3.1

1.23

mmol/l

5.00

3030

10551

Interstitial lung disease endpoints

810

4389

1.98

63.65

5.0

4.0

1.22

mmol/l

2.75

739

3817

Interstitial lung disease

810

4389

1.98

63.65

5.0

4.0

1.22

mmol/l

2.75

739

3817

Sarcoidosis

719

3742

2.06

63.56

4.5

3.9

1.23

mmol/l

1.08

666

3278

Other neurological diseases

3481

20784

1.38

63.29

4.0

3.8

1.22

1.23

mmol/l

2.91

3166

17979

Rheumatism, unspecified

792

4265

1.98

63.09

3.4

3.5

1.23

1.24

mmol/l

1.09

703

3656

Cystitis

4137

19124

1.35

63.08

4.1

3.5

1.23

mmol/l

1.86

3604

16634

Other dorsopathies, not elsewhere classified

4942

20129

1.32

62.75

3.8

1.23

mmol/l

0.25

4349

17532

Bipolar affective disorders

844

4615

1.91

62.63

4.0

3.6

1.23

mmol/l

2.86

737

4092

Conduction disorders

1460

7675

1.65

62.24

4.9

3.3

1.22

1.23

mmol/l

7.35

1313

6542

Substance abuse

2598

17676

1.44

62.18

4.2

4.0

1.21

1.22

mmol/l

14.67

2291

15546

Dorsopathies

5100

20201

1.31

61.81

3.7

3.8

1.23

mmol/l

0.08

4479

17601

Chronic pancreatitis

642

3244

2.13

61.81

6.6

4.0

1.21

1.22

mmol/l

5.22

606

2851

1492

8460

1.64

61.69

3.9

3.8

1.22

1.23

mmol/l

4.33

1225

7299

Hyperkinetic disorders, excluding more controls

345

1288

2.73

61.34

3.1

1.22

mmol/l

0.11

290

1133

Non-follicular lymphoma, hilmo, excluding all cancers

494

2270

2.36

61.28

10.6

3.1

1.23

mmol/l

0.33

482

1932

Rheumatoid arthritis

1638

9738

1.59

60.91

3.6

1.23

mmol/l

0.79

1510

8388

Meniscus derangement

2773

13608

1.43

60.81

3.8

3.7

1.23

mmol/l

0.19

2423

11842

Nerve, nerve root and plexus disorders

5099

25058

1.30

60.73

3.9

3.8

1.23

mmol/l

0.14

4519

21844

Falls/tendency to fall

5439

21355

1.30

60.64

4.1

3.6

1.22

1.23

mmol/l

4.38

4745

18666

Glaucoma

2746

17419

1.43

60.47

4.1

3.9

1.23

mmol/l

0.22

2354

15118

Unspecified kidney failure

533

2539

2.27

60.40

13.6

3.0

1.21

1.22

mmol/l

4.77

507

2175

Malignant neoplasm of thyroid gland

410

1761

2.58

60.29

7.6

3.5

1.20

1.23

mmol/l

14.14

382

1522

Lyme disease

343

8027

0.41

60.13

2.6

3.9

1.23

mmol/l

0.80

309

6995

Temporomandibular joint disorders

760

4076

1.95

60.04

3.2

3.4

1.23

mmol/l

0.11

677

3526

Sequelae of external causes of morbidity and mortality

1239

7671

1.69

59.76

5.5

3.8

1.22

1.23

mmol/l

1.73

1110

6675

External causes of morbidity and mortality

3459

12784

1.38

59.52

4.1

3.3

1.23

mmol/l

2.18

3040

11127

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

301

1128

3.03

59.29

11.5

2.9

1.22

1.23

mmol/l

0.33

288

946

Leisure time condition

870

4908

1.87

59.09

4.4

3.8

1.23

mmol/l

0.02

776

4284

Other spirochaetal diseases

354

8126

0.42

59.07

2.6

3.9

1.23

mmol/l

0.92

319

7086

Other and unspecified dermatitis

2378

16899

1.45

58.36

5.0

3.6

1.23

mmol/l

0.13

2116

14690

Other headache syndromes

1892

12883

1.51

58.13

3.4

3.7

1.23

mmol/l

3.01

1658

11184

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

702

3347

1.98

57.88

3.3

3.4

1.22

mmol/l

0.34

595

2893

Dental operations, only avohilmo

3535

13501

1.37

57.45

4.2

3.8

1.23

mmol/l

0.34

3082

11829

Other respiratory diseases principally affecting the interstitium

914

5291

1.83

57.35

5.8

3.9

1.22

mmol/l

4.25

834

4598

Other hearing loss

1409

8939

1.62

56.76

4.7

3.8

1.22

1.23

mmol/l

0.41

1162

7751

Alcohol use disorder, Swedish definition

2470

16439

1.43

56.69

4.5

4.0

1.21

1.22

mmol/l

14.91

2215

14460

Methotrexate

750

4098

1.93

56.60

3.2

3.4

1.23

mmol/l

0.13

693

3508

Dental caries

1146

6959

1.69

56.50

9.9

3.4

1.22

1.23

mmol/l

4.31

1065

6097

Outcome of delivery

2587

0.21

56.36

2.1

3.2

1.23

mmol/l

0.77

2237

malignant neoplasm of male genital organs

1863

7986

1.53

56.25

4.7

4.3

1.22

1.21

mmol/l

1.03

1635

7020

Other joint disorders

4156

16966

1.33

55.73

3.6

1.23

mmol/l

0.12

3631

14703

Post-traumatic stress disorder

359

1485

2.57

55.64

3.1

1.23

mmol/l

0.21

304

1299

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2590

15292

1.42

55.42

4.0

3.5

1.22

1.23

mmol/l

5.01

2221

13364

Other diseases of liver

871

5016

1.83

55.32

4.5

3.9

1.22

1.23

mmol/l

2.01

794

4401

Thyrotoxicosis, other and/or unspecified

947

5575

1.78

55.22

4.0

3.5

1.22

1.23

mmol/l

5.00

843

4852

Dizziness and giddiness

3545

21865

1.34

54.98

3.8

1.23

mmol/l

1.13

3105

19034

Asthma, hospital admissions , main diagnosis only

3814

26255

1.33

54.75

3.7

3.8

1.23

mmol/l

0.24

3408

22816

Migraine

2005

11810

1.48

54.75

3.1

3.6

1.23

mmol/l

2.92

1776

10281

ILD, hospital admissions 1, main diag only

702

3823

1.97

54.46

4.7

4.1

1.22

mmol/l

1.92

641

3337

Pleural effusion

788

4436

1.89

54.43

6.5

3.7

1.21

1.22

mmol/l

6.39

734

3827

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1322

4979

1.65

54.41

5.1

3.5

1.22

1.21

mmol/l

0.97

1158

4291

Volume depletion

492

2367

2.24

54.15

8.7

3.2

1.21

1.23

mmol/l

4.35

456

2027

Open wound of head

2348

16607

1.43

53.91

4.7

3.9

1.22

1.23

mmol/l

4.72

2043

14483

Acute upper respiratory infections

4984

24710

1.28

53.90

4.4

3.6

1.22

1.23

mmol/l

5.46

4425

21451

Other disorders of teeth and supporting structures

1023

6191

1.73

53.74

6.7

3.5

1.22

1.23

mmol/l

0.96

953

5381

Viral infections characterized by skin and mucous membrane lesions

1850

12744

1.49

53.64

6.6

3.7

1.22

1.23

mmol/l

2.74

1691

11096

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1972

13736

1.47

53.63

4.2

4.1

1.21

1.22

mmol/l

13.23

1751

12129

Suicide or other Intentional self-harm

1082

6632

1.69

53.59

4.3

3.7

1.22

1.23

mmol/l

3.58

947

5851

Symptoms and signs involving appearance and behaviour

173

7.40

53.51

4.5

3.3

1.21

1.22

mmol/l

1.03

151

Dentinal caries

1018

6119

1.72

53.36

9.9

3.4

1.22

1.23

mmol/l

3.77

949

5368

Carbimazole or st.post thyroidectomy, condition for graves disease

1003

6069

1.73

52.97

5.1

3.5

1.21

1.23

mmol/l

22.32

900

5295

Unspecified haematuria

1965

11731

1.48

52.96

5.8

3.8

1.22

mmol/l

2.51

1751

10199

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2422

11882

1.43

52.79

4.8

3.0

1.23

mmol/l

0.01

2095

10036

Alcohol use disorder, ICD-based

1829

12617

1.49

52.76

4.2

4.1

1.21

1.22

mmol/l

11.97

1626

11150

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

469

2250

2.28

52.71

5.9

3.7

1.22

1.23

mmol/l

1.17

430

1936

1082

6326

1.70

52.69

4.1

3.8

1.22

1.23

mmol/l

2.87

879

5443

Specific personality disorders

1002

6051

1.72

52.48

3.5

3.6

1.22

1.23

mmol/l

1.74

846

5341

Gingivitis and periodontal diseases

4435

17852

1.31

52.28

4.1

3.4

1.23

mmol/l

0.17

3879

15529

ILD, hospital admissions 3, with pneumonia sepsis

458

2183

2.29

52.21

5.9

3.4

1.21

1.23

mmol/l

3.56

433

1868

Sulfasalazine

1308

8447

1.60

52.01

3.4

1.23

mmol/l

0.39

1193

7269

Respiratory conditions due to other external agents

170

500

4.18

51.97

7.0

3.5

1.23

mmol/l

0.01

162

434

Other disorders of ear

4343

22668

1.30

51.84

4.4

3.8

1.23

mmol/l

0.07

3725

19903

Primary open-angle glaucoma, strict

1334

8689

1.60

51.69

4.1

3.9

1.23

mmol/l

0.20

1134

7446

Secondary uncertain malignant neoplasm

660

3580

1.97

51.60

7.7

3.9

1.23

1.22

mmol/l

1.38

634

3121

Sub-endpoint used in defining T1D endpoints

1346

8617

1.59

51.39

7.5

3.6

1.21

1.23

mmol/l

8.44

1188

7506

Benign neoplasm of other and unspecified endocrine glands

591

3090

2.03

51.29

4.0

3.0

1.23

mmol/l

0.17

547

2615

Degeneration of macula and posterior pole

2282

13570

1.43

50.81

4.1

3.8

1.22

1.23

mmol/l

4.48

1915

11773

Symptoms and signs concerning food and fluid intake

506

2511

2.14

50.75

5.2

3.1

1.22

1.23

mmol/l

2.22

441

2148

Gout, idiopatic and unspecified

1153

7309

1.65

50.66

8.0

3.9

1.21

1.22

mmol/l

4.76

1048

6362

Infections of the skin and subcutaneous tissue

2477

18071

1.40

50.25

6.0

3.7

1.22

1.23

mmol/l

3.15

2246

15786

Other noninfective gastroenteritis and colitis

1138

7185

1.65

50.08

5.9

3.7

1.22

1.23

mmol/l

5.10

1043

6256

Asthma/COPD (KELA code 203)

4419

24568

1.29

50.01

3.7

3.8

1.23

mmol/l

0.61

3896

21348

Gout, unspecified

971

5934

1.72

49.75

8.3

3.8

1.21

1.22

mmol/l

5.28

875

5160

KRA_PSY_EATING, excluding more controls

315

1284

2.57

49.64

3.6

2.7

1.22

1.23

mmol/l

0.38

270

1106

Other external causes of accidental injury

4189

16336

1.31

49.52

4.2

3.5

1.22

1.23

mmol/l

3.01

3666

14324

Accidents

4188

16336

1.31

49.42

4.2

3.5

1.22

1.23

mmol/l

2.76

3664

14324

Primary open-angle glaucoma

1585

10538

1.53

49.28

4.0

3.9

1.23

mmol/l

0.09

1351

9055

Acute sinusitis

2212

14867

1.42

48.97

4.4

3.5

1.22

1.23

mmol/l

6.73

1953

12983

Malignant neoplasm of prostate

1797

7829

1.50

48.63

4.7

4.3

1.22

1.21

mmol/l

0.67

1570

6881

Gout, strict definition

854

5080

1.78

48.63

8.5

3.9

1.21

1.22

mmol/l

3.61

775

4425

120

283

4.78

48.07

2.5

2.6

1.23

mmol/l

0.18

102

234

Abnormal findings on examination of blood, without diagnosis

2122

14345

1.42

47.22

5.3

4.0

1.22

mmol/l

0.13

1959

12479

Thyrotoxicosis

1192

7759

1.60

46.38

3.9

3.6

1.22

1.23

mmol/l

3.79

1053

6723

Viral hepatitis, IBD co-morbidity

222

790

2.97

46.35

4.5

3.0

1.21

1.23

mmol/l

2.85

198

680

Abnormal results of function studies

435

2124

2.20

46.14

4.8

3.8

1.22

1.23

mmol/l

1.62

385

1853

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2794

21076

1.35

45.93

5.5

3.6

1.22

1.23

mmol/l

5.87

2553

18228

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2173

10776

1.42

45.71

4.6

3.0

1.23

mmol/l

0.04

1867

9066

Cerebrovascular diseases

3487

19417

1.32

45.34

4.5

3.9

1.22

1.23

mmol/l

9.90

3164

16786

AV-block

864

4739

1.73

45.29

5.6

3.2

1.22

1.23

mmol/l

4.96

775

4012

Acute pancreatitis

911

5599

1.70

45.23

5.4

3.9

1.21

1.23

mmol/l

7.81

844

4865

Injury, poisoning and certain other consequences of external causes

2772

10342

1.37

45.13

4.0

3.4

1.23

mmol/l

1.09

2434

8967

Intestinal malabsorption

264

1058

2.76

45.12

7.2

3.4

1.22

1.23

mmol/l

2.60

237

901

Hyperkalaemia

311

1344

2.55

45.11

14.1

3.1

1.20

1.23

mmol/l

9.01

287

1147

Other diseases of hard tissues of teeth

2873

16217

1.35

45.06

4.8

3.4

1.23

mmol/l

0.98

2480

14150

Viral pneumonia

590

3221

1.93

44.74

7.4

3.3

1.21

1.23

mmol/l

8.77

553

2781

Diseases of the ear and mastoid process

5580

23010

1.24

44.74

4.0

3.7

1.23

mmol/l

0.73

4860

20150

Benign neoplasm: Pancreas

173

561

3.61

44.68

5.1

2.8

1.23

mmol/l

0.33

165

464

Multiple myeloma and malignant plasma cell neoplasms

264

1066

2.76

44.60

20.6

3.0

1.21

1.23

mmol/l

2.15

258

901

Ulcerative ileocolitis

237

904

2.90

44.59

4.5

3.7

1.22

1.23

mmol/l

2.15

212

782

Schizophrenia

720

4166

1.81

44.58

3.5

4.0

1.23

mmol/l

1.57

623

3689

Psoriatic and enteropathic arthropathies

566

3058

1.96

44.38

2.9

3.8

1.23

mmol/l

0.01

509

2663

Tracheo-bronchomalasia

11.65

44.17

3.0

2.7

1.23

1.24

mmol/l

0.40

Other diseases of blood and blood-forming organs

368

1720

2.33

44.13

4.0

3.7

1.22

1.23

mmol/l

0.45

320

1499

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

319

1395

2.44

44.01

3.6

1.21

1.23

mmol/l

2.64

279

1214

Stroke, including SAH

2976

16866

1.34

43.59

4.5

3.9

1.22

1.23

mmol/l

7.02

2707

14503

GI-bleeding

1481

10208

1.50

43.42

6.3

3.8

1.22

mmol/l

5.13

1349

8817

Disorders of eyelid, lacrimal system and orbit

3884

24155

1.28

43.21

4.0

3.8

1.23

mmol/l

1.23

3388

21086

Dental caries 2 and operation codes, only avohilmo

1990

16952

0.71

43.20

3.5

4.1

1.23

mmol/l

0.17

1695

14888

Diabetic retinopathy, excluding more controls

1300

4849

1.58

43.08

7.3

3.4

1.22

1.23

mmol/l

7.97

1120

4240

Biological medication for rheuma

673

3862

1.82

42.95

2.8

3.9

1.23

mmol/l

0.26

621

3398

L02BX Other hormone antagonists and related agents

306

1351

2.53

42.87

7.5

4.6

1.21

mmol/l

0.00

287

1200

Abnormal findings on diagnostic imaging of lung

2192

15770

1.39

42.78

5.1

3.8

1.22

1.23

mmol/l

0.55

2018

13617

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

548

2975

1.95

42.56

7.0

3.1

1.23

1.22

mmol/l

0.11

508

2521

Multiple myeloma, excluding all cancers (controls excluding all cancers)

261

1074

2.70

42.34

20.4

3.0

1.21

1.23

mmol/l

2.28

255

905

Inflammatory bowel disease

1363

9281

1.51

42.22

3.9

3.8

1.22

1.23

mmol/l

1.21

1216

8158

Gonarthrosis [arthrosis of knee](FG)

3536

16266

1.30

42.22

3.7

1.23

mmol/l

0.18

3110

14104

Dentofacial anomalies [including malocclusion]

1142

7409

1.57

42.13

4.1

3.2

1.23

mmol/l

0.21

1014

6474

Emotional disorders and disorders of social functioning with onset specific to childhood

214

777

2.89

42.03

4.0

3.3

1.22

1.23

mmol/l

0.26

177

663

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

204

741

3.02

41.92

9.4

3.4

1.22

1.23

mmol/l

2.45

189

662

Other complications of surgical and medical care, not elsewhere classified

481

2518

2.03

41.85

5.6

3.3

1.22

1.23

mmol/l

1.12

447

2165

Hypertrophy of (infrapatellar) fat pad

205

5.66

41.80

4.4

3.5

1.22

1.23

mmol/l

0.45

185

Other diseases of the digestive system

1466

10168

1.49

41.64

6.3

3.8

1.22

1.23

mmol/l

5.48

1328

8785

Other and unspecified effects of external causes

1144

7537

1.57

41.62

4.0

3.7

1.22

1.23

mmol/l

3.33

997

6624

Non-ischemic cardiomyopathy

1436

8116

1.51

41.52

5.7

3.5

1.21

1.23

mmol/l

24.46

1321

6900

Stroke, excluding SAH

2821

16058

1.34

41.31

4.5

3.9

1.22

1.23

mmol/l

5.72

2574

13781

Other respiratory disorders and diseases

959

6118

1.64

40.99

6.4

3.8

1.21

1.22

mmol/l

6.77

884

5284

Other diseases of the respiratory system

959

6118

1.64

40.99

6.4

3.8

1.21

1.22

mmol/l

6.77

884

5284

Diabetic nephropathy, excluding more controls

747

3727

1.77

40.96

15.3

3.4

1.20

1.23

mmol/l

19.10

684

3258

Substance use, excluding alcohol

811

4952

1.70

40.92

4.0

3.9

1.22

1.23

mmol/l

3.59

709

4388

Other diseases of biliary tract

450

2328

2.08

40.91

6.0

3.6

1.21

1.23

mmol/l

4.77

421

2000

Osteoporosis with pathological fracture (FG)

400

1998

2.19

40.78

6.2

3.3

1.24

mmol/l

0.00

379

1645

Other/unspecified dorsalgia

1694

12026

1.44

40.68

4.1

3.7

1.23

mmol/l

0.38

1463

10418

Behavioural syndromes associated with physiological disturbances and physical factors

1272

8598

1.52

40.57

4.2

3.6

1.22

1.23

mmol/l

1.41

1108

7564

Dissociative [conversion] disorders

207

772

2.93

40.46

3.7

3.0

1.23

mmol/l

0.58

184

673

Paralytic ileus and intestinal obstruction

1240

8376

1.53

40.44

5.1

3.6

1.22

1.23

mmol/l

7.57

1114

7184

Other CVD

919

5849

1.65

39.86

5.8

3.8

1.22

1.23

mmol/l

3.70

827

5045

Other disorders of white blood cells

304

1373

2.42

39.82

5.4

3.5

1.21

1.23

mmol/l

2.58

272

1184

Arthrosis

3382

14537

1.30

39.69

3.7

1.23

mmol/l

0.23

3014

12660

COPD (mode)

1450

7993

1.49

39.54

5.1

3.3

1.21

1.23

mmol/l

22.35

1316

6760

Other or unspecified ileus, impaction or obstruction

899

5696

1.65

39.52

5.0

3.7

1.22

1.23

mmol/l

6.22

804

4875

Coxibs

1451

5278

1.50

39.51

3.1

4.6

1.22

mmol/l

0.02

1263

4645

Secondary and unspecified malignant neoplasm of lymph nodes

433

2243

2.08

39.28

8.4

3.9

1.23

1.22

mmol/l

2.28

420

1948

Non-follicular lymphoma

494

2675

1.98

39.24

10.6

4.0

1.23

1.22

mmol/l

1.01

482

2352

Dermatitis and eczema

4972

26746

1.24

39.19

4.7

3.6

1.23

mmol/l

0.12

4392

23311

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

686

3931

1.76

38.93

7.6

3.9

1.23

mmol/l

0.11

649

3436

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

478

2558

1.98

38.91

7.1

3.1

1.23

1.22

mmol/l

0.21

446

2172

Emotionally unstable personality disorder

496

2671

1.94

38.87

3.5

3.3

1.23

mmol/l

0.35

420

2329

Tumor necrosis factor alpha inhibitors

603

3456

1.82

38.73

2.8

3.8

1.23

mmol/l

0.17

555

3037

Major coronary heart disease event

3334

17521

1.30

38.70

5.0

3.9

1.22

1.23

mmol/l

12.90

3041

15126

Acute pancreatitis (for exclusion)

911

5820

1.63

38.65

5.4

3.9

1.21

1.22

mmol/l

6.37

844

5075

Dysphagia

1107

7376

1.56

38.60

5.0

3.5

1.22

1.23

mmol/l

3.03

976

6337

Mixed and other personality disorders

365

1780

2.17

38.52

4.2

3.7

1.22

1.23

mmol/l

1.73

311

1564

Polyarthrosis

988

6169

1.60

38.43

3.9

3.6

1.23

mmol/l

0.85

862

5280

Myocarditis

216

842

2.74

38.21

4.7

3.0

1.22

1.23

mmol/l

1.39

200

713

Sensorineural hearing loss

3530

19638

1.28

38.11

4.3

3.8

1.23

mmol/l

0.50

3015

17208

Pain in joint

2517

12647

1.34

37.97

3.7

1.23

mmol/l

0.18

2231

10988

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1169

7636

1.53

37.90

4.6

3.1

1.22

1.23

mmol/l

1.31

1063

6428

Polycystic ovarian syndrome, consortium definition

3185

15044

1.30

37.77

3.5

3.3

1.23

mmol/l

0.52

2775

12959

IBD patients in KELA-register

963

6247

1.59

37.69

3.7

1.22

1.23

mmol/l

0.48

849

5512

Papillary adenocarcinoma of thyroid gland

286

1290

2.43

37.63

8.2

3.6

1.20

1.23

mmol/l

11.81

263

1112

Intestinal stricture

1396

9790

1.47

37.55

5.5

3.9

1.22

1.23

mmol/l

5.84

1260

8470

Insulin, fast-acting (human)

628

3675

1.78

37.33

8.3

3.4

1.22

1.23

mmol/l

3.76

555

3206

Respiratory insufficiency

409

2105

2.07

37.27

6.7

3.2

1.20

1.23

mmol/l

11.51

380

1770

Cough

1778

12442

1.40

37.25

4.1

3.5

1.23

mmol/l

1.85

1590

10752

In situ neoplasms

1653

11970

1.42

36.94

4.7

3.6

1.23

mmol/l

0.62

1420

10333

Disorders of sclera, cornea, iris and ciliary body

2334

17777

1.34

36.86

4.4

3.8

1.23

mmol/l

0.66

2081

15503

Nontoxic multinodular goitre

968

6346

1.59

36.86

4.7

3.6

1.22

1.24

mmol/l

7.76

867

5495

Collagenous colitis

447

2390

2.00

36.81

5.7

3.6

1.22

1.23

mmol/l

2.49

406

2064

Emotional disorders starting during childhood or adolescence

203

774

2.76

36.79

3.7

3.5

1.22

1.23

mmol/l

0.29

167

660

Conductive and sensorineural hearing loss

3673

20387

1.27

36.77

4.3

3.8

1.23

mmol/l

0.44

3138

17878

L01XE Protein kinase inhibitors

318

1516

2.30

36.73

9.3

3.8

1.22

1.23

mmol/l

0.37

308

1325

Rheumatoid arthritis, including avohilmo

1777

13029

1.40

36.70

3.5

3.7

1.23

mmol/l

0.19

1637

11250

Internal derangement of knee

1651

11908

1.42

36.61

4.0

3.7

1.23

mmol/l

0.13

1434

10365

Diffuse large B-cell lymphoma, helper endpoint

236

992

2.63

36.60

12.5

3.0

1.23

mmol/l

0.99

230

828

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

236

992

2.63

36.60

12.5

3.0

1.23

mmol/l

0.99

230

828

Delirium, not induced by alcohol and other psychoactive substances

534

3014

1.87

36.52

6.4

3.8

1.22

mmol/l

0.58

465

2638

Injuries to the thorax

1933

14363

1.38

36.30

4.7

3.9

1.22

1.23

mmol/l

3.68

1733

12488

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2557

19762

1.32

36.24

5.5

3.6

1.22

1.23

mmol/l

4.94

2338

17131

Other diseases of pancreas

381

1944

2.11

36.15

5.1

3.8

1.22

1.23

mmol/l

1.93

355

1690

Acute alcohol intoxication, ICD10

821

5191

1.64

36.12

4.7

4.0

1.20

1.22

mmol/l

10.81

734

4580

Hypertensive Renal Disease

198

768

2.84

36.09

17.2

3.0

1.21

1.22

mmol/l

1.31

182

658

Congenital malformations, deformations and chromosomal abnormalities

2390

17513

1.33

36.05

4.9

3.6

1.23

mmol/l

0.44

2141

15303

Brachial plexus disorders

421

2212

2.01

36.02

3.0

3.7

1.23

mmol/l

0.06

375

1939

Gastro-oesophageal reflux disease

3091

21647

1.29

35.98

4.2

3.7

1.23

mmol/l

0.87

2767

18799

Follicular lymphoma

228

951

2.65

35.97

8.1

2.9

1.23

mmol/l

0.93

219

799

Other disorders of skin and subcutaneous tissue

3074

22284

1.29

35.78

6.1

3.6

1.22

1.23

mmol/l

2.26

2766

19319

Lung diseases due to external agents

643

3846

1.75

35.73

5.7

4.0

1.22

mmol/l

1.73

588

3338

Malignant neoplasm of digestive organs

1734

12529

1.40

35.56

5.1

3.9

1.22

1.23

mmol/l

6.44

1596

10803

Acute and transient psychotic disorders

529

3000

1.85

35.41

4.0

3.9

1.23

mmol/l

0.59

476

2627

Congenital malformations of the urinary system

287

1325

2.33

35.32

13.2

3.6

1.23

mmol/l

0.13

277

1155

Injuries to the abdomen, lower back, lumbar spine and pelvis

1705

12397

1.40

35.28

4.7

3.7

1.22

1.23

mmol/l

5.46

1527

10727

1906

13373

1.38

35.26

4.6

3.8

1.23

mmol/l

0.53

1631

11537

5-aminosalicylic acid

864

5551

1.61

35.24

4.1

3.5

1.23

mmol/l

0.36

756

4830

Actinic keratosis

1771

12412

1.40

35.20

4.7

3.8

1.23

mmol/l

0.45

1514

10700

Phlebitis and thrombophlebitis (not including DVT)

1019

6818

1.55

34.99

5.6

3.7

1.22

1.23

mmol/l

1.68

907

5903

Inflammatory bowel disease, strict (require KELA)

963

6353

1.56

34.95

3.7

3.8

1.22

1.23

mmol/l

0.37

849

5620

Fibrosis and cirrhosis of liver

373

1914

2.10

34.88

5.1

3.9

1.21

1.23

mmol/l

4.70

357

1664

Panic disorder

559

3223

1.80

34.81

3.4

1.23

mmol/l

0.49

489

2812

Ischaemic Stroke, excluding all haemorrhages

2611

15325

1.32

34.80

4.4

4.0

1.22

1.23

mmol/l

4.68

2383

13156

Abnormal findings on diagnostic imaging of other body structures

605

3596

1.77

34.69

4.9

3.7

1.23

mmol/l

0.36

554

3114

Infective dermatitis

544

3136

1.83

34.67

4.6

3.7

1.23

1.22

mmol/l

0.26

477

2744

Noninfectious colitis NAS

611

3637

1.76

34.49

5.8

3.6

1.22

1.23

mmol/l

3.41

569

3149

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

195

5.22

34.46

6.4

2.5

1.20

1.23

mmol/l

2.48

166

Skin changes due to chronic exposure to nonionizing radiation

1801

12697

1.38

33.63

4.6

3.8

1.23

mmol/l

0.39

1538

10952

Crohn disease

560

3275

1.79

33.59

4.4

3.7

1.22

1.23

mmol/l

0.75

500

2865

Other diseases of pericardium

237

1037

2.50

33.47

9.5

3.5

1.21

1.23

mmol/l

2.69

225

898

Other viral diseases

1128

7725

1.49

33.39

6.6

3.6

1.22

1.23

mmol/l

0.51

1023

6782

Other necrotizing vasculopathies

369

1918

2.07

33.32

5.6

3.9

1.22

1.23

mmol/l

0.61

348

1666

Organic, including symptomatic, mental disorders

2276

12601

1.34

33.21

4.0

3.9

1.23

mmol/l

0.06

1908

10928

Seropositive rheumatoid arthritis

1182

8202

1.48

33.21

3.6

1.23

mmol/l

0.85

1097

6999

Arthropathic psoriasis

514

2952

1.83

33.20

3.0

4.0

1.23

mmol/l

0.28

468

2586

Thyrotoxicosis with diffuse goitre

618

3726

1.73

33.19

3.8

3.4

1.23

mmol/l

2.94

544

3267

Multiple myeloma and malignant plasma cell neoplasms

264

1219

2.39

33.14

20.6

3.8

1.21

1.22

mmol/l

1.66

258

1043

Psoriatic arthropathies

477

2680

1.87

33.14

2.9

3.8

1.23

mmol/l

0.08

436

2344

Hypotension

769

4907

1.64

33.13

5.9

3.8

1.21

1.22

mmol/l

4.40

686

4226

Pneumonia due to other infectious organisms, not elsewhere classified

184

722

2.83

33.06

9.7

3.2

1.22

mmol/l

1.29

170

609

Nonorganic sleeping disorders, excluding more controls

682

4206

1.67

33.03

4.1

3.5

1.22

1.23

mmol/l

2.46

604

3726

Other condition

598

3580

1.75

33.03

4.6

3.9

1.23

mmol/l

0.41

569

3133

Benign neoplasm: Pancreas

173

667

3.00

32.92

5.1

3.5

1.23

mmol/l

0.07

165

584

Artificial joint operation, meniscal resection

4179

22848

1.24

32.92

3.5

4.0

1.23

mmol/l

0.22

3664

19994

Cholangitis (primary sclerosing, PSC)

304

1478

2.21

32.86

5.7

3.5

1.22

1.23

mmol/l

1.04

291

1260

Benign neoplasms

4513

20785

1.23

32.83

4.5

3.6

1.22

mmol/l

0.84

4022

18085

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2048

10640

1.35

32.81

4.4

3.0

1.23

mmol/l

0.41

1750

8947

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2023

10522

1.36

32.78

4.3

3.0

1.23

mmol/l

0.45

1729

8851

Other disorders involving the immune mechanism, not elsewhere classified

173

661

2.91

32.73

15.3

3.9

1.22

1.23

mmol/l

0.39

168

576

Hyperplasia of prostate

1552

6371

1.42

32.62

4.4

4.5

1.22

1.21

mmol/l

0.76

1373

5658

Carrier of infectious disease

142

490

3.26

32.60

5.2

3.4

1.21

1.23

mmol/l

2.67

131

425

Parodontitis or operation codes

4043

24451

1.24

32.54

4.4

3.8

1.23

mmol/l

0.25

3606

21368

Early onset COPD, excluding more controls

864

5656

1.58

32.53

5.1

3.4

1.21

1.23

mmol/l

8.56

786

4824

Ulcerative colitis

1033

7025

1.51

32.42

4.1

3.7

1.22

1.23

mmol/l

0.87

925

6170

Coxarthrosis [arthrosis of hip](FG)

2468

13862

1.31

32.42

3.6

3.8

1.23

mmol/l

1.41

2170

11934

Polymyalgia rheumatica

661

4103

1.70

32.32

4.1

3.9

1.23

mmol/l

0.16

598

3533

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1044

4547

1.52

32.19

2.7

2.9

1.22

1.23

mmol/l

1.34

902

3954

Gonarthrosis

3002

13640

1.28

32.18

3.7

1.23

mmol/l

0.03

2639

11855

149

531

3.12

32.13

4.8

3.6

1.22

1.23

mmol/l

1.60

116

462

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

228

1001

2.50

32.06

6.6

2.9

1.23

1.22

mmol/l

0.53

211

836

Nonalcoholic fatty liver disease

414

2259

1.94

31.79

4.0

3.9

1.22

1.23

mmol/l

1.32

377

1980

Carcinoma in situ of skin of other and unspecified parts of face

378

2012

2.02

31.77

5.9

2.9

1.22

1.23

mmol/l

0.52

318

1694

Parodontitis

4031

24452

1.23

31.75

4.4

3.8

1.23

mmol/l

0.27

3597

21369

Benign neoplasm: Pituitary gland, craniopharyngeal duct

231

1018

2.44

31.72

3.7

2.8

1.23

mmol/l

0.00

210

844

Epilepsy

1271

8993

1.44

31.59

4.2

3.8

1.22

1.23

mmol/l

8.79

1159

7788

Eosinophilic disease (BM)

107

319

3.90

31.58

5.1

3.2

1.22

1.23

mmol/l

0.36

267

Other symptoms and signs involving the digestive system and abdomen

741

4730

1.63

31.54

4.9

3.4

1.23

1.24

mmol/l

0.72

658

4057

Psoriasis

1216

8591

1.46

31.32

3.8

1.23

mmol/l

0.12

1086

7540

Other specific joint derangements/joint disorders

3056

16356

1.27

31.24

3.7

3.6

1.23

mmol/l

0.55

2703

14203

Other obstetric conditions, not elsewhere classified

1066

4696

1.51

31.22

2.7

2.9

1.22

1.23

mmol/l

1.59

922

4093

Abnormal weight loss

424

2351

1.92

31.20

4.3

3.9

1.22

1.23

mmol/l

0.51

369

2043

Other necrotizing vasculopathies (FG)

318

1607

2.14

31.16

5.3

3.8

1.22

1.23

mmol/l

2.22

299

1376

Irritable bowel syndrome

1210

8550

1.46

31.05

3.3

3.4

1.23

mmol/l

1.55

1066

7368

Asthma-related pneumonia

1567

11545

1.39

31.04

4.8

3.8

1.22

1.23

mmol/l

8.40

1445

9935

Benign neoplasm of other and unspecified endocrine glands

591

3597

1.73

31.01

4.0

1.23

mmol/l

0.02

547

3144

Unspecified fall

2070

15762

1.33

31.00

4.3

3.8

1.22

1.23

mmol/l

4.65

1788

13689

Viral pneumonia (unknown virus, not influenza)

308

1537

2.13

30.85

8.1

3.7

1.21

1.23

mmol/l

6.17

294

1330

Seronegative rheumatoid arthritis

574

3471

1.74

30.80

3.5

3.7

1.23

mmol/l

0.11

530

2946

Parodontitis and operation codes

3786

24164

1.24

30.78

4.3

3.8

1.23

mmol/l

0.56

3373

21141

Colitis, primary sclerosing

228

4.40

30.77

5.1

3.2

1.22

1.23

mmol/l

1.11

205

Dental pulpitis 3

409

1572

1.93

30.70

3.9

3.1

1.22

mmol/l

2.05

344

1315

Cholangitis (primary sclerosing, PSC), with reimbursement 202

112

349

3.66

30.62

5.3

3.8

1.23

mmol/l

0.04

106

308

Asthma-related pneumonia or sepsis

1567

11571

1.39

30.59

4.8

3.8

1.22

1.23

mmol/l

8.51

1445

9959

Asthma, hospital admissions 3, pneumonia

1567

11571

1.39

30.59

4.8

3.8

1.22

1.23

mmol/l

8.51

1445

9959

Mental and behavioural disorders due to opioids

171

667

2.76

30.51

5.6

3.5

1.21

1.23

mmol/l

4.01

145

580

Disorders of ocular muscles, binocular movement, accommodation and refraction

1872

14079

1.34

30.42

4.5

3.7

1.23

mmol/l

0.02

1591

12326

Dermatographic urticaria

311

1566

2.11

30.39

4.0

3.3

1.23

mmol/l

0.02

268

1354

Chronic periodontitis, including avohilmo

4001

24454

1.23

30.37

4.4

3.8

1.23

mmol/l

0.30

3575

21366

Disturbance of activity and attention

332

1675

2.03

30.23

3.1

3.3

1.22

mmol/l

0.19

279

1448

Weight loss

456

2607

1.85

30.22

4.6

3.8

1.22

1.23

mmol/l

0.89

396

2268

Diseases of arteries, arterioles and capillaries

3012

18055

1.27

30.16

6.3

3.7

1.22

1.23

mmol/l

20.24

2714

15622

Paracetamol of NSAID medication

817

2621

1.60

30.14

4.0

3.6

1.22

1.23

mmol/l

0.09

708

2279

Iron deficiency anaemia secondary to blood loss (chronic)

737

4760

1.61

30.06

6.4

3.5

1.22

1.23

mmol/l

4.66

672

4101

Other special examinations and investigations of persons without complaint or reported diagnosis

3452

14134

1.25

29.95

4.0

3.7

1.23

mmol/l

0.13

3054

12046

Urolithiasis

1388

10114

1.41

29.86

4.2

4.1

1.23

1.22

mmol/l

4.99

1238

8858

Malnutrition

129

446

3.32

29.86

7.2

4.0

1.21

1.23

mmol/l

2.15

119

386

Coronary angioplasty

1730

9968

1.37

29.78

4.7

3.7

1.22

1.23

mmol/l

4.96

1604

8562

Undetermined asthma, excluding more controls

543

3252

1.74

29.73

3.7

3.0

1.23

mmol/l

2.96

487

2741

Attention to artificial openings

201

864

2.54

29.61

5.9

2.9

1.23

1.22

mmol/l

0.09

189

733

Benign neoplasm: Adrenal gland

326

1690

2.06

29.47

3.9

3.0

1.23

mmol/l

0.02

306

1427

Zoster [herpes zoster]

800

5303

1.57

29.01

5.8

3.7

1.23

mmol/l

0.43

731

4586

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

156

602

2.87

28.96

15.5

4.0

1.22

mmol/l

0.07

151

527

Non-invasive ventilation

272

5026

0.50

28.95

7.6

3.1

1.20

1.23

mmol/l

14.69

253

4277

Coxarthrosis

2274

12019

1.31

28.84

3.7

3.8

1.23

mmol/l

1.06

2000

10392

Other pleural conditions

471

2757

1.80

28.64

6.4

3.5

1.21

1.22

mmol/l

3.39

438

2389

Diseases of male genital organs

2099

8122

1.33

28.64

4.9

4.4

1.22

mmol/l

0.33

1862

7242

Alcohol dependence

1099

7762

1.45

28.29

4.5

4.1

1.21

1.22

mmol/l

6.54

985

6859

Transient ischemic attack

2368

15485

1.29

28.26

3.7

3.9

1.23

mmol/l

1.03

2173

13275

Maternal care for other conditions predominantly related to pregnancy

731

4688

1.58

28.25

2.7

3.2

1.23

mmol/l

0.56

640

4143

Diabetic retinopathy, strict definition

842

4980

1.56

28.25

8.6

4.2

1.21

1.22

mmol/l

5.79

725

4436

Dental pulpitis 3, only avohilmo

375

1465

1.92

28.11

3.7

3.2

1.22

mmol/l

1.94

314

1221

Dementia, including avohilmo

2022

10772

1.33

28.04

3.3

4.0

1.23

mmol/l

0.43

1684

9316

Obesity, other/unspecified

1305

9500

1.41

27.99

4.1

3.5

1.22

1.23

mmol/l

5.47

1143

8322

Other psoriatic arthropathies

453

2642

1.80

27.81

2.8

4.1

1.23

mmol/l

0.16

414

2314

Disorders of refraction and accommodation

1023

7123

1.47

27.79

4.7

3.7

1.23

mmol/l

0.41

846

6264

Undetermined asthma

543

3317

1.70

27.60

3.7

3.1

1.23

mmol/l

2.28

487

2821

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

402

2279

1.86

27.31

6.3

3.5

1.23

mmol/l

0.66

373

1966

Ulcerative colitis (strict) with PSC

122

5.68

27.30

4.9

3.3

1.22

1.23

mmol/l

0.96

111

Psychotic depression

257

1252

2.16

27.23

4.2

3.5

1.22

1.23

mmol/l

1.15

215

1113

Alcohol abuse, main dg, excluding more controls

558

3444

1.67

27.14

4.7

3.9

1.21

1.22

mmol/l

8.05

504

3076

Psoriatic arthropathies, ICD10

462

2728

1.78

27.13

2.9

4.1

1.23

mmol/l

0.15

423

2388

Iridocyclitis

963

6703

1.48

27.07

4.1

3.8

1.23

mmol/l

0.37

859

5881

Phobic anxiety disorders

457

2674

1.76

27.02

3.8

3.4

1.22

1.23

mmol/l

0.72

377

2349

Other specified and unspecified personality disorders

382

2134

1.87

27.00

3.9

3.7

1.22

1.23

mmol/l

1.86

333

1861

Coronary revascularization (ANGIO or CABG)

2084

11327

1.31

26.90

4.9

3.8

1.22

1.23

mmol/l

5.10

1908

9742

Calculus of kidney and ureter

1274

9317

1.41

26.89

4.2

4.1

1.23

1.22

mmol/l

4.31

1139

8157

Papulosquamous disorders

1662

12643

1.35

26.86

3.7

3.8

1.23

mmol/l

0.78

1479

11043

Acute peritonitis

310

1633

2.03

26.86

14.3

3.9

1.21

1.22

mmol/l

2.02

294

1418

Nontoxic goitre/thyroid nodule

1364

10108

1.39

26.69

4.3

3.6

1.23

mmol/l

5.38

1224

8725

Statin medication

3127

14248

1.25

26.62

4.4

3.5

1.23

mmol/l

2.93

2771

12511

Diabetic nephropathy

750

4948

1.57

26.60

15.2

3.8

1.20

1.22

mmol/l

13.24

685

4350

Varicose veins

2890

17713

1.25

26.57

4.0

3.7

1.23

mmol/l

1.06

2537

15369

Sicca syndrome [Sjögren]

421

2446

1.82

26.51

3.7

1.23

1.24

mmol/l

1.27

364

2122

Mental and behavioural disorders due to sedatives or hypnotics

295

1529

2.04

26.49

4.5

3.7

1.21

1.23

mmol/l

3.27

249

1334

Other and unspecified drugs and medicaments

382

2157

1.87

26.42

6.4

3.6

1.22

1.23

mmol/l

0.25

356

1870

IBD (strict) with PSC

154

4.93

26.38

5.7

3.2

1.22

1.23

mmol/l

1.19

138

Leiomyoma of uterus

1856

7989

1.33

26.37

3.5

2.7

1.24

1.23

mmol/l

0.82

1605

6786

Eosinophilia

107

358

3.45

26.31

5.1

3.1

1.22

1.23

mmol/l

0.49

315

Hyperkinetic disorders

346

1856

1.90

26.26

3.1

3.3

1.22

mmol/l

0.25

291

1606

Benign paroxysmal vertigo

1271

9348

1.40

26.11

3.9

3.8

1.23

mmol/l

0.59

1100

8096

Combinations of oral blood glucose lowering drugs

1186

8632

1.41

25.89

3.8

4.0

1.22

1.23

mmol/l

1.99

1050

7521

Urticaria and erythema

1454

10899

1.36

25.87

4.6

3.6

1.23

mmol/l

1.67

1263

9522

Continuous positive airway pressure

247

4165

0.50

25.81

4.6

3.3

1.23

mmol/l

0.24

231

3537

Schizoaffective disorder

330

1792

1.94

25.70

3.7

1.24

1.23

mmol/l

2.06

293

1573

Adalimumab

365

2044

1.87

25.66

2.8

3.8

1.23

mmol/l

0.17

331

1784

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

776

5240

1.53

25.60

4.3

3.1

1.22

1.23

mmol/l

0.83

713

4386

Faecal incontinence

441

2623

1.78

25.50

3.7

3.2

1.23

1.24

mmol/l

2.08

372

2235

Dementia in Alzheimer disease

803

4657

1.53

25.48

3.3

3.6

1.23

1.22

mmol/l

0.84

615

4029

Injuries to the elbow and forearm

2934

21674

1.24

25.46

4.2

3.7

1.23

mmol/l

0.76

2539

18879

Ulcerative colitis (strict definition, require KELA)

669

4378

1.58

25.46

3.9

1.22

1.23

mmol/l

0.41

595

3859

Other and unspecified tonsillitis

1137

6938

1.41

25.32

4.3

3.5

1.22

mmol/l

1.27

990

6099

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

514

3179

1.69

25.24

5.9

3.1

1.22

mmol/l

0.19

451

2653

Diffuse large B-cell lymphoma

236

1162

2.22

25.20

12.5

3.8

1.23

1.22

mmol/l

1.66

230

1002

Acute and subacute iridocyclitis

813

5559

1.51

25.17

4.3

3.9

1.23

mmol/l

0.84

723

4885

Other disorders of glucose regulation and pancreatic internal secretion

365

2060

1.86

25.11

7.7

3.7

1.21

1.23

mmol/l

4.19

326

1789

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

645

4203

1.59

25.04

3.9

1.22

1.23

mmol/l

0.42

575

3702

Follicular lymphoma, hilmo

228

1112

2.24

24.97

8.1

4.0

1.23

1.22

mmol/l

1.63

219

964

Testicular hypofunction

145

579

2.72

24.92

5.8

4.0

1.21

1.22

mmol/l

0.57

129

522

Persons encountering health services for specific procedures, not carried out

321

1749

1.93

24.74

5.9

2.7

1.21

1.23

mmol/l

6.88

281

1493

Injuries to the hip and thigh

2002

14413

1.30

24.73

4.3

3.8

1.22

1.23

mmol/l

1.25

1776

12466

Diabetic retinopathy

1549

7412

1.36

24.70

7.0

4.2

1.21

1.22

mmol/l

5.82

1331

6584

Benign neoplasm of other and ill-defined parts of digestive system

704

4698

1.55

24.67

4.8

2.9

1.23

mmol/l

0.48

641

3934

Migraine with aura

857

5926

1.48

24.58

3.3

3.4

1.23

mmol/l

1.82

783

5157

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

192

876

2.37

24.57

8.6

3.0

1.23

1.22

mmol/l

0.39

186

736

Eating disorder

315

1700

1.92

24.57

3.6

2.7

1.22

1.23

mmol/l

0.43

270

1440

Streptococcal septicaemia

369

2109

1.84

24.43

9.8

3.1

1.21

1.23

mmol/l

3.33

343

1802

Other ulcerative colitis

258

1316

2.08

24.39

5.2

3.5

1.23

mmol/l

0.01

239

1138

Crohn's disease NAS

282

1485

2.00

24.22

4.3

3.5

1.22

1.23

mmol/l

0.52

254

1294

Maltreatment syndromes

208

979

2.24

24.20

3.5

3.2

1.22

1.23

mmol/l

2.16

182

848

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

776

5300

1.51

24.18

4.7

3.1

1.22

1.23

mmol/l

1.67

701

4458

Glaucoma suspect

1561

11966

1.34

24.14

3.9

3.8

1.23

mmol/l

0.21

1308

10387

Fluid overload

9.22

24.13

41.9

2.7

1.18

1.22

mmol/l

2.09

Fracture of rib(s), sternum and thoracic spine

1229

9097

1.39

24.09

4.3

3.9

1.22

1.23

mmol/l

3.96

1098

7923

Other eating disorders

197

908

2.28

24.07

3.8

2.7

1.22

1.23

mmol/l

0.83

171

769

Abnormal findings on diagnostic imaging of central nervous system

211

1010

2.24

23.89

3.8

3.6

1.22

1.23

mmol/l

0.80

196

864

Mouth breathing

1605

12337

1.33

23.85

4.0

4.1

1.22

1.23

mmol/l

0.24

1370

10917

Myeloproliferative diseases

397

2344

1.79

23.68

3.3

3.9

1.22

1.23

mmol/l

2.38

344

2038

Wet age-related macular degeneration

787

5327

1.51

23.67

3.3

3.8

1.22

1.23

mmol/l

2.54

647

4575

Other specified disorders of kidney and ureter

176

790

2.44

23.67

10.5

3.7

1.22

1.23

mmol/l

0.27

158

688

Vitreous haemorrhage

447

2723

1.72

23.53

8.6

4.1

1.22

1.23

mmol/l

2.10

401

2378

Cutaneous abscess, furuncle and carbuncle

990

7096

1.43

23.51

6.2

3.6

1.22

1.23

mmol/l

4.03

900

6237

Artrosis, including avohilmo

3851

17738

1.21

23.50

3.5

4.0

1.23

mmol/l

0.11

3402

15591

Secondary polycythaemia

129

505

2.84

23.47

3.7

3.8

1.22

mmol/l

0.17

116

448

Testicular dysfunction

153

644

2.55

23.45

5.7

3.9

1.21

1.22

mmol/l

0.67

136

584

Temporomandibular joint disorders, including avohilmo

1582

12147

1.32

23.43

3.0

3.5

1.23

mmol/l

0.26

1367

10590

Type 1 diabetes, definitions combined

356

2020

1.82

23.41

4.1

3.3

1.22

1.23

mmol/l

0.69

302

1757

Injuries to the ankle and foot

2716

20234

1.24

23.39

4.1

3.8

1.22

1.23

mmol/l

2.15

2361

17734

Other embolism and thrombosis

566

3652

1.61

23.30

6.6

3.6

1.22

1.23

mmol/l

2.41

512

3174

Colitis, primary sclerosing, strict definition

174

4.36

23.24

4.5

3.5

1.21

1.23

mmol/l

2.20

158

Eating disorders

383

2230

1.78

23.21

3.7

3.0

1.22

1.23

mmol/l

0.52

326

1903

Other and unspecified disorders of white blood cells

204

979

2.26

23.15

5.6

3.6

1.21

1.23

mmol/l

2.69

183

842

Cardiomyopathy

727

4945

1.52

23.14

5.3

3.4

1.21

1.23

mmol/l

11.12

671

4244

Deposits [accretions] on teeth

286

1479

1.96

23.13

15.6

3.4

1.22

1.23

mmol/l

1.34

273

1303

Molar incisor enamel hypoplasia, with caries

7.38

23.09

20.7

7.5

1.24

1.23

mmol/l

0.40

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

596

3901

1.59

23.04

5.4

4.2

1.20

1.22

mmol/l

9.51

561

3440

Acute alcohol intoxication

1005

7250

1.42

22.97

4.8

4.0

1.21

1.22

mmol/l

10.17

901

6367

Type 1 diabetes, strict (exclude DM2)

354

2019

1.81

22.90

4.2

3.4

1.22

1.23

mmol/l

0.67

301

1755

Other and unspecified glaucoma

332

1884

1.87

22.83

4.1

3.5

1.23

mmol/l

0.25

298

1620

Other and unspecified vasculitis limited to skin

135

549

2.74

22.82

5.4

3.6

1.22

1.23

mmol/l

0.73

123

475

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

710

4815

1.52

22.82

3.8

3.9

1.22

1.23

mmol/l

0.74

627

4235

All influenza

1004

7251

1.42

22.82

6.5

3.4

1.22

1.23

mmol/l

4.15

931

6240

Adverse effects, not elsewhere classified

776

5360

1.49

22.74

4.1

3.7

1.22

1.23

mmol/l

1.61

673

4679

Abnormal findings on examination of urine, without diagnosis

210

1026

2.20

22.62

10.3

3.8

1.22

mmol/l

0.03

198

887

Other infectious diseases

355

2058

1.82

22.48

8.3

3.7

1.22

mmol/l

0.34

336

1775

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

149

636

2.56

22.46

5.6

2.8

1.21

1.22

mmol/l

1.48

144

531

Anterior Iridocyclitis

847

5970

1.46

22.37

4.3

3.9

1.23

mmol/l

0.77

754

5251

Ovarian cyst

1597

7084

1.33

22.35

3.5

3.3

1.23

mmol/l

0.43

1394

6120

L02BB Anti-androgens

398

2386

1.76

22.34

7.1

4.2

1.21

mmol/l

0.46

371

2085

Use of pramipexole

949

6836

1.43

22.30

4.7

3.9

1.23

mmol/l

0.93

805

5942

Other degenerative diseases of the nervous system

1180

6618

1.38

22.29

3.6

1.23

mmol/l

0.79

966

5651

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

949

6555

1.43

22.25

3.4

2.8

1.24

mmol/l

0.61

852

5463

Fungal Sepsis

189

896

2.29

22.21

11.6

3.2

1.21

1.23

mmol/l

2.63

172

768

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

264

1404

1.99

22.15

5.1

3.1

1.21

1.22

mmol/l

2.76

245

1189

COPD

1953

12794

1.28

22.14

4.8

4.0

1.21

1.23

mmol/l

15.19

1764

11027

Chronic diseases of tonsils and adenoids

2390

18606

0.80

22.08

3.7

3.9

1.23

mmol/l

0.43

2113

16262

Carcinoma in situ of skin of other and unspecified parts of face

378

2251

1.79

22.05

5.9

3.5

1.22

1.23

mmol/l

0.32

318

1929

Mental and behavioural disorders due to use of other stimulants, including caffeine

118

451

2.80

22.01

3.4

3.5

1.20

1.23

mmol/l

3.22

105

395

Asthma mixed form (mode), excluding more controls

243

1257

2.03

21.96

3.5

3.1

1.23

mmol/l

0.16

227

1051

Clear cell adenocarcinoma of kidney

228

1167

2.12

21.89

6.6

4.1

1.23

1.22

mmol/l

0.96

211

1023

Normotensive glaucoma

409

2494

1.74

21.82

4.1

3.7

1.23

mmol/l

0.08

339

2142

Benign neoplasm of thyroid gland

158

700

2.45

21.78

4.3

2.5

1.22

1.23

mmol/l

1.22

143

582

Hypoglycaemia, other or unspecified

290

1599

1.91

21.67

7.7

3.8

1.21

1.22

mmol/l

2.74

259

1380

Myeloproliferative diseases (CML excluded)

358

2110

1.80

21.57

3.2

3.9

1.22

1.23

mmol/l

1.64

307

1829

Other abnormal uterine and vaginal bleeding

1052

5480

1.41

21.50

3.3

3.4

1.24

mmol/l

0.42

910

4715

Pleural plaque

437

2712

1.69

21.48

3.6

3.9

1.21

1.22

mmol/l

3.04

379

2341

Hyperfunction of pituitary gland

209

1035

2.14

21.46

4.7

2.8

1.23

mmol/l

0.32

186

885

Spinal stenosis

2259

14339

1.26

21.35

3.8

3.9

1.23

mmol/l

1.26

1975

12445

Speech therapy

1149

8586

1.37

21.31

3.2

3.9

1.24

1.23

mmol/l

10.52

1107

7457

Disorders of lacrimal system

1772

14028

1.29

21.21

4.2

3.7

1.23

mmol/l

1.43

1543

12177

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1158

8674

1.37

21.19

3.6

3.8

1.23

mmol/l

1.12

1076

7495

Excessive, frequent and irregular menstruation

1688

7303

1.31

21.10

3.4

3.3

1.23

mmol/l

0.51

1476

6290

Other Crohn's disease

284

1567

1.90

21.09

4.7

3.4

1.23

mmol/l

0.33

242

1360

Elevated blood glucose level

354

2087

1.78

21.08

6.1

3.8

1.22

1.23

mmol/l

1.17

324

1804

Explicit bacterial Sepsis

423

2608

1.69

21.05

9.3

3.1

1.21

1.23

mmol/l

3.98

393

2240

Isolated proteinuria

148

650

2.49

20.95

11.9

3.7

1.22

mmol/l

0.07

141

557

Protozoal diseases

145

633

2.52

20.94

10.6

3.7

1.21

1.23

mmol/l

2.09

136

542

Ulcerative colitis, NAS

551

3615

1.57

20.89

4.6

3.7

1.22

1.23

mmol/l

1.45

494

3154

Migraine without aura

658

4465

1.51

20.85

3.3

3.4

1.23

mmol/l

1.74

589

3897

Etanercept

265

1439

1.94

20.83

2.8

3.6

1.23

mmol/l

0.10

246

1251

Malignant neoplasm of skin

2742

17097

1.23

20.77

4.4

3.8

1.23

mmol/l

0.46

2368

14810

Viral and other specified intestinal infections

730

4936

1.47

20.76

6.8

3.2

1.22

1.23

mmol/l

2.02

666

4234

Endocarditis

168

780

2.32

20.67

10.7

3.4

1.21

1.23

mmol/l

2.88

157

671

Total colectomy operation

193

945

2.19

20.67

6.2

3.7

1.22

1.23

mmol/l

0.70

175

819

Total colectomy

193

945

2.19

20.67

6.2

3.7

1.22

1.23

mmol/l

0.70

175

819

Impingement syndrome of shoulder

507

7707

0.64

20.65

4.0

3.9

1.23

mmol/l

0.45

460

6759

Other/unspecified seropositive rheumatoid arthritis

1171

8820

1.36

20.63

3.6

3.8

1.23

mmol/l

1.08

1087

7615

Generalized anxiety disorder

512

3306

1.59

20.59

3.3

3.4

1.23

mmol/l

0.65

428

2898

Seropositive rheumatoid arthritis, wide

1182

8923

1.36

20.51

3.6

3.8

1.23

mmol/l

1.12

1097

7703

Disorders of skin appendages

1832

14590

1.28

20.49

4.9

3.6

1.23

mmol/l

0.18

1617

12751

Colectomy operation

726

5068

1.48

20.48

4.9

3.9

1.22

1.23

mmol/l

1.24

663

4405

Cellulitis

855

6129

1.43

20.48

6.9

3.6

1.22

1.23

mmol/l

3.18

782

5360

Arthropathies in other diseases classified elsewhere

176

836

2.27

20.48

11.6

3.5

1.21

1.23

mmol/l

1.89

162

718

Iron deficiency

102

378

2.94

20.45

2.4

3.0

1.21

1.23

mmol/l

3.94

319

Transport accidents

1848

13044

1.27

20.41

3.6

1.23

mmol/l

1.03

1660

11455

Cirrhosis of liver, NAS

234

1239

2.03

20.23

5.8

4.1

1.20

1.22

mmol/l

5.60

225

1081

Alzheimer’s disease (Atypical or mixed), excluding more controls

362

1867

1.76

20.23

3.5

1.23

1.22

mmol/l

0.90

279

1590

Asthma mixed form (mode)

243

1294

1.97

20.20

3.5

3.2

1.23

mmol/l

0.43

227

1092

Other disorders starting during childhood or adolecense, excluding more controls

133

535

2.49

20.18

5.0

3.4

1.22

1.23

mmol/l

0.27

118

464

Injuries to the shoulder and upper arm

3543

25240

1.19

20.14

4.1

3.8

1.23

mmol/l

1.22

3110

22036

Vasculitis limited to skin, not elsewhere classified

142

626

2.50

20.11

5.4

3.5

1.22

1.23

mmol/l

0.88

129

541

Diseases of peritoneum

442

2797

1.65

19.95

11.3

3.9

1.22

1.23

mmol/l

2.27

405

2439

Traumatic subdural haemorrhage

548

3570

1.56

19.95

4.8

3.7

1.21

1.22

mmol/l

4.39

483

3064

Radiculopathy

736

5171

1.47

19.94

3.8

1.22

1.23

mmol/l

1.11

621

4468

Sleep disorders

807

5753

1.44

19.88

4.2

3.7

1.22

1.23

mmol/l

2.00

715

5061

Assault

459

2919

1.62

19.85

4.6

3.9

1.22

1.23

mmol/l

1.34

406

2577

Intentional self-harm by sharp object

109

423

2.77

19.83

4.1

3.0

1.22

1.23

mmol/l

0.40

368

Haemorrhage, not elsewhere classified

175

841

2.24

19.76

6.9

2.8

1.21

1.23

mmol/l

1.89

160

708

Pain and other conditions associated with female genital organs and menstrual cycle

745

5016

1.46

19.76

2.6

3.2

1.23

mmol/l

0.12

635

4351

Other (seronegative) rheumatoid arthritis, wide

835

6014

1.43

19.69

3.9

3.8

1.23

mmol/l

0.29

767

5208

Childhood asthma (age<16), excluding more controls

383

1826

1.70

19.69

3.0

2.7

1.23

mmol/l

0.02

334

1558

Emphysema

311

1805

1.81

19.68

4.3

4.1

1.22

mmol/l

0.60

270

1564

Carcinoma in situ of skin

337

2003

1.78

19.68

6.4

3.1

1.22

1.23

mmol/l

0.94

294

1683

Mucosal proctocolitis

482

3113

1.60

19.62

3.5

3.8

1.22

1.23

mmol/l

0.72

434

2711

Other disorders of lacrimal gland

1416

11026

1.31

19.48

4.4

3.7

1.23

mmol/l

1.68

1233

9601

FESS (DNB20)

502

3283

1.59

19.47

3.9

4.0

1.23

mmol/l

0.24

428

2882

Melanocytic naevi, other sites/unspecified

289

1642

1.84

19.46

6.6

2.8

1.23

mmol/l

0.02

258

1384

Graves disease, strict definition

403

2509

1.67

19.37

3.8

3.5

1.22

1.23

mmol/l

1.72

357

2188

Malignant neoplasm of urinary organs

431

2738

1.65

19.27

7.4

4.0

1.23

1.22

mmol/l

0.35

400

2384

Aortic aneurysm

964

7000

1.39

19.25

5.2

3.7

1.21

1.22

mmol/l

3.81

865

6095

Implicit fungal Sepsis

167

799

2.26

19.21

12.6

3.3

1.21

1.23

mmol/l

2.72

154

686

Other and unspecified myopathies

368

2253

1.71

19.12

6.0

3.9

1.21

1.22

mmol/l

2.98

332

1964

Benign neoplasm: Pituitary gland, craniopharyngeal duct

231

1238

1.98

19.11

3.7

3.6

1.23

mmol/l

0.02

210

1074

Childhood asthma (age<16)

383

1842

1.68

19.10

3.0

2.7

1.23

1.22

mmol/l

0.04

334

1574

Benign neoplasm of colon, rectum, anus and anal canal

2098

12164

1.25

19.09

4.7

3.0

1.23

mmol/l

1.14

1893

10271

Other obstructive and reflux uropathy

195

987

2.09

18.97

9.0

2.7

1.22

1.23

mmol/l

0.15

174

833

Crystal arthropathies, rheuma endpoint

109

439

2.79

18.96

4.8

3.5

1.22

1.23

mmol/l

0.36

100

369

Other follicular disorders

281

1598

1.84

18.93

5.7

3.5

1.23

mmol/l

0.07

252

1391

Disorders of tooth development and eruption

181

862

2.13

18.93

10.9

3.4

1.23

mmol/l

0.21

171

756

Nontoxic single thyroid nodule

326

1940

1.77

18.90

4.3

3.5

1.23

mmol/l

0.02

298

1678

Mixed disorders of conduct and emotions, excluding more controls

237

3.29

18.83

3.8

2.5

1.22

mmol/l

0.19

203

Other chronic obstructive pulmonary disease, including avohilmo

2282

15625

1.24

18.70

4.6

3.9

1.21

1.23

mmol/l

14.43

2051

13522

Valvular operations

596

4082

1.51

18.51

4.6

3.4

1.21

1.23

mmol/l

8.10

534

3490

Chronic myeloproliferative disease

307

3.19

18.45

3.7

3.8

1.20

1.23

mmol/l

3.12

262

Fall on same level involving ice and snow

2317

19157

1.23

18.44

4.1

3.8

1.23

mmol/l

0.83

2037

16677

Other specified/unspecified inflammatory spondylopathies

204

1058

2.03

18.44

4.4

3.3

1.22

1.23

mmol/l

0.51

187

916

Ethmoidectomy

515

3434

1.55

18.27

3.8

4.0

1.23

mmol/l

0.14

438

3019

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

952

6981

1.37

18.23

4.6

3.4

1.23

mmol/l

0.02

820

6127

Crohn's disease of small intestine

275

1572

1.83

18.23

4.7

3.3

1.23

mmol/l

0.33

250

1370

Other crystal arthropathies

109

449

2.72

18.12

4.8

3.3

1.22

1.23

mmol/l

0.25

100

375

Unspecified nephritic syndrome

120

514

2.56

18.11

10.4

3.6

1.22

1.23

mmol/l

1.13

113

446

Diseases of the myoneural junction and muscle

495

3284

1.57

18.11

5.7

3.8

1.21

1.23

mmol/l

3.00

444

2867

1998

0.36

18.03

5.1

4.3

1.17

1.22

mmol/l

7.06

1767

Carcinoma in situ of skin, other sites/unspecified

256

3.38

18.00

8.5

2.9

1.23

1.22

mmol/l

0.19

212

Polyglandular dysfunction

8.66

17.99

17.2

3.1

1.21

1.23

mmol/l

0.61

Personal history of certain other diseases

306

3.01

17.97

4.3

2.8

1.21

1.23

mmol/l

1.82

257

Other problems related to primary support group, including family circumstances

394

2412

1.64

17.96

5.9

3.4

1.23

mmol/l

0.07

348

2096

Haemorrhage in early pregnancy

1015

7440

1.36

17.93

3.0

3.3

1.23

mmol/l

0.57

874

6519

Hypoplasia of dental enamel, including avohilmo

5.65

17.92

24.6

8.3

1.24

mmol/l

0.34

Injuries to the knee and lower leg

5222

26260

1.15

17.90

4.2

3.7

1.22

1.23

mmol/l

2.09

4614

22865

Other sleep disorders

427

2745

1.61

17.87

4.4

3.9

1.22

mmol/l

0.13

378

2396

Urticaria

1121

8555

1.34

17.81

4.2

3.6

1.23

mmol/l

0.92

965

7485

Spondyloarthritis

708

5033

1.44

17.78

4.6

3.8

1.22

1.23

mmol/l

0.64

645

4391

Malignant neoplasm of kidney, except renal pelvis

392

2484

1.65

17.77

7.4

3.9

1.23

1.22

mmol/l

0.40

365

2169

Acute pharyngitis

477

3112

1.56

17.77

4.4

3.5

1.22

mmol/l

0.06

425

2709

Non-allergic asthma (mode), excluding more controls

773

5526

1.42

17.73

3.6

3.0

1.23

mmol/l

2.75

679

4635

Endometriosis

1482

6917

1.30

17.68

3.2

3.3

1.23

mmol/l

0.50

1260

5976

Diverticular disease of intestine

3137

17688

1.19

17.66

4.5

3.7

1.23

mmol/l

0.85

2795

15321

Sciatica+with lumbago

2056

16012

1.24

17.58

3.6

3.8

1.23

mmol/l

0.20

1817

13981

Tubulo-interstitial nephritis, not specified as acute or chronic

300

1779

1.76

17.53

6.8

2.8

1.22

1.23

mmol/l

1.30

261

1500

Lymphoid leukaemia

226

1237

1.93

17.47

5.6

3.1

1.22

1.23

mmol/l

0.20

212

1039

Migraine with aura and triptan purchases

520

3497

1.53

17.47

2.6

3.4

1.23

mmol/l

0.05

470

3067

Simple and mucopurulent chronic bronchitis

198

1040

2.02

17.39

4.0

1.22

mmol/l

0.00

173

890

Osteonecrosis

257

1468

1.85

17.38

9.3

3.5

1.23

mmol/l

0.11

244

1269

Disorders of vitreous body and globe

2115

17021

1.23

17.36

4.8

3.8

1.23

mmol/l

0.57

1849

14780

Spondylopathies (FG)

530

3588

1.52

17.33

3.7

3.8

1.23

mmol/l

0.05

479

3113

Disorders of vestibular function (Vertigo)

1968

16019

1.24

17.32

3.8

1.23

mmol/l

0.95

1707

13904

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

457

2998

1.57

17.29

4.7

3.3

1.22

mmol/l

0.34

400

2539

Hernia of abdominal wall

1830

14889

1.25

17.23

5.2

3.9

1.22

1.23

mmol/l

4.91

1621

13012

Seropositive rheumatoid arthritis, strict definition

646

4561

1.46

17.20

3.3

3.7

1.24

1.23

mmol/l

1.41

595

3966

Thyroiditis, ILD-related definition

459

3026

1.57

17.20

3.7

3.5

1.23

mmol/l

0.37

393

2616

Ulcerative colitis (strict definition, all Crohn cases excluded)

536

3644

1.51

17.18

3.3

3.8

1.23

mmol/l

0.03

477

3194

Septal defects

236

1283

1.88

17.15

3.7

4.1

1.22

1.23

mmol/l

0.85

221

1116

Complications of internal orthopaedic prosthetic devices, implants and grafts

969

7308

1.36

17.12

4.6

3.6

1.22

1.23

mmol/l

1.66

868

6236

DVT of lower extremities

792

5789

1.41

17.09

5.4

3.7

1.23

mmol/l

0.04

699

5022

Deforming dorsopathies

1131

8697

1.33

17.09

3.6

3.7

1.23

mmol/l

0.16

999

7546

Injuries to the neck

838

6169

1.39

17.07

3.4

3.8

1.22

1.23

mmol/l

1.12

731

5421

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

604

3965

1.48

17.04

5.5

3.1

1.23

1.22

mmol/l

2.42

570

3338

Other chronic obstructive pulmonary disease

1835

12407

1.25

17.01

4.9

4.0

1.21

1.23

mmol/l

14.94

1665

10686

Mental and behavioural disorders due to cannabinoids

112

473

2.50

16.98

2.3

3.5

1.22

1.23

mmol/l

0.56

413

Congenital malformations of cardiac septa

245

1335

1.85

16.95

3.9

4.1

1.22

1.23

mmol/l

0.61

230

1165

Disorders of vitreous body

2055

16595

1.23

16.94

4.8

3.8

1.23

mmol/l

0.41

1799

14414

Benign neoplasm: Adrenal gland

326

2002

1.72

16.93

3.9

4.0

1.23

mmol/l

0.39

306

1753

Other viral diseases, not elsewhere classified

665

4704

1.44

16.92

6.3

3.7

1.23

mmol/l

0.09

607

4137

Gonarthrosis, primary, with knee surgery

2475

16939

1.21

16.92

3.3

4.0

1.23

mmol/l

0.72

2125

14695

Herpesviral [herpes simplex] infections

463

3071

1.56

16.91

7.0

3.6

1.22

1.23

mmol/l

3.18

427

2657

Eustachian salpingitis and obstruction

283

1666

1.76

16.80

3.7

3.4

1.22

1.23

mmol/l

2.15

253

1466

Manic episode

138

644

2.29

16.77

4.3

3.5

1.24

1.23

mmol/l

1.10

120

557

Correction of physiology of bite - demanding therapy visit

277

1627

1.78

16.75

3.8

3.4

1.22

1.23

mmol/l

1.03

242

1408

Fracture of lumbar spine and pelvis

892

6654

1.37

16.75

5.2

3.8

1.22

1.23

mmol/l

2.34

794

5724

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2384

15722

1.22

16.74

4.3

3.8

1.23

mmol/l

0.50

2050

13598

Postmenopausal osteoporosis with pathological fracture

298

1802

1.76

16.70

5.5

3.2

1.24

mmol/l

0.16

280

1525

Renal agenesis and other reduction defects of kidney

5.30

16.69

15.2

4.5

1.21

1.22

mmol/l

0.42

Diabetes mellitus in pregnancy

1008

4908

1.35

16.67

2.9

3.1

1.22

1.23

mmol/l

3.31

853

4333

Lung transplant status

159

4.06

16.61

12.3

4.6

1.22

mmol/l

0.14

143

Lung transplantation

159

4.05

16.61

12.3

4.6

1.22

mmol/l

0.14

143

Mental retardation, excluding more controls

136

619

2.27

16.57

4.5

4.3

1.24

1.23

mmol/l

0.41

123

546

Coeliac disease

488

3286

1.53

16.56

4.5

3.7

1.22

1.23

mmol/l

2.18

428

2844

Acetic acid derivatives and related substances

1297

5236

1.31

16.55

3.5

4.6

1.22

mmol/l

0.28

1113

4611

Autoimmune hyperthyroidism

249

1424

1.83

16.55

3.8

3.4

1.22

1.23

mmol/l

1.99

228

1230

Cardiomyopathies, Primary/intrinsic

495

3344

1.53

16.54

4.9

3.4

1.21

1.23

mmol/l

8.70

458

2887

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

130

4.32

16.49

6.3

3.3

1.22

1.23

mmol/l

0.14

113

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

926

5823

1.36

16.43

5.7

3.1

1.23

1.22

mmol/l

1.22

874

4886

Ulcer of lower limb, not elsewhere classified

572

3985

1.49

16.43

10.8

3.7

1.21

1.23

mmol/l

5.72

540

3458

SLE (Finngen)

154

756

2.17

16.43

5.0

3.2

1.22

1.23

mmol/l

1.07

144

649

Other diseases of anus and rectum

1262

9893

1.30

16.41

4.2

3.6

1.22

1.23

mmol/l

1.79

1120

8493

Calcific aortic valvular stenosis, including rheumatic fever

1269

9753

1.30

16.39

5.6

3.8

1.22

mmol/l

4.26

1114

8403

Calcific aortic valvular stenosis

1265

9729

1.30

16.36

5.5

3.8

1.22

mmol/l

4.23

1110

8384

Calcific aortic valvular stenosis, operated

1265

9729

1.30

16.36

5.5

3.8

1.22

mmol/l

4.23

1110

8384

Disorders of adrenal gland, other and/or unspecified

105

4.95

16.36

4.7

3.1

1.22

1.23

mmol/l

0.73

Calcific aortic valvular stenosis, diagnosis (helper)

1264

9723

1.30

16.32

5.5

3.8

1.22

mmol/l

4.16

1109

8380

Operations 2 for CAVS

1264

9723

1.30

16.32

5.5

3.8

1.22

mmol/l

4.16

1109

8380

Giant cell arteritis

204

1113

1.97

16.32

4.4

3.7

1.22

1.23

mmol/l

0.60

190

951

Excessive attrition of teeth

1638

7118

1.27

16.29

3.8

3.5

1.23

mmol/l

0.06

1402

6198

Crohn's disease of large intestine

212

1162

1.92

16.26

5.4

3.5

1.22

1.23

mmol/l

1.26

187

1002

Somatoform disorder

623

4421

1.45

15.95

3.7

3.6

1.22

1.23

mmol/l

1.69

550

3885

Non-allergic asthma (mode)

773

5627

1.39

15.94

3.6

3.1

1.23

mmol/l

1.89

679

4745

Secondary right heart disease

193

1040

1.98

15.91

5.6

3.3

1.21

1.22

mmol/l

2.26

180

884

Idiopathic pulmonary fibrosis

327

2041

1.68

15.90

4.1

3.9

1.21

1.22

mmol/l

2.19

298

1776

Myocardial infarction

2112

12570

1.23

15.85

5.6

3.8

1.21

1.23

mmol/l

19.13

1913

10842

Gonarthrosis,primary

3928

21509

1.16

15.84

3.7

4.0

1.23

mmol/l

0.30

3443

18802

Postprocedural disorders of nervous system

272

1613

1.75

15.82

3.4

3.2

1.22

1.23

mmol/l

1.00

247

1391

Intentional self-harm by unspecified means

176

3.56

15.77

2.9

2.6

1.22

mmol/l

0.08

151

Colorectal cancer

972

7422

1.34

15.75

4.6

3.9

1.22

1.23

mmol/l

1.93

880

6409

Other diseases of oesophagus

415

2736

1.58

15.73

4.9

3.9

1.22

1.23

mmol/l

1.51

368

2355

Myalgia

875

6571

1.36

15.69

3.6

3.5

1.23

mmol/l

1.10

782

5703

Other pulmonary heart/vessel disease

209

1160

1.91

15.65

6.1

3.5

1.21

1.22

mmol/l

1.60

195

990

Left side

125

4.79

15.64

2.6

4.7

1.23

1.22

mmol/l

0.91

105

Amenorrhoea

243

1398

1.80

15.63

4.2

2.9

1.23

mmol/l

0.16

222

1209

Cardiomyopathy (excluding other)

503

3451

1.50

15.57

4.9

3.4

1.21

1.23

mmol/l

9.23

465

2984

Right side

164

4.10

15.53

3.1

4.3

1.24

1.23

mmol/l

1.36

148

Emergency coronary revascularization (for ACS)

2361

14244

1.21

15.51

4.7

4.0

1.22

mmol/l

3.13

2148

12293

Hyperaldosteronism

136

656

2.25

15.46

6.2

3.8

1.22

mmol/l

0.44

126

570

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

374

2415

1.60

15.44

4.9

3.1

1.23

1.22

mmol/l

0.18

346

2053

Obsessive-compulsive disorder

206

1132

1.88

15.42

2.4

3.2

1.22

1.23

mmol/l

0.54

173

975

Irregular menses

1761

11672

1.24

15.39

3.5

3.2

1.23

mmol/l

1.42

1560

10125

Premature rupture of membranes

701

3718

1.41

15.38

2.6

3.3

1.23

mmol/l

0.07

605

3259

Other ill-defined and unspecified causes of mortality

268

1605

1.76

15.35

5.1

4.0

1.21

1.22

mmol/l

3.15

234

1402

Excessive vomiting in pregnancy

299

1833

1.69

15.30

3.0

3.1

1.23

mmol/l

0.65

257

1600

Other coagulation defects

287

1746

1.72

15.29

5.4

3.4

1.22

1.23

mmol/l

2.30

261

1503

Vitamin D deficiency

359

2.71

15.27

5.8

3.4

1.22

1.23

mmol/l

1.02

315

Nonorganic sleeping disorders

682

4952

1.41

15.22

4.1

3.6

1.22

1.23

mmol/l

1.83

604

4326

Spirochaetal infections, other/unspecified

105

2254

0.45

15.20

2.6

3.8

1.22

1.23

mmol/l

0.78

1969

Fracture of femur

1105

7857

1.31

15.17

4.7

3.8

1.22

1.23

mmol/l

1.16

976

6725

Family history of malignant neoplasm

389

2544

1.58

15.16

3.8

3.1

1.23

mmol/l

0.14

349

2223

Other diseases of spinal cord

142

700

2.18

15.14

5.4

3.9

1.21

1.23

mmol/l

1.27

119

608

Fracture of shoulder and upper arm

1423

11443

1.26

14.92

4.4

3.8

1.23

mmol/l

1.52

1264

9894

Intussusception

115

528

2.38

14.86

3.5

3.3

1.23

mmol/l

0.36

110

450

Benign neoplasm: Endocrine pancreas

117

4.40

14.84

4.4

3.0

1.23

1.22

mmol/l

0.08

103

Immunodeficiencies

202

1126

1.89

14.83

9.4

3.7

1.23

mmol/l

0.53

190

970

Other blood glucose lowering drugs, excl. Insulins

702

5157

1.40

14.82

5.4

3.9

1.22

1.23

mmol/l

3.34

611

4451

Keratitis

1353

10835

1.27

14.78

4.6

3.7

1.22

1.23

mmol/l

1.45

1208

9423

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

450

3057

1.52

14.74

4.5

3.0

1.22

1.23

mmol/l

0.68

409

2568

Dislocation, sprain and strain of joints and ligaments at neck level

531

3713

1.47

14.74

3.1

3.6

1.22

1.23

mmol/l

0.64

462

3248

Major coronary heart disease event excluding revascularizations

2807

16572

1.18

14.72

5.2

3.9

1.22

1.23

mmol/l

19.46

2540

14293

Heterophoria

302

1879

1.67

14.65

5.2

3.4

1.22

1.23

mmol/l

0.98

265

1620

Left ventricular outflow tract obstruction (LVOTO), broad definition

367

2390

1.59

14.64

5.4

4.4

1.22

mmol/l

2.05

334

2122

Memory loss

141

2700

0.50

14.63

3.2

3.8

1.23

mmol/l

0.18

122

2361

Type 1 diabetes, strict definition, subgroup 1

234

1353

1.77

14.60

3.9

3.2

1.22

1.23

mmol/l

0.61

190

1172

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2106

17279

1.21

14.58

3.7

4.0

1.22

1.23

mmol/l

1.48

1847

15133

Menorrhagia

1495

6642

1.26

14.56

3.4

1.23

mmol/l

0.25

1289

5744

Ulcerative rectosigmoiditis

314

1976

1.65

14.54

3.9

3.5

1.23

mmol/l

0.12

285

1718

Impotence

211

1198

1.85

14.54

6.9

4.8

1.21

mmol/l

0.92

184

1082

Superficial injury of thorax

571

4062

1.44

14.52

5.2

3.9

1.22

1.23

mmol/l

0.72

509

3560

Ascites

305

1913

1.67

14.51

7.1

3.8

1.20

1.23

mmol/l

8.78

290

1653

Disturbances of skin sensation

1014

7860

1.31

14.50

3.5

3.6

1.23

mmol/l

0.58

910

6896

L01XX Other antineoplastic agents

254

1527

1.76

14.47

4.2

3.9

1.22

1.23

mmol/l

2.04

219

1325

Oxicams

1100

4850

1.31

14.42

3.1

4.6

1.22

mmol/l

0.24

961

4290

Other noninflammatory disorders of uterus, except cervix

988

5187

1.33

14.39

3.7

3.5

1.24

mmol/l

0.75

865

4469

Malignant melanoma, excluding all cancers (controls excluding all cancers)

630

4566

1.42

14.38

5.3

3.1

1.23

mmol/l

0.34

555

3840

Alcohol abuse, main dg

558

3959

1.45

14.34

4.7

4.1

1.21

1.22

mmol/l

7.82

504

3495

Ventral hernia

999

7755

1.32

14.32

5.4

3.8

1.22

1.23

mmol/l

2.87

883

6730

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

253

1514

1.74

14.31

4.8

3.5

1.22

1.23

mmol/l

2.35

229

1307

Congenital malformations of the circulatory system

497

3343

1.48

14.31

3.9

4.1

1.22

1.23

mmol/l

0.76

457

2927

Cyst of kidney

291

1814

1.69

14.30

5.4

3.7

1.23

1.22

mmol/l

1.41

264

1586

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

465

3198

1.50

14.27

4.7

3.1

1.22

1.23

mmol/l

0.92

414

2708

Acidosis

428

2.50

14.25

10.9

3.3

1.19

1.22

mmol/l

3.74

375

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

347

2.66

14.21

10.4

2.6

1.23

1.22

mmol/l

0.20

287

Other and unspecified injuries of lower leg

282

1740

1.68

14.18

4.3

3.3

1.23

mmol/l

0.26

248

1500

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

404

2.54

14.14

4.9

2.7

1.21

1.22

mmol/l

2.70

346

Budesonide

485

3363

1.48

14.14

3.9

3.4

1.23

mmol/l

0.08

441

2893

Superficial injury of abdomen, lower back and pelvis

558

3970

1.44

14.14

4.3

3.6

1.22

1.23

mmol/l

2.22

502

3449

Osteomyelitis

254

1531

1.74

14.13

11.2

3.7

1.21

1.22

mmol/l

1.32

242

1317

Misadventures to patients during surgical and medical care

552

3928

1.45

14.11

6.4

3.6

1.22

1.23

mmol/l

1.89

516

3411

Vitamin deficiency

199

1121

1.87

14.10

5.5

3.3

1.22

1.23

mmol/l

1.61

182

957

Vitamin deficiency, wide

199

1121

1.87

14.10

5.5

3.3

1.22

1.23

mmol/l

1.61

182

957

Lung cancer and mesothelioma

803

5171

1.36

14.07

5.7

3.3

1.23

mmol/l

0.15

761

4361

Use of disulfiram, acamprosate or naltrexone

320

2039

1.63

14.06

3.7

4.4

1.22

mmol/l

0.02

292

1820

Any event in hilmo or specialist outpatient

25.68

14.04

4.0

1.2

1.21

1.23

mmol/l

—

Polycythaemia vera

150

775

2.06

14.03

3.0

2.8

1.21

1.23

mmol/l

2.05

124

645

Gestational diabetes (for exclusion)

1133

6281

1.29

14.03

2.6

3.1

1.22

1.23

mmol/l

5.00

961

5535

Alcohol-induced chronic pancreatitis

256

1550

1.73

13.99

6.0

4.5

1.21

1.22

mmol/l

1.49

241

1374

Aortic valve malfunction, age under 60 years

343

2225

1.60

13.98

5.5

4.4

1.22

mmol/l

1.84

311

1977

Hypertrophy of breast

657

4816

1.40

13.98

3.2

3.3

1.23

1.24

mmol/l

0.32

560

4210

Congenital malformations of heart and great arteries

449

2975

1.50

13.98

3.8

4.1

1.22

1.23

mmol/l

0.50

417

2608

Carcinoma in situ of breast, other/unspecified

317

2.79

13.97

4.1

2.6

1.24

mmol/l

0.43

257

Ill-defined and unknown causes of mortality

291

1823

1.67

13.96

5.0

4.0

1.21

1.22

mmol/l

3.56

254

1592

Type 1 diabetes, strict definition

248

1476

1.72

13.94

4.0

3.1

1.22

1.23

mmol/l

0.52

203

1285

Other disorders of nervous system

274

1692

1.70

13.93

5.6

4.0

1.22

1.23

mmol/l

0.66

236

1464

TMD related pain

150

776

2.05

13.92

2.5

3.2

1.23

mmol/l

0.36

134

664

Squamous cell neoplasms and carcinomas of the skin

514

3628

1.47

13.89

5.9

3.8

1.22

mmol/l

0.01

451

3122

Traumatic subarachnoid haemorrhage

153

800

2.03

13.76

4.2

3.4

1.22

mmol/l

0.64

136

677

Neuromuscular dysfunction of bladder

363

2396

1.57

13.74

5.3

3.8

1.22

1.23

mmol/l

2.33

311

2093

Pure hypercholesterolaemia

2978

17244

1.17

13.73

4.6

3.3

1.23

mmol/l

3.39

2695

14842

Dipeptidyl peptidase 4 (DPP-4) inhibitors

480

3353

1.48

13.73

5.1

3.9

1.22

1.23

mmol/l

1.75

411

2935

Functional dyspepsia

1074

8453

1.30

13.73

3.9

3.6

1.23

mmol/l

0.27

968

7304

Pericarditis

155

815

2.01

13.70

7.5

3.5

1.22

1.23

mmol/l

0.93

149

705

Seborrhoeic dermatitis

378

2518

1.55

13.68

6.6

3.8

1.22

mmol/l

0.47

329

2202

Endometriosis of pelvic peritoneum

590

4203

1.42

13.65

2.9

3.3

1.23

mmol/l

1.54

493

3687

Other and unspecified types of non-Hodgkin lymphoma, hilmo

192

1089

1.88

13.51

8.6

4.0

1.23

1.22

mmol/l

0.43

186

938

Other overlap syndromes

427

2.46

13.42

3.8

3.6

1.22

1.23

mmol/l

0.71

372

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

233

1391

1.75

13.39

5.0

3.0

1.22

mmol/l

0.75

218

1173

Pyoderma gangrenosum

140

3.80

13.37

4.2

3.8

1.22

mmol/l

0.25

120

Unspecified jaundice

208

1206

1.81

13.35

5.2

3.7

1.22

1.23

mmol/l

0.61

189

1031

Hypertrophy of breast in women and men

736

5534

1.36

13.25

3.4

1.23

mmol/l

0.14

634

4844

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

100

453

2.37

13.23

5.2

3.4

1.24

1.22

mmol/l

1.00

383

Use of biperiden

219

1293

1.78

13.21

3.6

4.0

1.23

mmol/l

0.60

185

1132

Focal epilepsy

790

6001

1.34

13.19

4.1

4.0

1.21

1.23

mmol/l

7.28

734

5233

Acute suppurative otitis media

833

5932

1.33

13.18

4.4

3.5

1.22

mmol/l

1.79

738

5166

Visual field defects

348

2302

1.57

13.12

4.5

3.9

1.22

1.23

mmol/l

1.06

310

1996

Other arthrosis

2145

12959

1.20

13.12

3.8

3.7

1.23

mmol/l

0.30

1882

11264

Superficial injury of hip and thigh

571

4135

1.42

13.12

4.3

3.7

1.22

1.23

mmol/l

0.72

506

3566

Visual disturbances

1860

15582

1.21

13.11

4.2

3.8

1.22

1.23

mmol/l

3.78

1666

13528

Dronedarone medication

146

771

2.04

13.02

2.8

3.5

1.22

1.23

mmol/l

0.38

122

669

L04AC Interleukin inhibitors

186

1051

1.85

13.02

2.8

3.7

1.23

mmol/l

0.43

176

918

Systemic sclerosis (FG)

117

570

2.21

13.00

3.8

3.3

1.23

mmol/l

0.95

108

477

Benign neoplasm of thyroid gland

158

855

1.97

12.99

4.3

3.4

1.22

1.23

mmol/l

1.09

143

736

Oesophageal varices

173

962

1.91

12.95

6.0

4.0

1.20

1.22

mmol/l

3.53

167

837

Chorioretinal inflammation

128

645

2.12

12.91

4.2

3.6

1.23

mmol/l

0.06

113

562

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

408

2.44

12.87

4.9

3.4

1.25

1.22

mmol/l

1.42

348

Other gastritis (incl. Duodenitis)

943

7370

1.31

12.86

5.1

3.8

1.22

1.23

mmol/l

2.65

865

6357

Wide developmental disorders, excluding more controls

307

2.58

12.85

3.7

4.1

1.21

1.23

mmol/l

1.57

266

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

797

5063

1.34

12.83

5.6

3.1

1.23

1.22

mmol/l

1.63

752

4258

Hypertensive heart and/or renal disease

965

5834

1.31

12.79

8.7

3.2

1.22

1.23

mmol/l

5.71

878

4922

Temporal arteritis

176

992

1.90

12.78

4.4

3.7

1.22

1.23

mmol/l

1.47

164

850

Dental caries 2

2267

20858

0.85

12.75

3.7

1.23

mmol/l

0.32

1933

18304

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1266

10209

1.25

12.73

3.7

3.6

1.22

1.23

mmol/l

1.17

1098

8989

Dental caries 2, only avohilmo

2217

20501

0.84

12.69

3.4

3.8

1.23

mmol/l

0.31

1882

18001

Fracture of foot, except ankle

865

6688

1.32

12.68

4.3

3.8

1.22

1.23

mmol/l

1.52

746

5869

Hypermetropia

264

1650

1.66

12.67

5.6

3.9

1.23

mmol/l

0.87

219

1424

Oter anti-inflammatory and antirheumatic agents, non-steroids

1048

4558

1.30

12.65

3.6

4.6

1.22

mmol/l

0.14

923

4035

Parodontitis, operation under 40 years and operation codes

252

1550

1.66

12.62

4.7

3.0

1.22

mmol/l

0.88

228

1321

Orchitis and epididymitis

325

2130

1.57

12.61

5.2

4.5

1.22

mmol/l

0.54

287

1905

Viral warts

361

2421

1.54

12.61

9.0

3.4

1.22

1.23

mmol/l

1.13

329

2099

Folate deficiency anaemia

166

3.43

12.60

8.7

3.9

1.20

1.22

mmol/l

1.55

148

Essential (haemorrhagic) thrombocythaemia

152

818

1.97

12.60

3.5

2.9

1.23

mmol/l

0.16

128

679

Abnormalities of gait and mobility

461

3248

1.47

12.60

3.9

1.22

1.23

mmol/l

0.73

391

2828

Noninflammatory disorders of female genital tract

1777

7414

1.22

12.52

3.4

3.3

1.23

mmol/l

0.16

1526

6380

Schizotypal disorder

456

2.31

12.52

2.6

4.2

1.22

1.23

mmol/l

0.34

401

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

368

2484

1.53

12.51

4.8

3.1

1.22

mmol/l

1.77

327

2107

Pre-eclampsia or poor fetal growth

1026

8094

1.28

12.48

3.5

3.1

1.23

mmol/l

0.06

899

7064

6-mercaptopurine

110

528

2.19

12.43

3.3

1.22

1.23

mmol/l

0.96

442

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

249

1541

1.68

12.43

3.6

3.5

1.23

mmol/l

0.07

218

1340

Fracture of forearm

2202

17594

1.19

12.40

4.3

3.7

1.23

mmol/l

1.25

1898

15280

Unspecified acute lower respiratory infection

534

3860

1.42

12.39

5.2

3.6

1.22

mmol/l

2.23

505

3380

Arthropod-borne viral fevers and viral haemorrhagic fevers

371

2515

1.53

12.39

4.2

4.1

1.22

mmol/l

0.01

337

2201

Superficial injury of lower leg

910

7106

1.30

12.38

4.6

3.7

1.22

1.23

mmol/l

3.75

808

6181

Giant cell arteritis with polymyalgia rheumatica

176

1003

1.88

12.34

4.4

3.6

1.22

1.23

mmol/l

1.51

164

862

Inflammatory diseases of prostate (prostatitis)

456

3212

1.46

12.33

3.9

4.5

1.21

mmol/l

0.23

389

2860

Cerebral cysts

211

1256

1.75

12.30

5.3

3.5

1.22

1.23

mmol/l

0.91

188

1069

Fitting and adjustment of other devices

1385

10555

1.24

12.29

3.1

1.23

mmol/l

0.06

1312

8931

Other disorders of conjunctiva

567

4156

1.40

12.28

4.2

4.0

1.23

mmol/l

0.09

504

3637

Insomnia

559

4078

1.40

12.26

4.3

3.6

1.22

1.23

mmol/l

1.22

504

3572

Early onset COPD

864

6721

1.31

12.24

5.1

4.1

1.21

1.23

mmol/l

5.30

786

5903

Alzheimer’s disease (Atypical or mixed)

369

2502

1.53

12.22

3.5

3.6

1.23

1.22

mmol/l

1.24

284

2148

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

355

2392

1.53

12.19

4.8

3.0

1.22

mmol/l

1.94

317

2033

Dementia

1773

10250

1.21

12.17

3.4

3.9

1.23

mmol/l

0.50

1456

8872

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

271

2.78

12.16

4.8

2.6

1.22

mmol/l

0.34

225

Autism spe, excluding more controls

237

2.78

12.16

2.9

4.4

1.21

1.23

mmol/l

1.88

205

Extrapyramidal and movement disorders

1488

12311

1.23

12.14

3.6

3.9

1.23

mmol/l

0.26

1268

10672

Universal erythroderma, KELA reimbursement

313

2.63

12.13

5.3

4.6

1.21

1.22

mmol/l

0.63

281

Idiopathic thrombocytopenic purpura

133

697

2.03

12.02

4.3

3.5

1.22

1.23

mmol/l

0.62

118

600

Carcinoma in situ of skin, other sites/unspecified

318

2.68

12.02

8.5

3.9

1.23

1.22

mmol/l

0.31

278

Opening and dilatation of root channel of tooth

1473

0.40

11.96

3.7

3.6

1.22

1.23

mmol/l

0.59

1277

Cardiomyopathy, other and unspecified

308

2024

1.58

11.96

6.0

3.5

1.21

1.23

mmol/l

6.29

287

1740

Monoamine oxidase A inhibitors

460

3267

1.45

11.93

4.1

3.8

1.23

mmol/l

0.05

386

2907

Parodontitis, under 40 years and operation codes

249

1550

1.64

11.92

4.6

3.0

1.22

mmol/l

0.94

225

1321

Carcinoid syndrome

235

2.98

11.91

5.4

3.6

1.21

1.22

mmol/l

0.74

199

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

166

937

1.88

11.91

4.7

3.7

1.22

1.23

mmol/l

0.61

148

799

Abnormal blood-pressure reading, without diagnosis

176

1006

1.83

11.90

3.1

3.6

1.23

mmol/l

0.48

151

859

All influenza (not pneumonia)

533

3877

1.41

11.88

6.2

3.4

1.22

1.23

mmol/l

0.20

491

3360

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

112

554

2.15

11.87

4.9

3.0

1.21

1.22

mmol/l

0.87

105

469

Thoracic aortic aneurysm

534

3902

1.41

11.83

5.1

3.9

1.22

mmol/l

1.56

479

3427

Malignant neoplasm of colon

601

4475

1.38

11.81

4.5

3.9

1.22

1.23

mmol/l

1.03

551

3874

Parkinson's disease, excluding more controls

534

3797

1.41

11.78

3.2

3.8

1.23

mmol/l

0.37

457

3244

COPD, hospital admissions

1853

13250

1.20

11.74

4.9

4.0

1.21

1.23

mmol/l

13.73

1681

11444

Anisometropia and aniseikonia

138

738

1.99

11.73

4.7

3.8

1.23

mmol/l

0.06

105

642

Thyrotoxicosis with toxic multinodular goitre

267

1715

1.63

11.71

4.0

3.6

1.22

1.23

mmol/l

1.10

238

1478

Alzheimer disease, excluding more controls

757

3860

1.34

11.69

3.4

3.7

1.23

mmol/l

0.16

597

3270

Other inflammatory liver diseases

260

1655

1.64

11.69

5.3

3.8

1.22

1.23

mmol/l

1.49

240

1428

Scabies

162

908

1.86

11.68

6.4

4.1

1.22

mmol/l

0.40

149

797

Disorders of pituitary gland, other and/or unspecified

122

3.81

11.65

5.6

3.0

1.21

1.23

mmol/l

0.77

107

Carcinoma in situ of skin of scalp and neck

102

494

2.24

11.60

6.7

2.6

1.22

mmol/l

0.19

414

Status post-ami

121

1864

0.52

11.60

5.5

3.5

1.21

1.22

mmol/l

0.72

111

1561

Acute lymphadenitis

221

1352

1.70

11.59

6.4

3.3

1.22

1.23

mmol/l

0.44

200

1164

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

161

906

1.87

11.55

7.6

2.8

1.23

mmol/l

0.39

145

754

Carcinoma in situ of skin

337

2283

1.54

11.54

6.4

3.6

1.22

1.23

mmol/l

0.30

294

1976

Persistent mood disorders

722

5524

1.33

11.53

3.8

3.6

1.22

1.23

mmol/l

2.04

629

4850

Disorders of phosphorus metabolism and phosphatases

4.38

11.53

10.0

3.5

1.24

1.23

mmol/l

0.27

Polyneuropathies and other disorders of the peripheral nervous system

836

6532

1.31

11.52

6.6

4.0

1.22

mmol/l

2.18

749

5702

Mixed connective tissue disease

260

1662

1.63

11.52

4.2

3.6

1.23

mmol/l

0.73

240

1442

Acne

297

1942

1.56

11.50

6.1

3.1

1.23

mmol/l

0.03

257

1671

Myocardial infarction, without ST-elevation

1625

12561

1.21

11.49

5.9

3.9

1.21

1.22

mmol/l

11.38

1459

10847

Pain in thoracic spine

568

4201

1.38

11.49

3.6

1.23

mmol/l

0.32

518

3669

Car occupant injured in other and unspecified transport accidents

658

4970

1.35

11.49

3.8

3.7

1.23

mmol/l

0.06

579

4340

Malignant neoplasm of breast, HER-negative

827

6452

1.31

11.48

3.5

3.3

1.24

mmol/l

0.95

737

5436

Systemic sclerosis

117

599

2.10

11.42

3.8

3.6

1.23

mmol/l

0.70

108

518

Acne vulgaris

238

1483

1.65

11.41

5.6

3.0

1.22

1.23

mmol/l

0.31

210

1271

Pyogenic arthritis

260

1663

1.62

11.40

6.9

3.9

1.22

mmol/l

0.98

240

1448

Chronic viral hepatitis

182

1062

1.78

11.37

4.6

3.7

1.21

1.23

mmol/l

4.59

162

927

Juvenile arthritis (FINNGEN)

160

899

1.85

11.35

3.8

3.1

1.22

1.23

mmol/l

0.80

141

762

Shoulder lesions

3307

17836

1.15

11.32

3.8

1.23

mmol/l

0.11

2944

15571

Mental retardation

136

728

1.95

11.31

4.5

4.6

1.24

1.23

mmol/l

0.29

123

643

Gingival hyperplasia

135

725

1.97

11.30

13.6

3.4

1.21

1.23

mmol/l

1.48

127

641

Redundant prepuce, phimosis and paraphimosis

641

4810

1.35

11.26

5.3

4.3

1.22

mmol/l

0.28

567

4304

Other symptoms and signs involving general sensations and perceptions

165

944

1.84

11.26

3.9

3.7

1.23

mmol/l

0.08

137

806

Hidradenitis suppurativa

135

725

1.95

11.20

5.1

3.2

1.22

1.23

mmol/l

0.91

120

627

Pneumonia due to Streptococcus pneumoniae

167

958

1.82

11.20

5.7

3.5

1.22

mmol/l

0.24

151

816

Other juvenile arthritis

138

744

1.93

11.19

3.6

3.1

1.22

1.23

mmol/l

0.62

120

632

Dental caries 2 and operation codes

2236

20602

0.85

11.19

3.7

1.23

mmol/l

0.24

1910

18081

Malignant neoplasm of adrenal gland

4.79

11.17

7.1

5.0

1.24

1.23

mmol/l

0.29

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

304

2023

1.55

11.16

5.8

3.0

1.22

1.23

mmol/l

1.35

287

1709

Benign neoplasm of other and ill-defined parts of digestive system

704

5406

1.33

11.16

4.8

3.9

1.23

mmol/l

0.26

641

4715

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

254

1623

1.62

11.15

5.8

2.8

1.22

1.23

mmol/l

1.10

235

1362

Unspecified chronic bronchitis

158

894

1.85

11.13

4.6

3.9

1.22

mmol/l

0.27

139

766

Diseases of inner ear

2211

18658

1.17

11.12

3.8

1.23

mmol/l

0.23

1915

16237

Other fall from one level to another

775

6012

1.31

11.12

4.2

4.0

1.23

1.22

mmol/l

0.16

681

5279

Systemic lupus erythematosus

154

867

1.88

11.12

5.0

3.4

1.22

1.23

mmol/l

0.84

144

737

Benign neoplasm of middle ear and respiratory system

276

1799

1.59

11.11

3.8

3.1

1.22

1.23

mmol/l

0.51

250

1532

severe traumatic brain injury, does not include concussion

840

6597

1.30

11.07

4.3

4.0

1.21

1.22

mmol/l

4.08

726

5729

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

320

2.50

11.03

5.4

3.4

1.25

1.22

mmol/l

1.12

276

Leiomyoma of uterus

2587

12767

1.17

11.02

3.6

3.3

1.24

mmol/l

0.81

2214

11150

Unspecified/other endometriosis

311

2079

1.53

11.00

2.9

3.0

1.23

mmol/l

0.08

259

1822

Other sexually transmitted chlamydial diseases

1242

0.38

10.97

2.4

2.8

1.23

1.22

mmol/l

0.21

1055

Later onset COPD, excluding more controls

887

5463

1.29

10.91

4.9

3.2

1.21

1.23

mmol/l

12.04

801

4569

Other viral hepatitis

212

1303

1.68

10.90

4.4

3.8

1.21

1.23

mmol/l

2.75

190

1128

Chronic Coagulation defects

102

504

2.15

10.88

5.9

3.3

1.22

1.23

mmol/l

0.36

429

Parodontitis, under 40 years, or operation codes

258

1657

1.59

10.86

4.7

2.9

1.22

mmol/l

0.73

233

1413

Other and unspecified follicular disorders

154

872

1.86

10.86

6.6

3.5

1.23

mmol/l

0.61

140

750

Mumps

112

574

2.07

10.79

3.6

3.7

1.23

mmol/l

0.07

102

505

Anorexia (incl.atypical)

209

1282

1.68

10.79

4.0

3.1

1.22

1.23

mmol/l

0.26

182

1096

Chronic hepatitis, not elsewhere classified

144

803

1.90

10.75

4.2

3.4

1.22

1.23

mmol/l

1.11

134

687

Scoliosis

317

2142

1.52

10.75

3.3

3.2

1.23

mmol/l

0.68

281

1830

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

249

1601

1.62

10.74

7.1

2.9

1.23

mmol/l

0.07

227

1344

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

238

1516

1.64

10.74

6.0

3.1

1.22

mmol/l

0.06

226

1278

Impacted teeth

529

3626

1.38

10.72

3.7

3.2

1.23

1.22

mmol/l

0.33

457

3105

Visual disturbances and blindness

1976

16939

1.18

10.69

4.2

3.8

1.22

1.23

mmol/l

3.45

1763

14694

Psoriasis vulgaris

686

5273

1.33

10.69

4.1

1.23

mmol/l

0.19

610

4644

Crohn disease (strict definition, require KELA, min 2 HDR)

223

1397

1.65

10.67

3.6

1.23

mmol/l

0.04

195

1213

Peritonsillar abscess

741

5747

1.31

10.66

3.9

1.23

1.22

mmol/l

0.27

653

5066

Benign neoplasm: Skin, unspecified

145

810

1.88

10.65

5.1

2.7

1.22

1.23

mmol/l

0.30

128

670

Fentanyl

399

2822

1.45

10.65

8.3

3.2

1.22

1.23

mmol/l

0.27

373

2391

COPD, early/later onset

1853

13332

1.19

10.64

4.9

4.0

1.21

1.23

mmol/l

13.58

1681

11512

Disorders of muscles

372

2599

1.47

10.62

4.3

3.9

1.23

mmol/l

0.02

324

2261

Calcific tendinitis of shoulder

231

1465

1.64

10.58

3.3

3.9

1.23

mmol/l

0.34

206

1273

Hyperprolactinaemia

128

689

1.95

10.56

3.8

2.7

1.23

mmol/l

0.32

113

586

Strabismus

952

7614

1.27

10.53

4.5

3.8

1.23

mmol/l

0.46

832

6673

Otitis externa, unspecified

389

2746

1.46

10.51

4.9

3.8

1.23

mmol/l

0.08

334

2398

Maternal care for cervical incompetence

168

987

1.79

10.49

3.6

3.1

1.24

mmol/l

0.04

147

837

Symptoms and signs involving emotional state

119

628

2.00

10.49

4.2

3.6

1.23

mmol/l

0.15

113

547

Drug-induced interstitial lung disorders, unspecified

6.80

10.47

6.3

4.0

1.23

mmol/l

0.09

Systemic sclerosis, icd10

115

604

2.04

10.47

3.8

3.5

1.23

mmol/l

0.76

106

523

Chronic tubulo-interstitial nephritis

165

964

1.80

10.46

12.5

3.0

1.22

1.23

mmol/l

1.08

153

812

Melanocytic naevi, other sites/unspecified

289

1931

1.55

10.44

6.6

3.6

1.23

mmol/l

0.05

258

1682

L02BA Anti-estrogens

656

5036

1.33

10.43

5.2

3.4

1.24

mmol/l

0.16

617

4337

Dermatitis due to substances taken internally

215

1346

1.66

10.40

6.9

3.4

1.22

1.23

mmol/l

1.36

189

1161

Other enthesopathies

1148

9399

1.24

10.40

3.5

3.7

1.23

mmol/l

0.82

1024

8204

Benign neoplasm: Colon

1754

11405

1.19

10.39

4.8

3.0

1.22

1.23

mmol/l

1.25

1589

9606

Crohn disease (strict definition, require KELA)

227

1438

1.63

10.38

3.6

1.23

mmol/l

0.03

198

1246

Degenerative macular diseases

508

3768

1.39

10.36

4.4

3.9

1.22

1.23

mmol/l

1.22

434

3283

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

114

597

2.02

10.34

4.7

3.0

1.22

mmol/l

0.18

108

492

Psoriasis (vulgaris), strict definition

124

667

1.96

10.34

3.3

4.1

1.22

1.23

mmol/l

0.85

112

590

Lymphoid leukaemia

226

1438

1.64

10.32

5.6

3.9

1.22

mmol/l

0.13

212

1255

Carcinoma in situ of cervix uteri

269

1769

1.56

10.31

3.2

2.3

1.23

mmol/l

0.36

228

1468

Carpal tunnel syndrome

2458

19364

1.16

10.30

3.7

3.8

1.23

mmol/l

1.01

2165

16859

Missing teeth due to accident, extraction or parodontitis

445

3231

1.42

10.28

5.9

3.5

1.23

mmol/l

0.32

417

2824

Other specified/unspecified soft tissue disorders

214

1345

1.66

10.26

3.4

3.5

1.23

mmol/l

0.30

181

1133

Focal epilepsy, strict definition

714

5547

1.31

10.25

4.1

4.0

1.22

1.23

mmol/l

5.36

664

4836

Parodontitis, under 40 years

255

1656

1.57

10.25

4.6

2.9

1.22

mmol/l

0.74

230

1412

Abnormal findings in cerebrospinal fluid

5.25

10.21

7.3

4.0

1.22

1.23

mmol/l

0.32

Laparoscopic right hemicolectomy

234

1509

1.63

10.20

4.0

3.9

1.23

mmol/l

0.06

213

1313

Tobacco use

192

1175

1.70

10.19

3.5

3.9

1.22

mmol/l

0.62

172

1023

Chronic iridocyclitis

197

1215

1.69

10.17

4.1

3.7

1.23

mmol/l

0.01

177

1041

Alcohol withdrawal state with delirium

257

1687

1.58

10.13

4.7

4.6

1.20

1.22

mmol/l

5.23

232

1504

Symptoms and signs involving speech and voice

1279

10625

1.22

10.09

4.1

3.7

1.22

1.23

mmol/l

4.36

1112

9230

Cholecystitis

532

3983

1.37

10.06

4.3

3.9

1.22

1.23

mmol/l

1.33

477

3435

SLE, ICD10

148

850

1.84

10.05

5.0

3.4

1.22

1.23

mmol/l

0.89

139

723

SLE, strict definition

148

850

1.84

10.05

5.0

3.4

1.22

1.23

mmol/l

0.89

139

723

Papilloedema, unspecified

465

2.15

10.04

7.9

3.4

1.21

1.23

mmol/l

1.67

401

Abnormal reflex

103

3.83

10.04

4.3

3.9

1.21

1.23

mmol/l

1.43

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

387

2764

1.45

9.98

3.2

2.9

1.24

mmol/l

0.43

333

2264

Other and unspecified polyneuropathies, also in other diseases

723

5655

1.31

9.98

7.1

4.0

1.22

mmol/l

1.81

646

4943

Monoarthritis, not elsewhere classified

172

1029

1.74

9.98

5.5

3.6

1.23

mmol/l

0.04

150

883

Other maternal disorders predominantly related to pregnancy

2097

11357

1.17

9.98

3.2

3.3

1.23

mmol/l

1.93

1806

9891

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

688

5253

1.32

9.97

3.4

2.8

1.24

mmol/l

0.10

601

4368

Presence of other devices

515

6846

0.74

9.96

2.8

3.6

1.23

mmol/l

1.09

498

5910

Superficial injury of head

815

6458

1.28

9.95

3.6

3.8

1.23

mmol/l

0.26

718

5603

Basal cell carcinoma

2343

16276

1.16

9.93

4.2

3.9

1.23

mmol/l

0.68

2005

14091

Carcinoma in situ of other and unspecified digestive organs

102

523

2.08

9.93

5.5

2.6

1.22

mmol/l

0.15

433

Migraine without aura and triptan purchases

493

3647

1.38

9.92

2.9

3.4

1.23

mmol/l

0.80

443

3204

Viral hepatitis

243

1581

1.58

9.87

4.5

3.8

1.21

1.23

mmol/l

2.19

216

1383

Postmenopausal atrophic vaginitis

1076

5267

1.25

9.85

3.3

3.6

1.24

mmol/l

0.55

956

4562

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

4.18

9.84

5.4

2.3

1.23

1.22

mmol/l

0.25

Suppurative and unspecified otitis media

1201

8781

1.23

9.84

4.1

3.5

1.22

1.23

mmol/l

2.55

1047

7680

Osteonecrosis due to drugs

295

2.52

9.83

14.6

3.6

1.23

mmol/l

0.16

258

Bronchiectasis

329

2290

1.49

9.82

4.7

3.8

1.22

1.23

mmol/l

2.14

297

1977

Status epilepticus

144

825

1.83

9.79

5.0

3.5

1.21

1.23

mmol/l

3.87

137

714

259

2.51

9.79

2.9

2.7

1.21

1.23

mmol/l

0.95

216

Focal epilepsy, mode (most common among epilepsy diagnosis)

671

5205

1.31

9.78

4.3

4.0

1.22

1.23

mmol/l

5.23

625

4547

Basal cell carcinoma, including avohilmo

2398

16507

1.16

9.77

4.2

3.9

1.23

mmol/l

0.68

2054

14298

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

185

1137

1.70

9.77

5.7

3.8

1.20

1.22

mmol/l

3.17

173

986

Pneumonitis due to solids and liquids

298

2033

1.51

9.74

5.9

4.0

1.21

1.22

mmol/l

2.94

273

1765

Benign intracranial hypertension

151

3.10

9.72

5.4

2.9

1.22

mmol/l

0.07

128

Mandibular retrognathia

217

1377

1.62

9.70

3.3

3.6

1.23

mmol/l

0.66

196

1205

Chronic sinusitis

1675

14279

1.19

9.69

3.7

3.8

1.23

mmol/l

1.51

1459

12457

Other strabismus

758

5959

1.29

9.66

4.3

3.7

1.23

mmol/l

0.45

663

5220

Urethral stricture

221

1420

1.62

9.64

6.0

4.2

1.22

mmol/l

0.01

189

1259

Hypermobility syndrome

186

1144

1.68

9.63

2.7

3.1

1.23

mmol/l

0.46

156

983

Poisoning by narcotics and psychodysleptics [hallucinogens]

269

2.49

9.59

5.1

3.2

1.20

1.22

mmol/l

1.65

231

Assault by unspecified means

345

2.30

9.58

3.9

4.0

1.20

1.22

mmol/l

1.77

308

Other and unspecified diseases of blood and blood-forming organs

111

594

1.99

9.56

5.3

3.7

1.23

mmol/l

0.05

516

Parodontitis or/and operation codes

2728

14279

1.15

9.55

4.4

4.0

1.23

mmol/l

0.68

2444

12468

Lateral epicondylitis

480

3565

1.38

9.54

3.1

3.9

1.23

mmol/l

0.95

420

3142

Open wound of lower leg

535

4044

1.35

9.49

5.3

3.6

1.22

1.23

mmol/l

1.49

488

3494

TMD related operations

575

4388

1.34

9.49

3.6

3.8

1.23

mmol/l

0.01

514

3864

Focal brain injury

231

1500

1.59

9.48

3.6

3.9

1.21

1.22

mmol/l

3.17

203

1306

Carcinoma in situ of colon

267

2.54

9.46

5.6

2.5

1.22

mmol/l

0.00

223

Viral haemorrhagic fevers, not elsewhere classified/unspecified

292

1998

1.51

9.44

4.0

4.1

1.22

1.23

mmol/l

0.29

263

1756

Enteropathic arthropathies

476

2.09

9.41

2.8

3.3

1.23

mmol/l

0.02

399

Other and unspecified psoriasis

250

1660

1.56

9.40

3.7

3.9

1.22

1.23

mmol/l

0.39

231

1446

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

148

846

1.77

9.40

5.1

3.6

1.22

1.23

mmol/l

0.37

132

726

Idiopathic gout

342

2416

1.46

9.39

7.2

4.1

1.21

1.22

mmol/l

0.67

317

2120

Colorectal adenocarcinoma

776

6173

1.28

9.37

4.7

4.0

1.22

1.23

mmol/l

1.63

701

5347

Other other unspecified disorders of the circulatory system

155

921

1.77

9.37

5.5

3.7

1.23

mmol/l

0.21

146

798

Other and unspecified injuries of ankle and foot

152

895

1.77

9.34

4.5

3.4

1.22

1.23

mmol/l

1.10

132

765

Disorders of optic nerve and visual pathways

334

2348

1.46

9.31

5.1

3.6

1.22

1.23

mmol/l

1.27

299

2037

Gastroduodenal ulcer

1067

8760

1.23

9.31

6.1

3.8

1.22

1.23

mmol/l

3.57

975

7494

Astigmatism

209

1333

1.62

9.30

6.3

3.7

1.23

mmol/l

0.25

176

1141

Fracture of skull and facial bones

726

5726

1.29

9.25

3.7

4.0

1.22

1.23

mmol/l

1.21

648

5040

Carcinoma in situ of breast, other/unspecified

383

2.28

9.22

4.1

3.5

1.24

mmol/l

0.47

327

Carcinoma in situ of other and unspecified sites

134

768

1.84

9.21

4.5

3.1

1.22

mmol/l

0.62

112

656

Other/unspecified mastoiditis and related conditions

3.75

9.18

4.4

3.6

1.22

mmol/l

0.28

Lichen simplex chronicus and prurigo

247

1646

1.56

9.16

6.8

3.6

1.21

1.23

mmol/l

3.97

220

1427

Type1 diabetes, definitions combined, early onset

194

1212

1.63

9.16

4.2

3.4

1.22

1.23

mmol/l

0.47

157

1051

Infections of genitourinary tract in pregnancy

337

2379

1.45

9.15

3.7

3.3

1.23

mmol/l

0.98

302

2063

Carcinoma in situ, bladder

125

704

1.88

9.13

4.3

3.2

1.23

1.22

mmol/l

1.06

105

600

Other and unspecified coagulation defects

176

1085

1.69

9.12

4.9

3.3

1.22

1.23

mmol/l

0.63

163

934

CR(E)ST syndrome

383

2.25

9.12

4.0

3.5

1.23

mmol/l

0.77

333

Disorders of continuity of bone

328

2308

1.46

9.10

6.0

3.4

1.23

mmol/l

0.29

297

2003

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

167

1016

1.71

9.07

5.9

2.8

1.23

1.22

mmol/l

0.57

155

841

Dislocation, sprain and strain of joints and ligaments of head

147

865

1.77

9.06

4.1

3.5

1.23

mmol/l

0.43

131

743

Benign neoplasm: Endocrine pancreas

161

3.13

9.04

4.4

4.2

1.23

1.22

mmol/l

0.09

149

Mental retardation, wide definition

140

812

1.79

9.04

4.4

4.5

1.24

1.23

mmol/l

0.50

127

716

Non-seminoma of testis

3.91

9.00

5.4

2.9

1.23

1.22

mmol/l

0.24

Mental disorders, not otherwise specified

276

1882

1.51

9.00

3.4

1.23

mmol/l

0.92

249

1640

Golimumab

121

677

1.87

8.92

2.5

3.8

1.24

1.23

mmol/l

1.62

114

591

Cystic fibrosis

5.47

8.90

6.1

3.6

1.23

mmol/l

0.12

Synovial cyst of popliteal space [Baker]

298

2074

1.49

8.90

3.8

3.9

1.24

1.23

mmol/l

1.17

266

1778

Other/unspecified rheumatoid arthritis

506

3839

1.35

8.89

4.2

3.6

1.23

mmol/l

0.01

464

3306

Sleep disorders, other/unspecified

119

663

1.87

8.88

3.8

3.5

1.21

1.23

mmol/l

1.72

576

Melanocytic naevi

920

7487

1.25

8.87

5.6

2.8

1.23

mmol/l

0.07

799

6339

Other bursopathies

507

3846

1.35

8.85

4.4

3.8

1.23

mmol/l

0.55

440

3349

Speech disturbances, not elsewhere classified

332

2360

1.45

8.81

4.1

3.7

1.22

1.23

mmol/l

0.83

295

2046

Kyphosis

322

2.34

8.78

5.5

3.3

1.23

mmol/l

0.20

283

Mixed hyperlipidaemia

164

1007

1.70

8.73

8.3

3.3

1.21

1.23

mmol/l

1.83

146

870

Carcinoma in situ of skin of trunk

118

664

1.88

8.68

6.6

2.7

1.23

1.22

mmol/l

1.10

551

Polyuria

839

6790

1.26

8.68

3.9

3.7

1.22

mmol/l

0.01

723

5912

Benign leiomyoma with endometriosis

579

4486

1.32

8.66

3.7

2.8

1.24

mmol/l

0.01

491

3735

Female genital prolapse

1234

5944

1.22

8.65

3.2

3.5

1.24

mmol/l

0.53

1068

5150

Presence of cardiac and vascular implants and grafts

1681

10930

1.18

8.65

4.9

3.8

1.22

1.23

mmol/l

7.48

1566

9509

Other and unspecified mood [affective] disorders

217

1418

1.57

8.64

4.9

3.3

1.23

mmol/l

0.44

194

1238

Preterm labour and delivery

904

7370

1.25

8.63

3.8

3.3

1.23

mmol/l

0.56

781

6414

Benign neoplasm of meninges

355

2561

1.43

8.62

4.3

3.0

1.24

1.23

mmol/l

0.24

315

2123

Peripheral retinal degeneration

132

769

1.81

8.59

3.4

3.7

1.23

mmol/l

0.20

114

674

Benign neoplasm: Cerebral meninges

324

2303

1.45

8.59

4.4

2.8

1.24

1.23

mmol/l

0.37

285

1912

Poor fetal growth

354

2546

1.42

8.56

3.0

2.9

1.22

1.23

mmol/l

0.56

292

2217

Bell's palsy

433

3226

1.37

8.55

3.6

3.9

1.23

mmol/l

0.05

388

2809

Primary gonarthrosis, bilateral

2102

16104

1.16

8.55

3.7

4.0

1.23

mmol/l

0.04

1820

13971

Non-small cell lung cancer

604

4716

1.31

8.53

5.5

4.0

1.23

1.22

mmol/l

2.95

570

4086

Unspecified misadventure during surgical and medical care

207

1351

1.60

8.53

6.7

3.7

1.22

1.23

mmol/l

0.50

202

1171

Other secondary gonarthrosis

212

1392

1.59

8.52

3.9

4.0

1.23

mmol/l

0.20

188

1211

Neuroendocrine tumor and carcinoma of small intestine

320

2.33

8.51

4.8

4.0

1.22

mmol/l

0.38

277

Disorders of synovium and tendon

2055

16174

1.15

8.51

3.9

3.7

1.23

mmol/l

0.11

1782

14095

Hyperhidrosis

108

592

1.90

8.49

3.8

2.6

1.23

mmol/l

0.06

500

Crohn disease (strict definition, all UC cases excluded)

174

1089

1.65

8.48

2.9

3.6

1.22

1.23

mmol/l

0.50

147

943

Other chondrocalcinosis

302

2.38

8.47

5.6

4.2

1.22

mmol/l

0.39

265

Ankylosing spondylitis

316

2239

1.45

8.45

3.3

3.9

1.23

1.22

mmol/l

1.25

284

1970

UC patients in KELA-register (code 208), prior to 1994

179

1133

1.65

8.44

4.5

3.8

1.22

1.23

mmol/l

0.65

155

1000

Alcoholic liver disease

356

2580

1.42

8.43

5.9

4.4

1.20

1.22

mmol/l

7.17

333

2295

Persistent delusional disorders

284

1978

1.48

8.42

3.0

3.8

1.23

mmol/l

0.74

240

1720

Chronic gastritis

790

9745

0.80

8.42

3.9

3.7

1.22

1.23

mmol/l

2.22

699

8352

Demyelinating diseases of the central nervous system

289

2016

1.47

8.42

3.9

3.5

1.23

mmol/l

0.32

249

1755

Cardiac arrest

218

1232

1.57

8.41

6.6

3.0

1.21

1.23

mmol/l

7.21

195

1026

Other disorders of gingiva or/and edentulous alveolar ridge

184

1171

1.63

8.41

11.3

3.3

1.22

1.23

mmol/l

0.17

173

1025

Mixed disorders of conduct and emotions

356

2.16

8.40

3.8

2.6

1.22

mmol/l

0.38

300

Superficial injuries involving multiple body regions

102

553

1.94

8.39

4.8

3.7

1.20

1.23

mmol/l

1.40

478

Pediculosis, acariasis and other infestations

198

1281

1.60

8.38

6.3

4.1

1.22

mmol/l

0.28

183

1127

Parkinson's disease, strict definition, excluding more controls

476

3541

1.35

8.30

3.0

3.7

1.23

mmol/l

0.04

407

3023

Open wound of ankle and foot

350

2533

1.42

8.30

6.5

3.8

1.22

mmol/l

0.56

319

2205

Other shoulder lesions

329

2358

1.43

8.26

4.5

3.8

1.23

mmol/l

0.51

290

2041

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

491

3745

1.34

8.25

4.9

3.0

1.23

mmol/l

0.28

435

3155

Mycoses

959

7912

1.23

8.22

6.1

3.7

1.23

mmol/l

0.53

862

6902

Benign neoplasm of major salivary glands

328

2353

1.43

8.22

4.5

3.1

1.21

1.23

mmol/l

5.13

294

1988

Open wound of wrist and hand

1520

12913

1.18

8.19

3.8

4.1

1.22

mmol/l

0.10

1303

11391

Atypical facial pain

195

1267

1.60

8.19

4.0

3.6

1.23

mmol/l

0.34

177

1081

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

109

609

1.88

8.18

4.1

2.8

1.20

1.22

mmol/l

3.34

104

508

Open wound of forearm

315

2246

1.44

8.16

4.3

3.7

1.22

mmol/l

0.75

277

1952

Fracture of lower leg, including ankle

2139

18744

1.15

8.14

4.6

3.7

1.22

1.23

mmol/l

3.25

1880

16308

Disorders of conjunctiva

3208

24166

1.12

8.14

3.6

3.7

1.23

mmol/l

0.29

2797

21081

Diplopia

483

3687

1.34

8.13

3.9

4.0

1.22

1.23

mmol/l

2.26

438

3229

Social phobias

230

1543

1.52

8.09

3.2

1.22

1.23

mmol/l

0.87

186

1341

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

131

774

1.77

8.07

5.3

2.9

1.21

1.22

mmol/l

2.26

125

644

Ulcerative enterocolitis

121

699

1.81

8.07

5.3

3.7

1.22

1.23

mmol/l

0.32

115

607

Cardiac murmurs and other cardiac sounds

303

2122

1.44

8.05

3.6

3.5

1.23

mmol/l

0.35

264

1812

Contact with nonpowered hand tool

152

934

1.69

8.03

3.7

4.5

1.22

mmol/l

0.41

126

830

Systemic lupus erythematosus, unspecified

125

732

1.80

8.03

4.8

3.5

1.22

1.23

mmol/l

1.14

117

623

Enterocolitis due to Clostridium difficile

402

2994

1.38

8.03

11.8

3.6

1.21

1.23

mmol/l

3.66

367

2581

Episcleritis

187

1209

1.60

8.00

3.9

3.6

1.23

mmol/l

0.05

171

1042

Restless leg syndrome

449

3403

1.35

7.98

3.5

3.8

1.22

1.23

mmol/l

1.35

364

2963

conjunctival haemorrhage

286

2020

1.46

7.97

4.2

4.0

1.23

mmol/l

0.17

255

1760

Acute generalized exanthematous pustulosis

169

1070

1.64

7.96

7.0

3.5

1.22

1.23

mmol/l

0.43

150

915

Acute laryngitis and tracheitis

347

2478

1.40

7.95

4.1

3.5

1.22

1.23

mmol/l

1.58

298

2150

Endometriosis ASRM stages 1,2

611

4817

1.29

7.93

3.0

3.2

1.23

mmol/l

2.00

511

4223

Vasomotor and allergic rhinitis

1367

11492

1.18

7.93

3.0

3.7

1.23

mmol/l

1.22

1231

10023

Other demyelinating diseases of the central nervous system

132

785

1.75

7.91

2.9

3.3

1.22

1.23

mmol/l

1.11

113

683

Other benign neoplasms of skin

1267

10547

1.19

7.89

4.7

2.9

1.23

mmol/l

0.96

1142

8890

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

118

682

1.81

7.89

7.1

3.1

1.21

1.22

mmol/l

0.63

108

567

Hepatic failure, not elsewhere classified

140

849

1.73

7.88

6.0

3.8

1.20

1.23

mmol/l

4.77

134

736

Speech and linguistic disorders, excluding more controls

189

1148

1.58

7.88

4.3

3.5

1.23

mmol/l

0.07

174

1005

Myopia

394

2928

1.37

7.86

4.7

3.5

1.23

mmol/l

0.37

325

2547

COPD related to multimorbidity

1554

11284

1.17

7.85

5.2

4.0

1.21

1.22

mmol/l

13.23

1417

9741

Pregnancy hypertension

1424

10990

1.18

7.83

3.5

3.3

1.23

mmol/l

0.50

1257

9567

Other skin changes

636

5055

1.28

7.83

6.0

3.9

1.23

mmol/l

0.05

574

4393

Other specified/unspecified systemic involvement of connective tissue

219

1475

1.54

7.78

4.2

3.5

1.23

mmol/l

0.27

206

1276

Other intervertebral disc disorders

3402

18803

1.11

7.76

3.5

3.8

1.23

mmol/l

2.00

2992

16429

Toxic effect of other and unspecified substances

232

2.44

7.74

3.8

3.7

1.21

1.23

mmol/l

0.83

206

Carcinoma in situ of skin of upper limb, including shoulder

484

1.98

7.73

7.8

2.6

1.23

1.22

mmol/l

0.24

409

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

349

2560

1.40

7.73

6.5

3.9

1.22

1.23

mmol/l

1.38

320

2238

Adrenomedullary hyperfunction

4.55

7.71

7.2

4.2

1.23

1.22

mmol/l

0.45

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

539

1.90

7.70

4.9

3.3

1.21

1.22

mmol/l

0.47

458

Symptoms and signs involving the skin and subcutaneous tissue

2680

23872

1.13

7.70

4.4

3.7

1.23

mmol/l

0.24

2421

20770

Coxarthrosis, primary, with hip surgery

1902

15817

1.15

7.69

3.5

4.0

1.23

mmol/l

0.94

1659

13680

Melanocytic naevi of trunk

360

2651

1.39

7.66

6.0

2.9

1.23

mmol/l

0.01

316

2246

Assault by bodily force

234

1597

1.50

7.65

4.2

3.7

1.23

mmol/l

0.02

207

1396

Malignant immunoproliferative diseases

204

2.59

7.65

14.0

2.7

1.23

1.22

mmol/l

0.29

169

Appendectomy

2448

20995

1.13

7.63

3.8

1.23

mmol/l

0.08

2185

18349

Coxarthrosis, primary

2431

18789

1.13

7.62

3.6

3.9

1.23

mmol/l

1.70

2129

16296

Special screening examination for neoplasms

1281

0.49

7.62

3.8

3.7

1.23

1.22

mmol/l

0.21

1085

Heart failure and coronary heart disease

1358

8656

1.19

7.61

6.9

3.8

1.21

1.23

mmol/l

23.46

1250

7374

Adhesive capsulitis of shoulder

647

5167

1.28

7.61

4.2

3.8

1.23

mmol/l

0.81

577

4499

Other disorders starting during childhood or adolescence

133

790

1.71

7.61

5.0

3.9

1.22

1.23

mmol/l

0.31

118

673

Hernia

3896

24068

1.11

7.60

4.4

3.7

1.22

1.23

mmol/l

3.83

3456

20999

Cerebral palsy and other paralytic syndromes

390

2914

1.37

7.59

4.4

3.9

1.22

1.23

mmol/l

1.17

358

2533

Melanoma in situ

150

936

1.68

7.58

6.4

3.0

1.22

1.23

mmol/l

0.26

130

791

Benign neoplasm: Parotid gland

260

1818

1.47

7.58

4.4

3.0

1.21

1.23

mmol/l

4.27

230

1533

Other disorders of amniotic fluid and membranes

392

2898

1.36

7.58

2.8

3.3

1.23

mmol/l

0.38

334

2546

Bacterial, viral and other infectious agents

282

1999

1.45

7.57

5.5

4.0

1.22

1.23

mmol/l

1.46

256

1755

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

242

1668

1.49

7.55

3.5

3.0

1.23

mmol/l

1.36

212

1466

Malignant neoplasm of stomach

194

1284

1.57

7.53

4.6

4.1

1.22

mmol/l

0.68

180

1121

Benign neoplasm of bone and articular cartilage

254

1768

1.47

7.52

4.0

2.8

1.22

1.23

mmol/l

0.78

218

1502

Localized swelling, mass and lump of skin and subcutaneous tissue

822

9985

0.81

7.52

4.3

3.8

1.23

mmol/l

0.11

751

8681

Superficial injury of forearm

316

2288

1.41

7.49

3.2

3.6

1.23

1.22

mmol/l

0.15

281

1992

Use of antiglaucoma preparations and miotics

318

2313

1.42

7.47

5.8

3.6

1.23

mmol/l

0.52

278

1974

Benign neoplasm of mouth and pharynx

356

2631

1.38

7.46

4.3

2.9

1.22

1.23

mmol/l

0.78

319

2227

Intermittent heterotropia

184

1202

1.57

7.45

5.1

3.8

1.23

mmol/l

0.14

159

1039

Biological medicines for asthma

256

2.35

7.45

3.2

3.4

1.23

mmol/l

0.10

232

Other injuries of spine and trunk, level unspecified

164

2.74

7.39

5.6

4.0

1.20

1.22

mmol/l

0.85

145

Haemolytic anaemias

129

779

1.73

7.39

9.5

3.8

1.22

1.23

mmol/l

0.18

120

673

Corneal ulcer

629

5022

1.27

7.38

4.9

3.8

1.22

1.23

mmol/l

0.75

567

4410

Primary angle-closure glaucoma

180

1180

1.59

7.38

4.5

4.0

1.23

mmol/l

0.05

158

1017

Other disorders of eyelid

1798

15227

1.15

7.37

3.6

3.8

1.23

mmol/l

0.70

1560

13179

Other appendicitis

305

2205

1.42

7.36

4.0

1.23

mmol/l

0.14

271

1928

Other and unspecified disorders of vitreous body

1603

13879

1.16

7.35

4.0

3.8

1.23

mmol/l

0.45

1392

12066

Portal vein thrombosis

325

2.18

7.31

6.6

4.4

1.23

mmol/l

0.08

291

Antenatal screening

482

3515

0.76

7.29

2.3

3.3

1.23

mmol/l

0.13

421

3059

Chronic periodontitis

531

4165

1.30

7.29

9.9

3.6

1.22

1.23

mmol/l

0.25

505

3660

Endometriosis of rectovaginal septum and vagina

314

2288

1.41

7.28

3.0

3.4

1.24

mmol/l

0.12

264

1950

Enthesopathies of lower limb, excluding foot

792

6492

1.24

7.28

3.3

3.7

1.23

mmol/l

0.03

691

5668

Diffuse brain injury

125

749

1.73

7.26

3.6

3.5

1.22

mmol/l

0.55

106

647

Diseases of spleen

388

2.07

7.25

7.3

3.4

1.22

1.23

mmol/l

0.71

344

Ocular pain

278

1987

1.44

7.20

3.7

3.5

1.23

mmol/l

0.32

247

1725

Congenital malformations and deformations of the musculoskeletal system

262

1839

1.45

7.19

4.0

3.6

1.23

mmol/l

0.17

233

1588

Generalized skin eruption due to drugs and medicaments

148

932

1.65

7.18

7.5

3.5

1.22

1.23

mmol/l

0.51

132

801

Conjunctivitis (acute, non atopic)

952

7928

1.21

7.15

4.5

3.7

1.23

mmol/l

0.46

828

6955

Use of rasagiline

112

661

1.80

7.15

3.1

3.8

1.23

1.22

mmol/l

0.10

573

Unstable angina pectoris

1573

11342

1.16

7.12

4.5

3.9

1.22

1.23

mmol/l

6.72

1437

9720

Lesion of ulnar nerve

484

3765

1.31

7.09

4.5

4.1

1.22

mmol/l

0.44

442

3318

Pre-eclampsia

669

5403

1.26

7.08

3.8

3.2

1.23

mmol/l

0.45

597

4733

Other local infections of skin and subcutaneous tissue

346

2570

1.38

7.07

7.6

3.6

1.23

mmol/l

0.04

314

2237

Other and unspecified urticaria

670

5416

1.26

7.06

4.0

3.7

1.23

mmol/l

1.12

570

4732

Haemangioma and lymphangioma, any site

277

1985

1.43

7.03

3.6

2.9

1.23

mmol/l

0.04

254

1666

Atopic conjunctivitis

161

1039

1.60

7.00

2.9

3.3

1.23

mmol/l

0.11

144

902

Trigeminal neuralgia

220

1517

1.50

7.00

3.3

3.6

1.23

mmol/l

0.33

196

1302

Calculus of lower urinary tract

199

1347

1.53

6.99

3.8

4.3

1.23

1.22

mmol/l

3.47

175

1181

Other infective otitis externa

1479

0.55

6.97

4.9

3.7

1.23

mmol/l

0.14

1274

Colon adenocarcinoma

450

3484

1.32

6.95

4.5

3.9

1.22

mmol/l

0.39

409

3030

Other and unspecified local infections of skin and subcutaneous tissue

327

2416

1.39

6.93

7.8

3.6

1.22

1.23

mmol/l

0.15

296

2096

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

152

2.78

6.93

15.8

2.6

1.24

1.22

mmol/l

1.43

125

Behavioural disorders, excluding more controls

248

2.25

6.90

3.7

3.9

1.23

mmol/l

0.01

212

Maternal care for other known or suspected fetal problems

670

3454

1.26

6.89

2.6

3.2

1.22

1.23

mmol/l

1.50

561

3037

Striae atrophicae

213

2.42

6.88

4.8

3.4

1.24

1.23

mmol/l

0.51

179

Alzheimer’s disease, wide definition

643

6632

0.80

6.87

3.2

3.8

1.23

mmol/l

0.56

494

5707

Postmenopausal bleeding

1145

5331

1.20

6.87

3.5

3.6

1.24

mmol/l

0.63

988

4602

Scleritis and episcleritis

209

1431

1.50

6.87

4.1

3.6

1.23

mmol/l

0.40

189

1234

Other bacterial intestinal infections

656

5312

1.26

6.86

9.5

3.6

1.22

1.23

mmol/l

4.70

602

4582

Benign neoplasm: Skin of trunk

136

848

1.66

6.84

6.2

2.8

1.23

mmol/l

0.34

127

698

Secondary parkinsonism, excluding more controls

517

1.86

6.81

4.9

3.6

1.24

1.23

mmol/l

0.67

447

Other and unspecified hydrocephalus

440

1.96

6.79

5.8

3.8

1.22

1.23

mmol/l

0.45

385

Dislocation of lens

314

2.14

6.75

6.3

3.5

1.23

1.22

mmol/l

0.19

266

Diseases of salivary glands

686

5591

1.25

6.72

3.6

3.4

1.23

mmol/l

0.71

613

4860

D07AA Corticosteroids, weak (group I)

492

3854

1.30

6.72

3.7

1.22

1.23

mmol/l

2.39

425

3344

Osteomyelitis of vertebra

3.80

6.71

5.0

3.3

1.19

1.23

mmol/l

2.56

Vitamin B12 deficiency anaemia

408

3131

1.33

6.70

4.4

3.5

1.21

1.23

mmol/l

3.54

355

2693

Pre-eclampsia or eclampsia

724

5940

1.24

6.64

3.8

3.2

1.23

mmol/l

0.50

650

5186

Microscopic polyangiitis

145

2.83

6.59

10.7

4.0

1.22

1.23

mmol/l

0.15

128

Disorders of iron metabolism

297

2.16

6.58

3.9

3.2

1.23

mmol/l

0.07

264

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

465

1.89

6.55

5.8

2.6

1.22

1.23

mmol/l

0.12

387

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

156

1014

1.58

6.55

6.1

2.8

1.21

1.23

mmol/l

1.48

146

855

Gestational [pregnancy-induced] hypertension

806

6678

1.22

6.50

3.1

1.23

mmol/l

0.02

702

5834

Carcinoma in situ of skin of scalp and neck

102

604

1.80

6.50

6.7

3.7

1.22

mmol/l

0.20

525

Spontaneous rupture of synovium and tendon

305

2256

1.39

6.49

4.5

4.0

1.23

mmol/l

0.36

279

1953

Abnormal involuntary movements

452

3530

1.31

6.48

4.3

3.8

1.22

1.23

mmol/l

0.47

392

3063

Cluster headache, wide

123

758

1.68

6.47

3.0

3.4

1.22

1.23

mmol/l

0.28

111

655

Dependent personality disorder

483

1.88

6.47

4.3

3.6

1.23

mmol/l

0.66

421

Injuries involving multiple body regions

131

822

1.65

6.46

4.6

3.8

1.21

1.23

mmol/l

1.41

115

710

Haemangioma, any site

257

1847

1.42

6.46

3.7

2.9

1.23

mmol/l

0.26

234

1549

Pruritus

383

2931

1.33

6.42

5.9

3.5

1.23

mmol/l

0.60

333

2525

Rash and other nonspecific skin eruption

354

2681

1.35

6.41

5.4

3.7

1.23

mmol/l

0.09

322

2341

Other and unspecified disorders of skin and subcutaneous tissue

107

1742

0.60

6.41

5.1

3.4

1.23

mmol/l

0.04

1511

Non-Hodgkin lymphoma, all

151

984

1.60

6.40

12.7

3.8

1.23

1.22

mmol/l

1.26

146

854

Cluster headache, strict, including avohilmo

160

1053

1.57

6.39

2.9

3.8

1.22

1.23

mmol/l

0.46

145

920

Suppurative and necrotic conditions of lower respiratory tract

190

1298

1.51

6.38

6.9

4.2

1.21

1.22

mmol/l

1.08

182

1135

Lumbar disc prolapse

2474

17692

1.12

6.37

3.5

3.8

1.23

mmol/l

0.89

2170

15493

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1601

12292

1.15

6.36

3.5

3.3

1.23

mmol/l

0.44

1410

10669

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

323

2.10

6.36

5.2

4.0

1.22

mmol/l

0.02

285

Thyroiditis

253

1822

1.43

6.35

3.2

3.6

1.23

mmol/l

0.27

206

1581

Benign neoplasm of eye and adnexa

320

2391

1.37

6.34

4.7

2.9

1.23

mmol/l

0.15

278

2015

Postprocedural disorders of digestive system, not elsewhere classified

122

758

1.68

6.33

7.4

3.5

1.23

mmol/l

0.14

116

650

Cluster headache, wide,, including avohilmo

170

1136

1.54

6.32

2.8

3.8

1.22

1.23

mmol/l

0.53

154

994

Other diseases of intestine

450

3527

1.30

6.32

6.5

3.8

1.22

1.23

mmol/l

1.11

404

3031

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

515

1.83

6.31

3.9

2.4

1.23

mmol/l

0.11

415

Embedded and impacted teeth

724

5060

1.23

6.29

3.8

3.4

1.23

1.22

mmol/l

0.54

620

4402

Triptan medication for migraine, min. 3 purchases

1906

13342

1.14

6.29

2.7

3.6

1.23

mmol/l

0.13

1659

11700

Other diseases of arteries and capillaries

329

2475

1.36

6.27

6.4

3.5

1.22

1.23

mmol/l

3.01

295

2142

Cervicalgia

763

6335

1.22

6.26

3.3

3.7

1.23

mmol/l

0.55

666

5473

Anti-inflammatory and antirheumatic products, non-steroids

1262

5445

1.18

6.25

3.7

4.7

1.22

mmol/l

0.36

1097

4796

Pedal cyclist injured in other and unspecified transport accidents

373

2855

1.33

6.24

3.3

3.8

1.22

1.23

mmol/l

0.39

338

2480

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

110

666

1.70

6.20

6.6

3.5

1.22

1.23

mmol/l

2.14

101

570

Myositis

101

601

1.76

6.20

6.2

3.7

1.22

mmol/l

0.07

515

Amputation of toe

253

1832

1.42

6.20

12.2

3.8

1.20

1.22

mmol/l

5.88

233

1598

False labour

886

4658

1.21

6.16

2.6

3.3

1.22

1.23

mmol/l

2.40

761

4099

Right bundle-branch block

134

857

1.62

6.15

4.0

3.4

1.22

1.23

mmol/l

0.24

117

743

Cluster headache, strict

113

692

1.69

6.12

3.0

3.3

1.22

1.23

mmol/l

0.18

102

605

Ehlers-Danlos syndrome

160

2.54

6.12

2.0

3.5

1.22

1.23

mmol/l

0.61

138

Arthropathy in Crohn disease

179

2.45

6.12

2.5

3.7

1.24

1.22

mmol/l

0.76

156

Otitis media, unspecified

337

2340

1.35

6.11

5.0

3.3

1.23

mmol/l

0.13

291

2007

Drug-induced hypoglycaemia without coma

340

2.02

6.11

8.7

3.8

1.20

1.23

mmol/l

2.33

294

Artificial opening status

180

1228

1.51

6.11

7.4

3.7

1.21

1.23

mmol/l

2.37

168

1066

Habit and impulse disorders

263

2.15

6.10

2.8

3.6

1.21

1.23

mmol/l

0.89

235

Inflammatory diseases of female pelvic organs

2327

15771

1.12

6.07

3.4

3.3

1.23

mmol/l

1.99

2001

13636

Any dementia, excluding more controls

1395

8441

1.16

6.07

3.5

3.7

1.23

mmol/l

0.04

1134

7278

Myocardial infarction, strict

1840

11918

1.14

6.06

5.6

3.8

1.21

1.23

mmol/l

14.44

1651

10276

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

123

774

1.65

6.04

5.8

3.1

1.22

mmol/l

0.37

117

655

Glaucoma, exfoliation

427

3350

1.30

6.01

3.3

3.6

1.23

mmol/l

1.80

369

2856

Triptan medication for migraine, single purchase ok

2905

17877

1.11

6.00

2.9

3.8

1.23

mmol/l

1.06

2534

15641

Migraine, single triptan purchase ok & required. ICD-code if available is included

2905

17877

1.11

6.00

2.9

3.8

1.23

mmol/l

1.06

2534

15641

Other specified and unspecified disorders of eye and adnexa

948

0.48

5.99

2.6

3.6

1.23

mmol/l

0.00

814

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

133

854

1.61

5.99

3.5

3.1

1.23

1.22

mmol/l

0.46

120

714

Injury of nerves and spinal cord at neck level

481

1.84

5.94

3.7

3.9

1.22

mmol/l

0.27

428

Disorders of psychological development

305

2109

1.36

5.93

4.3

3.6

1.22

1.23

mmol/l

0.62

271

1817

Congenital malformations of the musculoskeletal system, not elsewhere classified

274

2.12

5.91

2.6

3.7

1.22

mmol/l

0.34

236

Other extrapyramidal and movement disorders in other diseases

823

6926

1.21

5.91

3.9

1.23

mmol/l

0.77

688

6034

Anankastic personality disorder

122

770

1.64

5.88

3.0

3.5

1.23

mmol/l

0.03

666

Malignant melanoma

531

4285

1.26

5.87

5.1

4.0

1.23

mmol/l

0.55

470

3742

Ankylosing spondylitis, ICD10

299

2239

1.36

5.87

3.4

3.9

1.23

mmol/l

0.73

270

1960

Superficial injury of ankle and foot

359

2756

1.32

5.85

4.0

3.6

1.22

1.23

mmol/l

0.51

318

2392

Contusion of other and unspecified parts of foot

154

1025

1.54

5.85

3.5

3.4

1.22

1.23

mmol/l

0.61

134

873

Gastric ulcer

693

5746

1.23

5.84

6.1

3.9

1.22

1.23

mmol/l

3.63

634

4932

Candidiasis

460

3651

1.28

5.83

7.1

3.4

1.22

1.23

mmol/l

0.96

409

3159

Other misadventures during surgical and medical care

477

1.83

5.83

6.3

3.8

1.22

1.23

mmol/l

1.09

416

Malignant neoplasm of head and neck

290

2167

1.37

5.83

5.1

4.2

1.23

1.22

mmol/l

0.30

268

1907

Atopic dermatitis, strict definition with reimbursement

929

7648

1.19

5.82

4.2

3.4

1.23

mmol/l

0.00

827

6710

Nail disorders

277

2054

1.38

5.82

6.2

3.6

1.23

mmol/l

0.20

253

1779

Nummular dermatitis

290

2168

1.37

5.81

4.1

3.8

1.23

1.22

mmol/l

0.39

255

1892

Other and unspecified intracranial injuries

106

650

1.69

5.79

3.9

3.5

1.22

mmol/l

0.53

566

Glucosamine medication

2092

14991

1.12

5.79

3.5

3.9

1.23

mmol/l

1.28

1780

12981

Follow-up examination after treatment for conditions other than malignant neoplasms

1538

11429

0.87

5.77

3.2

3.7

1.23

mmol/l

1.14

1360

9698

Somnolence, stupor and coma

158

1063

1.53

5.76

6.1

3.8

1.21

1.22

mmol/l

1.72

146

917

Bacterial intestinal infections, IBD co-morbidities

652

5383

1.23

5.74

9.5

3.8

1.22

1.23

mmol/l

4.37

598

4672

Other/unspecified enthesopathies of lower limb, excluding foot

240

1743

1.41

5.73

3.0

3.5

1.23

mmol/l

0.11

210

1511

Sequelae of other and unspecified infectious and parasitic diseases

180

1243

1.49

5.72

4.2

3.8

1.22

1.23

mmol/l

0.66

157

1095

Localized skin eruption due to drugs and medicaments

259

2.16

5.70

4.2

3.9

1.21

1.22

mmol/l

1.14

232

Dystonia

196

1379

1.46

5.69

2.9

3.7

1.23

mmol/l

0.44

169

1195

Oligomenorrhoea

122

777

1.62

5.68

2.5

2.9

1.22

1.23

mmol/l

1.24

111

666

Ovarian dysfunction

208

1474

1.44

5.68

3.7

2.4

1.22

1.23

mmol/l

0.24

189

1254

Abnormality of red blood cells

119

2.83

5.64

5.9

4.1

1.20

1.22

mmol/l

0.69

103

Nonspecific lymphadenitis

200

1412

1.45

5.64

5.2

3.6

1.23

mmol/l

0.11

181

1230

Paralytic strabismus

249

1828

1.40

5.64

5.2

4.0

1.23

1.22

mmol/l

0.16

222

1582

Fenamates

611

3366

1.24

5.63

3.3

4.5

1.23

mmol/l

0.76

537

2963

Carcinoma in situ, bladder

125

808

1.62

5.60

4.3

4.2

1.23

1.22

mmol/l

1.22

105

709

Carcinoma in situ of other and unspecified sites

134

880

1.59

5.59

4.5

4.3

1.23

1.22

mmol/l

0.73

112

772

Other benign neoplasms of connective and other soft tissue

305

2308

1.35

5.58

4.8

3.0

1.23

mmol/l

0.09

271

1953

Cervicocranial syndrome

389

3046

1.30

5.54

3.5

3.7

1.23

mmol/l

0.09

342

2653

COPD, hospital admission 2, with asthma infections

1217

9042

1.16

5.54

5.2

3.9

1.21

1.22

mmol/l

12.90

1118

7820

Intercostal neuropathy

189

2.37

5.53

4.3

3.6

1.22

mmol/l

0.13

170

Autism

364

1.90

5.53

3.2

4.2

1.21

1.23

mmol/l

1.94

317

Burns and corrosions of external body surface, specified by site

341

2624

1.32

5.52

4.6

3.9

1.22

mmol/l

0.60

294

2298

Other mental disorders due to brain damage and dysfunction and to physical disease

408

3219

1.29

5.52

4.0

3.8

1.23

mmol/l

0.03

341

2818

Acute nephritic syndrome

477

1.80

5.51

12.9

3.3

1.22

1.23

mmol/l

0.55

419

Chronic periodontitis, complicated

324

2482

1.34

5.50

10.3

4.1

1.22

mmol/l

0.45

312

2178

Burns and corrosions

432

3426

1.28

5.50

4.4

4.0

1.22

mmol/l

0.44

378

3013

Mild mental retardation

484

1.78

5.47

4.0

3.8

1.24

1.23

mmol/l

0.96

433

Macular pucker

553

4523

1.25

5.47

4.5

3.9

1.23

mmol/l

0.60

476

3971

Decubitus ulcer and pressure area

204

1457

1.44

5.47

9.9

3.6

1.21

1.22

mmol/l

2.51

194

1264

Malignant immunoproliferative diseases

237

2.21

5.46

14.0

3.9

1.23

1.22

mmol/l

0.21

205

Autoimmune thyroiditis

383

1.89

5.42

3.8

3.1

1.23

1.24

mmol/l

0.20

330

Prurigo nodularis

101

626

1.69

5.41

7.1

3.6

1.21

1.23

mmol/l

2.78

543

Left bundle-branch block

258

1918

1.38

5.40

4.4

3.3

1.22

1.23

mmol/l

1.96

237

1645

Benign neoplasm: Small intestine

135

893

1.57

5.40

4.0

3.0

1.23

mmol/l

0.27

126

753

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

540

1.74

5.39

7.0

2.8

1.21

1.22

mmol/l

0.54

445

Juvenile rheumatoid arthirtis

419

1.83

5.39

4.2

2.9

1.22

1.23

mmol/l

0.80

351

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

163

2.39

5.39

5.9

3.0

1.24

1.22

mmol/l

1.20

138

Other disorders of optic [2nd] nerve and visual pathways

211

1520

1.43

5.36

5.9

3.6

1.22

1.23

mmol/l

1.06

188

1304

Family history of certain disabilities and chronic diseases leading to disablement

136

899

1.55

5.36

2.4

3.0

1.23

mmol/l

0.25

116

765

Malignant neoplasm of tonsil

336

1.97

5.36

4.7

4.1

1.25

1.22

mmol/l

0.82

301

Infectious mononucleosis

226

1642

1.40

5.33

3.3

3.1

1.22

1.23

mmol/l

2.32

194

1422

Peripheral artery disease

1746

12553

1.13

5.33

7.3

3.7

1.21

1.23

mmol/l

18.72

1566

10806

Cervical disc disorders

1380

12169

1.14

5.31

3.5

3.9

1.23

mmol/l

0.08

1206

10618

Abdominal aortic aneurysm (AAA)

371

2880

1.30

5.31

6.3

3.8

1.21

1.22

mmol/l

1.76

336

2501

Hereditary factor VIII deficiency

3.90

5.30

2.1

3.2

1.23

mmol/l

0.02

Neuralgia and neuritis, unspecified

175

1223

1.47

5.28

4.7

3.7

1.22

1.23

mmol/l

1.46

165

1052

Maternal care for known or suspected fetal abnormality and damage

251

2994

0.74

5.28

2.4

3.2

1.22

1.23

mmol/l

2.03

212

2628

Benign lipomatous neoplasm

941

8080

1.18

5.27

3.9

3.0

1.23

mmol/l

1.14

835

6840

Non-small cell lung cancer, adenocarcinoma, helper endpoint

238

1758

1.39

5.26

6.0

3.9

1.22

mmol/l

0.18

226

1527

Non-small cell lung cancer, adenocarcinoma

238

1758

1.39

5.26

6.0

3.9

1.22

mmol/l

0.18

226

1527

Injury of eye and orbit

444

3552

1.27

5.26

4.4

4.0

1.22

mmol/l

0.83

404

3118

Carcinoma in situ of colon

340

1.96

5.21

5.6

4.2

1.22

mmol/l

0.01

299

Duodenal ulcer

405

3216

1.28

5.19

6.0

4.0

1.22

mmol/l

1.02

370

2773

Benign neoplasm: Skin of other and unspecified parts of face

347

2702

1.31

5.19

4.6

2.9

1.23

mmol/l

0.09

309

2249

Appendicitis, broad definition

2825

23667

1.10

5.18

3.8

1.23

mmol/l

0.10

2518

20704

Other conditions related to polyarteritis nodosa

4.04

5.18

6.3

5.2

1.23

1.22

mmol/l

0.20

Chronic ulcer of skin, not elsewhere classified

242

1795

1.38

5.17

8.1

3.6

1.22

mmol/l

0.82

225

1547

Diseases of appendix

2853

23834

1.10

5.17

3.8

1.23

mmol/l

0.09

2544

20853

Voice disturbances

960

8277

1.17

5.16

4.2

3.7

1.22

1.23

mmol/l

2.97

830

7216

Agoraphobia

529

1.71

5.16

3.1

2.9

1.22

1.23

mmol/l

0.47

463

Ingrowing nail

179

1262

1.46

5.15

6.9

3.6

1.22

1.23

mmol/l

0.65

165

1105

Carcinoma in situ of other and unspecified digestive organs

102

643

1.67

5.15

5.5

4.0

1.22

mmol/l

0.15

558

Hepatocellular carcinoma

473

1.78

5.14

6.0

3.9

1.20

1.22

mmol/l

1.23

406

Rosacea

387

3063

1.29

5.10

4.1

3.7

1.23

mmol/l

0.37

331

2680

Wide developmental disorders

447

1.77

5.10

3.7

4.4

1.21

1.23

mmol/l

1.61

392

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

146

993

1.51

5.09

5.0

3.1

1.24

1.23

mmol/l

0.92

137

831

Reactive arthropathies

301

2307

1.33

5.08

4.8

3.9

1.22

1.23

mmol/l

0.63

268

2019

Polycystic ovarian syndrome

146

990

1.51

5.08

2.5

2.2

1.22

1.23

mmol/l

0.71

131

832

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

223

2.19

5.08

3.8

4.2

1.22

mmol/l

0.12

197

Benign neoplasm: Choroid

192

1376

1.44

5.08

4.7

2.9

1.23

mmol/l

0.23

161

1155

Iridocyclitis in diseases classified elsewhere

407

1.83

5.07

3.3

3.7

1.23

mmol/l

0.59

352

Allergic rhinitis

978

8363

1.17

5.06

2.9

3.7

1.23

mmol/l

0.14

891

7363

Superficial injury of shoulder and upper arm

368

2901

1.29

5.00

3.9

3.7

1.23

mmol/l

0.25

313

2516

Pain associated with micturition

408

3259

1.28

4.99

3.6

3.5

1.23

mmol/l

0.83

365

2818

Injury of other and unspecified intrathoracic organs

213

1557

1.40

4.99

4.6

4.2

1.22

mmol/l

0.60

198

1363

Benign neoplasm: Skin, unspecified

145

991

1.51

4.99

5.1

3.6

1.22

1.23

mmol/l

0.42

128

855

Alcohol-induced acute pancreatitis

120

788

1.58

4.98

6.2

4.4

1.20

1.22

mmol/l

2.82

105

697

Injuries to unspecified part of trunk, limb or body region

327

2543

1.31

4.97

5.7

3.8

1.22

1.23

mmol/l

1.03

297

2213

Autism spe

348

1.87

4.97

2.9

3.5

1.21

1.23

mmol/l

2.15

306

Contact with sharp glass

117

763

1.58

4.96

3.7

3.6

1.23

mmol/l

0.01

658

Pneumonia derived septicemia

119

782

1.58

4.93

5.4

3.9

1.22

mmol/l

0.01

107

671

Viral meningitis

121

797

1.57

4.93

4.9

3.3

1.22

1.23

mmol/l

0.48

105

684

Injury of blood vessels at lower leg level

2.86

4.91

12.4

4.1

1.21

1.22

mmol/l

0.62

Viral infections of the central nervous system

240

1791

1.37

4.91

6.4

3.7

1.22

1.23

mmol/l

0.82

212

1545

Malignant neoplasm of liver and intrahepatic bile ducts

119

784

1.58

4.91

6.1

3.9

1.20

1.22

mmol/l

1.36

110

679

Congenital malformations of great arteries

315

1.91

4.90

3.2

5.0

1.22

1.23

mmol/l

0.26

277

Benign neoplasm: Duodenum

548

1.70

4.90

3.6

2.8

1.22

mmol/l

0.02

462

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

353

2782

1.30

4.89

4.8

4.0

1.22

mmol/l

1.16

313

2436

Alzheimer’s disease (Late onset)

595

6108

0.82

4.89

3.2

3.7

1.23

1.22

mmol/l

0.50

455

5250

Other diseases of lip and oral mucosa

563

4665

1.22

4.86

5.0

3.5

1.23

mmol/l

0.33

504

4055

Exclusion endpoint for clefts

315

1.91

4.85

6.4

4.9

1.22

1.23

mmol/l

0.37

278

Atrophic disorders of skin

518

4261

1.24

4.85

3.5

3.4

1.23

mmol/l

0.26

448

3688

Other peripheral vertigo

334

2618

1.30

4.84

3.7

3.9

1.23

mmol/l

0.18

298

2268

Other congenital malformations

256

1930

1.35

4.83

4.7

3.7

1.22

1.23

mmol/l

0.56

233

1677

Polyhydramnios

132

888

1.52

4.83

3.7

3.0

1.22

1.23

mmol/l

1.83

111

773

MS-disease / Multiple Sclerosis

228

1692

1.38

4.82

4.0

3.4

1.23

mmol/l

0.33

192

1466

Open wound of shoulder and upper arm

390

1.82

4.82

5.5

4.0

1.23

mmol/l

0.12

342

Disorders of breast

1818

15183

1.12

4.82

3.3

3.4

1.24

1.23

mmol/l

2.37

1617

13104

Reactive arthropathies, FINNGEN

230

1710

1.37

4.82

4.2

3.8

1.23

mmol/l

0.20

207

1473

Assault by blunt object

246

2.04

4.81

4.3

4.1

1.22

mmol/l

0.17

223

Spondylolisthesis/Spondylolysis

660

5558

1.20

4.78

3.4

3.8

1.23

mmol/l

0.28

583

4819

Other specified congenital malformation syndromes affecting multiple systems

246

2.03

4.78

7.1

5.1

1.22

1.23

mmol/l

0.34

221

Benign neoplasm of middle ear and respiratory system

276

2114

1.34

4.76

3.8

3.9

1.22

mmol/l

0.22

250

1851

Other diseases of jaws

228

1697

1.37

4.76

6.0

3.4

1.23

mmol/l

0.99

211

1487

Diseases of middle ear and mastoid

2011

14912

1.11

4.75

4.2

3.6

1.22

1.23

mmol/l

2.55

1769

13010

Endometriosis of ovary

593

4934

1.21

4.74

3.2

3.4

1.23

mmol/l

0.10

519

4289

Bullous disorders

202

1480

1.40

4.72

5.1

3.7

1.23

mmol/l

1.09

183

1263

Other disorders of the musculoskeletal system and connective tissue

507

4173

1.24

4.72

3.7

3.9

1.23

mmol/l

0.18

443

3652

Other and unspecified injuries of wrist and hand

123

822

1.54

4.70

4.5

3.7

1.23

mmol/l

0.14

104

704

Pustular psoriasis

165

1170

1.45

4.68

3.9

3.7

1.23

mmol/l

0.33

142

1019

Soft tissue disorders related to use, overuse and pressure

967

8408

1.16

4.67

3.4

3.7

1.23

mmol/l

0.09

867

7321

Malignant neoplasm of mesothelium and soft tissue

159

1122

1.46

4.67

8.0

3.8

1.23

1.22

mmol/l

0.07

148

968

Melanoma in situ

150

1049

1.48

4.66

6.4

3.8

1.22

mmol/l

0.02

130

904

Arthropathy in ulcerative colitis

257

2.01

4.65

2.7

3.8

1.23

mmol/l

0.06

227

Malignant neoplasm of other connective and soft tissue

580

1.66

4.65

9.6

3.8

1.23

mmol/l

0.31

502

Aphakia

284

1.94

4.65

4.7

3.7

1.23

1.22

mmol/l

0.25

241

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

323

1.91

4.64

5.5

2.7

1.23

mmol/l

0.22

265

Carcinoma in situ of skin of lower limb, including hip

450

1.76

4.63

6.8

2.7

1.24

1.22

mmol/l

0.79

375

Optic neuritis

137

939

1.50

4.63

4.0

3.2

1.22

1.23

mmol/l

0.82

124

809

Pneumococcal septicemia

114

754

1.56

4.62

5.5

3.8

1.22

mmol/l

0.01

102

646

Retinal detachments and breaks

1304

11576

1.14

4.62

4.5

3.8

1.23

mmol/l

0.04

1116

10124

Carcinoma in situ of cervix uteri

269

2059

1.33

4.61

3.2

2.9

1.23

mmol/l

0.28

228

1758

Brain meningioma, excluding all cancers (controls excluding all cancers)

167

1190

1.44

4.60

3.8

2.9

1.23

mmol/l

0.04

151

987

Alopecia areata

572

1.65

4.60

4.1

3.2

1.23

mmol/l

0.49

490

Sequelae of injuries of neck and trunk

635

1.61

4.59

3.3

3.8

1.22

mmol/l

0.61

554

Other aneurysm

191

1394

1.41

4.58

7.4

3.7

1.22

mmol/l

0.42

172

1215

Myocardial infarction, unclassifiable

621

6570

0.83

4.58

5.2

3.9

1.21

1.22

mmol/l

7.70

556

5658

Acute appendicitis, no complications

1965

17780

1.11

4.58

3.7

3.8

1.23

mmol/l

0.13

1743

15589

Polyarthritis, unspecified

130

885

1.52

4.58

3.9

3.6

1.23

mmol/l

0.03

121

750

Polycystic ovarian syndrome, broad definition

288

2224

1.31

4.57

2.4

2.8

1.22

1.23

mmol/l

1.59

253

1911

Benign neoplasm: Sigmoid colon

464

5642

0.81

4.57

5.1

4.0

1.23

mmol/l

0.09

413

4921

Other and unspecified nerve root and plexus disorders, also in other diseases

623

5242

1.20

4.56

3.6

3.9

1.23

mmol/l

0.50

542

4606

Other and unspecified abdominal hernia

155

1094

1.47

4.56

6.4

3.9

1.23

mmol/l

0.30

140

935

Benign neoplasm: Oesophagus

224

2.08

4.56

8.0

3.0

1.23

1.22

mmol/l

0.40

190

Paralytic ileus

134

919

1.50

4.55

5.1

3.7

1.22

1.23

mmol/l

1.08

116

786

Panniculitis affecting regions of neck and back

131

894

1.51

4.54

3.6

3.2

1.23

mmol/l

0.05

122

759

Other renal tubulo-interstitial diseases

559

1.66

4.53

11.6

3.0

1.22

1.23

mmol/l

0.96

475

Carcinoma in situ of breast, intraductal

276

2131

1.32

4.51

3.3

2.7

1.24

mmol/l

0.83

250

1785

Malignant neoplasm of corpus uteri

328

2595

1.30

4.51

3.2

3.5

1.24

mmol/l

0.47

278

2211

Other or unspecified common variable immunodeficiency

3.30

4.51

5.8

3.6

1.21

1.23

mmol/l

0.69

Superficial injury of wrist and hand

613

5155

1.20

4.49

3.7

3.8

1.23

mmol/l

0.36

535

4513

Correction of physiology of bite - very demanding therapy visit

631

1.61

4.49

2.7

3.1

1.23

mmol/l

0.05

543

Noise effects on inner ear

936

0.55

4.48

3.8

4.5

1.21

1.22

mmol/l

0.22

835

Hypersomnia

304

1.91

4.47

2.9

3.8

1.23

mmol/l

0.13

266

Gluteal tendinitis

130

890

1.51

4.47

4.1

3.3

1.24

1.23

mmol/l

0.70

117

767

Asthma and allergy, excluding more controls

353

2769

1.27

4.46

3.0

2.8

1.23

mmol/l

0.48

317

2359

Vascular disorders of the intestines

241

1831

1.35

4.44

6.8

3.5

1.22

1.23

mmol/l

0.41

221

1568

Carcinoma in situ of skin of trunk

118

797

1.55

4.43

6.6

3.7

1.23

1.22

mmol/l

1.02

689

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

2.78

4.42

3.5

3.7

1.20

1.22

mmol/l

0.89

Melanoma in situ of trunk

248

2.00

4.41

4.1

2.7

1.22

mmol/l

0.27

215

Other symptoms and signs involving the circulatory and respiratory systems

204

1511

1.38

4.41

3.8

3.5

1.23

mmol/l

0.58

173

1291

Burn and corrosion of shoulder and upper limb, except wrist and hand

416

1.75

4.41

3.5

3.8

1.22

1.23

mmol/l

0.42

358

Other disorders of breast

281

3598

0.77

4.41

2.8

3.3

1.23

1.24

mmol/l

0.71

256

3118

Malignant neoplasm of oropharynx

381

1.80

4.40

4.6

4.2

1.25

1.22

mmol/l

1.08

341

Tonsillectomy and adenotomy

1531

11890

0.89

4.40

3.6

1.22

1.23

mmol/l

0.51

1332

10508

Rotator cuff syndrome

2450

16697

1.10

4.38

3.6

3.9

1.23

mmol/l

0.00

2196

14578

Striking against or struck by other objects

1028

9010

1.15

4.37

3.9

4.0

1.22

mmol/l

0.14

896

7938

Other/unspecified enthesopathies, not elsewhere classified

310

2440

1.29

4.35

3.4

3.9

1.23

mmol/l

0.33

285

2112

Amputation

340

2706

1.28

4.35

12.2

3.9

1.20

1.22

mmol/l

6.53

314

2356

Motorcycle rider injured in other and unspecified transport accidents

164

1175

1.42

4.33

3.3

4.1

1.22

mmol/l

0.30

153

1038

Maternal care for known or suspected abnormality of pelvic organs

726

4269

1.18

4.32

2.9

3.3

1.22

1.23

mmol/l

3.15

630

3749

Umbilical hernia

922

8039

1.16

4.32

4.8

4.0

1.22

mmol/l

4.23

815

7069

Perioral dermatitis

465

1.70

4.31

2.9

3.2

1.23

mmol/l

0.00

399

Adenocarcinoma and papilloma adenocarcinoma of rectum

335

2669

1.28

4.30

4.9

3.9

1.22

mmol/l

1.28

300

2335

Amiodarone users

352

2822

1.27

4.29

4.0

4.3

1.21

1.22

mmol/l

4.16

327

2485

Unspecific neurodegenerative disorder

1591

9875

1.12

4.27

3.0

4.0

1.23

mmol/l

0.99

1284

8535

Heartburn

336

2676

1.28

4.26

4.0

3.5

1.23

mmol/l

0.26

300

2317

Amblyopia ex anopsia

126

865

1.49

4.24

5.6

3.7

1.23

mmol/l

0.08

110

752

Male infertility

114

765

1.52

4.24

6.1

4.1

1.23

1.22

mmol/l

0.68

109

707

Perineal laceration during delivery

293

3319

0.78

4.22

2.8

3.0

1.23

mmol/l

0.02

257

2838

Erosion of teeth, including avohilmo

658

5409

1.19

4.21

5.5

3.6

1.23

mmol/l

0.03

575

4736

Deep endometriosis

342

2737

1.27

4.21

2.9

3.4

1.23

mmol/l

0.07

286

2359

Other disorders of bone

644

5474

1.19

4.21

4.9

3.4

1.22

1.23

mmol/l

0.95

586

4781

Otalgia

253

1950

1.32

4.20

3.7

3.3

1.23

mmol/l

0.43

222

1695

Bacterial pneumonia, not elsewhere classified

1143

11408

0.88

4.20

5.8

3.3

1.22

1.23

mmol/l

6.18

1043

9771

Asthma and allergy

353

2791

1.26

4.19

3.0

2.9

1.23

mmol/l

0.38

317

2388

Obstructed labour due to malposition and malpresentation of fetus

453

5169

0.82

4.19

3.1

3.2

1.23

mmol/l

0.00

404

4534

Glaucoma secondary to other eye disorders

140

985

1.46

4.19

9.0

4.0

1.22

mmol/l

0.45

127

847

Postprocedural musculoskeletal disorders, not elsewhere classified

244

1876

1.33

4.18

4.4

4.0

1.23

mmol/l

0.24

219

1642

Other menopausal disorders

1053

5328

1.15

4.17

2.8

3.5

1.24

mmol/l

0.03

883

4642

Personal history of other diseases and conditions

299

2341

1.29

4.17

4.6

3.1

1.22

1.23

mmol/l

3.95

256

2025

Sequelae of injuries of head

164

1186

1.42

4.16

3.4

4.3

1.22

mmol/l

0.55

134

1047

Benign neoplasm of ovary

579

4887

1.20

4.16

3.5

2.7

1.23

1.24

mmol/l

1.15

510

4055

Other neurotic disorders

174

1273

1.40

4.15

3.9

3.8

1.22

1.23

mmol/l

1.54

150

1103

Prolapse and hernia of ovary and fallopian tube

1243

0.63

4.13

3.4

3.5

1.24

1.23

mmol/l

0.47

1019

Asthma and opportunity respiratory infection

172

1260

1.41

4.12

3.8

3.6

1.22

1.23

mmol/l

1.15

159

1070

Toxic effects of substances chiefly nonmedicinal as to source

347

2785

1.26

4.12

3.5

3.9

1.22

mmol/l

1.08

306

2438

Female infertility, associated with anovulation

198

1474

1.36

4.11

2.4

2.8

1.22

1.23

mmol/l

1.51

176

1291

Dermatophytosis

431

3546

1.23

4.09

4.9

4.0

1.22

mmol/l

0.03

392

3124

Use of rotigotine

278

1.92

4.09

2.9

3.9

1.21

1.23

mmol/l

1.21

240

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

899

7853

1.15

4.08

3.3

3.7

1.22

1.23

mmol/l

1.13

784

6910

Malignant neoplasm of rectum

334

2679

1.27

4.07

4.9

4.0

1.22

mmol/l

1.53

294

2347

Persons encountering health services for examination and investigation

3043

14134

1.08

4.06

4.0

3.7

1.23

mmol/l

0.15

2719

12046

Other bullous disorders

100

664

1.56

4.06

4.3

3.8

1.24

1.23

mmol/l

0.88

565

Intestinal adhesions without obstruction

297

2351

1.29

4.04

5.5

3.7

1.22

1.23

mmol/l

2.60

267

2014

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

981

8630

1.15

4.04

4.0

3.8

1.22

1.23

mmol/l

0.79

867

7575

Hypotension due to drugs

338

1.82

4.04

6.6

4.1

1.21

1.22

mmol/l

0.78

299

Open wound of abdomen, lower back and pelvis

607

1.58

4.02

5.5

3.8

1.21

1.23

mmol/l

1.95

527

Other peripheral vascular diseases

271

2122

1.30

4.01

4.0

3.4

1.23

mmol/l

0.14

249

1836

Impetigo

124

858

1.48

4.01

4.4

3.2

1.23

mmol/l

0.03

112

741

Prolonged pregnancy

256

2997

0.77

4.01

2.6

3.3

1.23

mmol/l

0.03

219

2621

Pure hyperglyceridaemia

514

1.64

4.01

5.0

3.0

1.21

1.22

mmol/l

1.92

441

Disorders of endocrine glands in diseases classified elsewhere

4.37

3.99

10.3

4.7

1.23

mmol/l

0.02

Impacted maxillary molar

137

965

1.44

3.99

2.6

2.8

1.23

1.22

mmol/l

0.25

127

816

Childhood allergy (age < 16)

337

2217

1.26

3.99

3.4

3.2

1.22

mmol/l

0.29

291

1856

Varicella [chickenpox]

130

909

1.46

3.98

7.9

4.3

1.22

1.23

mmol/l

0.96

118

807

Paranoid personality disorder

375

1.75

3.98

3.3

3.7

1.23

1.22

mmol/l

0.26

327

Allergic contact dermatitis

451

3736

1.22

3.98

3.3

3.5

1.24

1.23

mmol/l

1.27

395

3271

Von Willebrand disease

279

1.88

3.98

3.9

3.5

1.23

mmol/l

0.03

236

Subacute thyroiditis

123

854

1.48

3.97

3.0

3.1

1.23

mmol/l

0.26

102

750

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

2.96

3.97

7.2

4.5

1.23

1.22

mmol/l

0.25

Other symptoms and signs involving cognitive functions and awareness

1688

14378

1.11

3.96

4.1

3.9

1.22

1.23

mmol/l

1.51

1480

12447

Pustulosis palmaris et plantaris

146

1047

1.43

3.96

3.8

1.23

mmol/l

0.59

126

913

Injuries to the wrist and hand

3905

26533

1.07

3.94

3.7

3.8

1.22

1.23

mmol/l

1.40

3389

23210

Other and unspecified rosacea

281

2216

1.29

3.94

4.4

3.7

1.23

mmol/l

0.23

239

1936

Benign neoplasm: Transverse colon

224

2900

0.76

3.94

4.9

4.1

1.22

1.23

mmol/l

0.61

200

2549

Chronic lymphocytic leukaemia, helper endpoint

604

1.58

3.93

7.2

2.5

1.22

mmol/l

0.47

501

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

604

1.58

3.93

7.2

2.5

1.22

mmol/l

0.47

501

Benign neoplasm: Long bones of lower limb

562

1.59

3.92

4.3

2.4

1.22

1.23

mmol/l

0.87

466

Oral lichen ruber planus wide, hypothyreosis or thyroxin

199

1505

1.36

3.90

3.6

3.7

1.23

mmol/l

0.55

175

1308

Allergic asthma (mode), excluding more controls

712

6020

1.17

3.90

3.1

2.9

1.23

mmol/l

0.42

635

5108

Injury of nerves at wrist and hand level

117

807

1.49

3.89

2.9

4.4

1.22

1.23

mmol/l

0.46

700

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

103

2.56

3.89

8.0

3.7

1.22

mmol/l

0.05

Cerebral atherosclerosis

288

1.86

3.89

5.1

3.8

1.23

1.22

mmol/l

0.70

242

Procreative management

1008

7500

1.14

3.88

4.4

3.9

1.23

mmol/l

0.80

901

6608

Unspecified privation

220

2852

0.76

3.86

5.4

3.9

1.22

1.23

mmol/l

0.18

197

2487

Other specified/unspecified hearing loss

162

2189

0.73

3.84

5.5

3.6

1.22

mmol/l

0.05

142

1897

Herpesviral keratitis and keratoconjunctivitis

147

1063

1.42

3.81

4.5

3.6

1.22

1.23

mmol/l

0.28

134

912

Other benign neoplasm of uterus: Other parts/unspecified

164

1211

1.40

3.80

3.3

2.9

1.24

mmol/l

0.11

129

988

Other congenital malformations of urinary system

2.88

3.79

15.9

4.0

1.26

1.22

mmol/l

3.16

Arterial embolism and thrombosis

201

1525

1.35

3.79

9.7

3.6

1.21

1.22

mmol/l

1.22

189

1316

Allergic colitis

318

1.77

3.78

3.3

3.8

1.23

mmol/l

0.06

276

Other keratitis

346

2807

1.25

3.77

4.9

3.8

1.22

1.23

mmol/l

0.72

305

2438

Erythema nodosum

109

750

1.50

3.74

4.2

3.5

1.22

1.23

mmol/l

0.61

636

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

131

2.30

3.71

7.4

2.4

1.21

1.22

mmol/l

0.20

110

Amputation of ankle bones

485

1.63

3.71

17.7

3.6

1.20

1.22

mmol/l

1.53

417

Primary coxarthrosis, bilateral

1090

9725

1.13

3.68

3.3

4.0

1.23

mmol/l

0.23

950

8394

Blepharochalasis

1123

10037

1.13

3.68

3.3

3.8

1.23

mmol/l

0.59

954

8690

Retinal detachment with retinal break

442

3690

1.22

3.67

4.6

4.1

1.22

1.23

mmol/l

0.19

385

3281

Carcinoma in situ of skin of upper limb, including shoulder

601

1.57

3.66

7.8

3.9

1.23

1.22

mmol/l

0.25

521

Henoch-Schönlein purpura nephritis (HSPN)

2.87

3.65

18.6

3.7

1.20

1.23

mmol/l

0.84

Disorders of oesophagus in diseases classified elsewhere

520

1.61

3.65

6.9

3.5

1.21

1.23

mmol/l

2.03

451

Polyp of the female genital tract

1207

6276

1.13

3.64

3.5

3.4

1.24

1.23

mmol/l

1.74

1048

5450

Other diseases of stomach and duodenum

226

1755

1.32

3.64

7.0

3.7

1.21

1.23

mmol/l

3.57

207

1518

Major anomalies of jaw size

566

1.57

3.63

2.8

3.6

1.23

mmol/l

0.19

493

Disorders of orbit

148

1081

1.40

3.62

3.5

3.4

1.23

mmol/l

0.32

134

931

Toxic liver disease

341

1.75

3.61

4.2

3.6

1.21

1.23

mmol/l

1.18

298

Peripheral arterial reconstruction

601

5158

1.18

3.61

9.4

3.8

1.21

1.22

mmol/l

9.24

539

4455

Viral encephalitis, not elsewhere classified/unspecified

449

1.64

3.60

9.7

3.8

1.22

mmol/l

0.11

392

Retinal vascular occlusion

424

3535

1.22

3.60

5.1

4.0

1.23

mmol/l

0.47

367

3096

Other conjunctival vascular disorders and cysts

602

1.56

3.59

3.5

3.9

1.24

1.23

mmol/l

0.75

528

Neovascular glaucoma

140

1015

1.42

3.59

9.0

3.6

1.22

1.23

mmol/l

0.80

127

874

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

259

2049

1.29

3.59

6.7

3.7

1.22

1.23

mmol/l

1.05

241

1766

Oesophagitis

186

1409

1.35

3.59

4.7

3.9

1.21

1.22

mmol/l

2.37

169

1219

Fall on and from stairs and steps

873

7692

1.15

3.59

4.2

3.8

1.22

1.23

mmol/l

1.78

761

6723

Adenocarcinoma and ductal carcinoma of pancreas

118

832

1.47

3.59

7.1

3.8

1.21

1.22

mmol/l

0.63

108

717

Other/unspecified synovitis and tenosynovitis

392

3241

1.23

3.58

3.6

3.8

1.23

mmol/l

0.28

334

2814

Other salmonella infections

129

924

1.43

3.55

4.2

3.5

1.22

1.23

mmol/l

0.63

106

789

Cramp and spasm

148

1085

1.40

3.54

3.9

3.5

1.22

1.23

mmol/l

1.52

132

940

Abscess of anal and rectal regions

256

2023

1.29

3.54

4.7

3.9

1.22

mmol/l

0.25

230

1759

Tic and related disorders

159

2.08

3.53

3.7

5.3

1.22

1.23

mmol/l

0.11

144

Early complications of trauma

130

933

1.43

3.53

5.9

4.0

1.22

1.23

mmol/l

0.45

118

813

!Aliquae complicationes praecoces traumatis

130

933

1.43

3.53

5.9

4.0

1.22

1.23

mmol/l

0.45

118

813

Volvulus

636

1.53

3.53

6.2

3.5

1.20

1.23

mmol/l

2.86

533

Acute bronchiolitis

146

955

1.40

3.52

6.3

3.3

1.22

1.23

mmol/l

0.52

133

813

Abnormality of white blood cells, not elsewhere classified

168

2.09

3.51

9.7

3.6

1.20

1.22

mmol/l

0.96

150

Ankylosing spondylitis, strict definition

129

925

1.43

3.50

3.2

3.9

1.22

1.23

mmol/l

0.73

120

797

Other encephalitis

596

1.54

3.50

6.3

3.7

1.21

1.23

mmol/l

1.64

525

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

107

743

1.48

3.50

7.5

2.7

1.23

1.22

mmol/l

0.46

618

Effects of heat and light

169

2.09

3.47

3.6

3.9

1.23

1.22

mmol/l

0.64

151

hereditary angioödema type 3

6.91

3.47

2.3

5.6

1.22

mmol/l

—

Lesion of radial nerve

126

903

1.43

3.47

5.1

3.7

1.22

mmol/l

0.58

115

771

Benign neoplasm: Bronchus and lung

262

1.84

3.46

3.1

2.4

1.22

1.23

mmol/l

0.13

219

Alzheimer’s disease (Early onset)

1149

0.65

3.45

2.4

3.6

1.23

1.22

mmol/l

0.34

985

Adenocarcinoma and papillary adenocarcinoma of stomach

672

1.50

3.44

4.9

3.8

1.21

1.22

mmol/l

0.55

587

Congenital malformations of the respiratory system

353

1.71

3.44

4.3

4.0

1.25

1.23

mmol/l

0.58

309

Other adrenocortical overactivity

2.50

3.44

11.9

2.6

1.22

1.23

mmol/l

0.98

Blood alcohol or alcohol intoxication level

477

1.60

3.44

3.9

1.20

1.23

mmol/l

3.40

409

Dermatopolymyositis, unspecified

109

2.39

3.43

4.1

4.4

1.22

mmol/l

0.10

Inflammatory disorders of male genital organs, not elsewhere classified

218

1.91

3.43

6.3

3.6

1.22

mmol/l

0.05

197

Benign neoplasm: Cerebral meninges

324

2646

1.25

3.43

4.4

3.7

1.24

1.23

mmol/l

0.54

285

2288

Fissure and fistula of anal and rectal regions

857

7567

1.14

3.42

3.7

3.6

1.23

mmol/l

0.71

758

6564

Benign neoplasm: Scapula and long bones of upper limb

169

2.05

3.41

3.5

2.3

1.21

1.22

mmol/l

0.57

146

Sacroiliitis, not elsewhere classified

134

971

1.41

3.41

2.7

3.1

1.23

mmol/l

0.13

121

834

Nystagmus and other irregular eye movements

271

1.81

3.39

4.6

3.7

1.23

mmol/l

0.22

239

Malignant neoplasm of palate

3.23

3.38

3.5

3.8

1.34

1.22

mmol/l

0.97

Salpingitis and oophoritis

640

5550

1.17

3.37

3.5

3.3

1.23

1.24

mmol/l

2.24

545

4817

Abnormal serum enzyme levels

829

9255

0.88

3.36

4.7

4.2

1.22

mmol/l

1.94

771

8088

Hypertensive Heart Disease

767

5497

1.15

3.35

7.0

3.2

1.22

1.23

mmol/l

4.48

698

4631

Congenital malformation of biliary tract

3.48

3.35

16.7

4.4

1.24

1.23

mmol/l

0.25

Hallux rigidus

362

4360

0.82

3.34

3.8

3.7

1.23

mmol/l

0.11

313

3745

Benign neoplasm: Larynx

626

1.51

3.34

4.8

3.1

1.21

1.22

mmol/l

0.82

526

Bulimia nervosa (incl. atypical)

617

1.51

3.32

2.8

2.5

1.22

1.23

mmol/l

0.35

521

Benign neoplasm: Rectosigmoid junction

126

911

1.42

3.32

5.1

3.1

1.23

mmol/l

0.13

111

768

Diabetic neuropathy

415

3467

1.21

3.31

8.0

4.5

1.21

1.22

mmol/l

3.16

375

3082

Retinal vascular disorders

429

3611

1.21

3.31

5.1

4.0

1.23

mmol/l

0.39

371

3157

Ovarian dysfunction, other/unspecified

104

2.36

3.30

4.4

3.4

1.23

mmol/l

0.01

Congenital iodine-deficiency syndrome/hypothyroidism

106

745

1.47

3.29

4.9

3.5

1.22

1.23

mmol/l

0.88

100

645

Endometriosis ASRM stages 3,4

799

7045

1.15

3.29

3.1

3.3

1.23

mmol/l

0.02

689

6083

Benign neoplasm of meninges

355

2939

1.23

3.29

4.3

3.7

1.24

1.23

mmol/l

0.43

315

2536

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

2.47

3.29

15.4

4.2

1.26

1.22

mmol/l

1.66

Ulcer of vagina/vulva

589

1.53

3.28

3.4

2.9

1.24

1.23

mmol/l

0.16

495

Atypical virus infections of central nervous system

223

1.90

3.28

4.2

3.5

1.24

1.23

mmol/l

0.35

198

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

565

1.54

3.28

5.8

3.8

1.22

1.23

mmol/l

0.39

492

Other bursitis of hip

493

1.58

3.27

2.9

3.3

1.23

mmol/l

0.11

422

Lupus erythematosus

615

1.52

3.26

5.3

3.6

1.24

1.23

mmol/l

0.23

526

Sequelae of injuries, of poisoning and of other consequences of external causes

762

6700

1.15

3.26

3.7

3.9

1.22

1.23

mmol/l

1.95

666

5907

Allergic asthma (mode)

712

6110

1.15

3.26

3.1

3.0

1.23

mmol/l

0.17

635

5211

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

166

2.05

3.26

8.3

2.9

1.21

1.22

mmol/l

0.33

134

Disorders of purine and pyrimidine metabolism

132

2.21

3.26

7.6

3.4

1.22

mmol/l

0.33

118

Fracture of neck

191

1475

1.32

3.25

4.1

1.22

mmol/l

0.49

170

1289

Other contact dermatitis

259

2074

1.27

3.25

4.3

3.6

1.23

mmol/l

0.61

228

1794

Erectile dysfunction

266

2140

1.27

3.24

4.4

4.5

1.21

mmol/l

0.04

235

1892

Other specified/unspecified spondylopathies

657

1.50

3.24

4.9

3.2

1.22

1.23

mmol/l

0.77

556

Mental and behavioural disorders of puerperium, not classified elsewhere

201

1.92

3.24

5.9

3.3

1.24

1.23

mmol/l

0.75

170

Suppurative otitis media, unspecified

557

1.53

3.24

4.1

3.3

1.22

1.23

mmol/l

0.54

473

Oral lichen ruber planus, hypothyreosis or thyroxin

416

1.64

3.23

3.2

3.8

1.24

1.23

mmol/l

0.30

356

Benign neoplasm: salivary glands, exclude unknown (D119)

295

2401

1.25

3.23

4.6

3.8

1.21

1.23

mmol/l

3.55

261

2088

Congenital malformations of the nervous system

405

1.63

3.23

6.7

3.3

1.23

mmol/l

0.26

347

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

328

1.71

3.23

5.2

4.8

1.23

1.22

mmol/l

0.14

286

Benign neoplasm: Tongue

550

1.54

3.22

4.6

2.7

1.22

1.23

mmol/l

0.58

453

Sequelae of injuries of upper limb

303

2472

1.24

3.21

3.7

4.0

1.22

1.23

mmol/l

1.23

269

2169

Ectopic pregnancy

568

4901

1.17

3.20

3.4

3.3

1.23

mmol/l

0.76

491

4288

Inflammatory disease of uterus

441

3728

1.20

3.20

2.9

3.1

1.23

mmol/l

2.15

379

3242

Encephalitis

641

1.49

3.20

6.2

3.6

1.21

1.23

mmol/l

2.03

563

Acute gastritis

266

2144

1.26

3.18

5.7

3.8

1.23

mmol/l

0.03

242

1845

Disorders of optic nerve, not elsewhere classified

513

1.56

3.18

3.9

3.6

1.22

1.23

mmol/l

0.31

449

Other abnormal findings in urine

362

1.67

3.17

6.6

4.1

1.23

1.22

mmol/l

0.31

315

Chronic hepatitis NAS

308

1.74

3.17

4.4

3.3

1.22

1.23

mmol/l

0.55

267

Parkinson's disease

534

4595

1.18

3.17

3.2

4.0

1.23

1.22

mmol/l

0.74

457

4003

Generalized epilepsy

122

883

1.41

3.17

4.1

3.6

1.21

1.23

mmol/l

2.45

111

754

Vestibular neuronitis

300

2452

1.24

3.17

3.0

3.9

1.23

mmol/l

0.16

260

2142

Other and unspecified iridocyclitis

134

987

1.39

3.16

3.5

3.7

1.23

mmol/l

0.18

125

843

Mental and behavioural disorders associated with the puerperium

203

1.90

3.15

5.9

3.3

1.24

1.23

mmol/l

0.89

170

Venous complications and haemorrhoids in the puerperium

256

1.81

3.14

2.5

2.8

1.23

1.24

mmol/l

0.27

224

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

417

1.61

3.13

5.4

3.4

1.20

1.22

mmol/l

0.70

355

Retinoschisis and retinal cysts

613

1.51

3.13

4.7

3.5

1.23

1.22

mmol/l

0.05

540

Abscess of tendon sheath

127

2.19

3.12

6.3

4.1

1.22

1.23

mmol/l

0.54

114

Disorders of myoneural junction and muscle in diseases classified elsewhere

176

2.00

3.12

7.3

3.6

1.22

1.23

mmol/l

0.37

158

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

120

2.22

3.12

5.2

2.8

1.22

1.23

mmol/l

0.09

Cysts of oral region, not elsewhere classified

140

1040

1.38

3.12

6.5

3.3

1.22

mmol/l

0.30

124

918

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

3.12

0.0

3.6

—

1.23

—

Left ventricular outflow tract obstruction, narrow definition

137

1014

1.38

3.11

4.5

4.4

1.22

mmol/l

0.19

126

887

Hypersensitivity angiitis

121

2.24

3.11

9.3

4.1

1.24

1.22

mmol/l

0.77

104

Haemorrhagic and haematological disorders of fetus and newborn

193

1.88

3.10

8.2

6.2

1.23

1.24

mmol/l

0.18

175

Other localized connective tissue disorders

467

1.58

3.10

6.6

3.6

1.24

1.23

mmol/l

0.38

404

Disorders of eyelid in diseases classified elsewhere

111

797

1.43

3.08

4.9

3.4

1.23

mmol/l

0.04

100

678

Propionic acid derivatives

1202

5444

1.12

3.07

3.6

4.7

1.22

mmol/l

0.31

1038

4795

Other and unspecified nail disorders

476

1.57

3.07

5.0

3.4

1.23

mmol/l

0.17

416

Common variable immunodeficiency

121

2.20

3.07

4.8

3.4

1.23

mmol/l

0.02

103

Contact with other hot fluids

605

1.49

3.06

4.0

3.8

1.22

1.23

mmol/l

0.95

527

Acute appendicitis

2569

22653

1.07

3.06

3.8

3.9

1.23

mmol/l

0.09

2294

19840

Nonischemic cardiomyopathy

179

1383

1.32

3.05

4.5

3.9

1.21

1.22

mmol/l

1.74

166

1211

Abrasion of teeth

973

6401

1.13

3.05

3.8

3.6

1.23

mmol/l

0.33

816

5598

Pilonidal cyst

232

1847

1.27

3.05

3.5

3.3

1.22

mmol/l

0.12

204

1618

Granulomatous disorders of skin and subcutaneous tissue

615

1.49

3.05

6.7

3.3

1.23

mmol/l

0.42

528

Overexertion and strenuous or repetitive movements

196

2491

0.78

3.02

3.7

3.8

1.22

1.23

mmol/l

0.47

171

2183

Conduct disorder

341

1.65

3.01

3.7

3.8

1.22

1.23

mmol/l

0.24

298

Conjunctivitis

2741

22380

1.07

3.01

3.6

3.7

1.23

mmol/l

0.94

2380

19524

Hydrocele

364

3044

1.21

3.01

5.9

4.5

1.21

mmol/l

0.74

325

2689

Inflammatory diseases of the central nervous system

257

2077

1.26

3.01

6.0

3.7

1.21

1.23

mmol/l

3.57

235

1810

Other surgical follow-up care

699

1.45

3.00

4.2

2.7

1.23

mmol/l

0.21

584

Other and unspecified vascular occlusions

326

2704

1.23

3.00

4.0

3.9

1.23

mmol/l

0.80

278

2377

Other and unspecified epidermal thickening

609

1.49

2.99

9.6

3.5

1.22

1.23

mmol/l

0.93

511

Benign neoplasm of major salivary glands

328

2723

1.22

2.98

4.5

3.8

1.21

1.23

mmol/l

4.14

294

2372

Complications of genitourinary prosthetic devices, implants and grafts

577

1.50

2.98

5.4

3.3

1.22

1.23

mmol/l

0.78

490

Secondary parkinsonism+Parkinsonism in other disease

677

1.46

2.97

5.0

3.6

1.24

1.22

mmol/l

1.15

581

Autonomic disorders

512

1.54

2.97

3.4

3.6

1.21

1.23

mmol/l

0.90

440

Recurring oral aphthae, including avohilmo

445

3794

1.19

2.97

4.3

3.6

1.23

mmol/l

0.66

394

3290

Dementia due to Parkinsons disease, excluding more controls

505

1.54

2.95

2.9

3.6

1.22

mmol/l

0.69

435

Carcinoma in situ of cervix uteri, endocervix

193

1.88

2.94

3.1

2.1

1.22

1.23

mmol/l

0.56

158

Benign neoplasm: Anus and anal canal

604

1.48

2.92

6.2

2.6

1.23

mmol/l

0.31

501

Malignant neoplasm of vulva

248

1.80

2.91

6.2

3.7

1.23

mmol/l

0.28

217

Paraplegia, diplegia of upper limbs

490

1.54

2.91

4.1

3.4

1.21

1.22

mmol/l

1.01

425

Parkinson's disease, including avohilmo

552

4798

1.17

2.90

3.2

4.0

1.23

1.22

mmol/l

0.73

472

4178

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

2.45

2.90

6.3

3.1

1.24

1.23

mmol/l

0.34

Acute lymphocytic leukaemia, helper endpoint

2.45

2.90

6.3

3.1

1.24

1.23

mmol/l

0.34

Dislocation, sprain and strain of joints and ligaments of thorax

100

713

1.44

2.89

3.7

3.8

1.23

mmol/l

0.24

622

Other obstructed labour

237

1909

1.26

2.88

3.1

3.2

1.23

mmol/l

0.31

211

1651

Special screening examination for other diseases and disorders

192

2429

0.78

2.87

5.5

3.7

1.22

mmol/l

0.30

167

2064

Obstructed labour due to maternal pelvic abnormality

373

4410

0.84

2.85

3.3

3.4

1.24

mmol/l

0.19

331

3836

Preparation and fitting of bite rail to mouth

410

3484

1.19

2.85

3.2

3.8

1.23

mmol/l

0.74

374

3061

Other congenital malformations of nervous system

159

1.96

2.85

3.6

4.1

1.23

mmol/l

0.36

136

Other disorders of pigmentation

145

1101

1.35

2.85

3.8

3.4

1.23

mmol/l

0.32

125

953

Benign neoplasm of bone and articular cartilage

254

2064

1.25

2.85

4.0

3.7

1.22

1.23

mmol/l

0.48

218

1804

Plantar fascial fibromatosis

314

2607

1.22

2.85

3.2

3.9

1.23

mmol/l

0.00

282

2266

Benign neoplasm: Skin of trunk

136

1023

1.36

2.84

6.2

3.7

1.23

mmol/l

0.22

127

878

Stomatitis and related lesions

249

2019

1.25

2.84

5.4

3.3

1.23

mmol/l

0.27

224

1761

Anxious personality disorder

324

1.65

2.83

2.6

3.3

1.22

1.23

mmol/l

0.17

284

Chondrocostal junction syndrome [Tietze]

121

895

1.39

2.83

3.4

3.5

1.23

mmol/l

0.03

104

762

Benign neoplasm: Other/unspecified site

302

1.68

2.82

3.6

2.4

1.23

mmol/l

0.13

255

Poisoning by medicine, drug-induced

264

1.73

2.80

5.4

3.8

1.21

1.23

mmol/l

1.05

236

Burns and corrosions of multiple and unspecified body regions

461

1.54

2.80

3.0

4.1

1.23

1.22

mmol/l

0.44

403

Delivery

1526

7405

1.10

2.80

3.3

3.6

1.23

mmol/l

0.17

1289

6340

Combined immunodeficiencies

242

1.77

2.80

4.5

3.8

1.25

1.23

mmol/l

0.88

216

Palindromic rheumatism

250

1.76

2.79

3.3

3.5

1.22

1.23

mmol/l

0.50

207

Spermatocele

232

1872

1.26

2.79

4.2

4.5

1.21

mmol/l

0.58

209

1666

Hypertrichosis

413

1.57

2.78

3.8

2.7

1.23

mmol/l

0.28

348

Other and unspecified disorders of pigmentation

126

2.09

2.76

3.8

1.22

mmol/l

0.02

115

Achalasia of cardia

456

1.55

2.76

4.5

4.0

1.22

mmol/l

0.64

394

Secondary parkinsonism

654

1.45

2.75

4.9

3.6

1.24

1.22

mmol/l

1.04

557

Disorders of lacrimal system and orbit in diseases classified elsewhere

604

1.47

2.75

3.2

3.3

1.22

1.23

mmol/l

1.49

510

Infection of intervertebral disc (pyogenic)

290

1.70

2.74

7.5

3.4

1.23

mmol/l

0.03

246

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

2.42

2.73

2.8

3.1

1.23

1.22

mmol/l

0.08

Contact with heat and hot substances

155

1194

1.32

2.73

5.3

3.9

1.22

1.23

mmol/l

0.48

127

1047

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

114

2.18

2.72

13.3

5.2

1.21

1.23

mmol/l

0.96

105

Congenital malformations of aortic and mitral valves

114

840

1.39

2.72

4.5

4.2

1.22

mmol/l

0.00

104

736

Malignant neoplasm of eye, brain and central nervous system

135

1022

1.35

2.71

5.6

3.8

1.22

1.23

mmol/l

0.08

126

882

Early lumbar disc prolapse, operated

242

1965

1.24

2.70

3.5

1.22

1.23

mmol/l

0.79

224

1748

Other and unspecified acne

236

1.75

2.70

9.9

2.9

1.23

mmol/l

0.11

202

Exposure to other and unspecified animate mechanical forces

555

1.48

2.69

4.3

3.3

1.23

mmol/l

0.52

481

Disorder of the sleep-wake schedule

337

1.62

2.69

6.2

3.9

1.23

mmol/l

0.02

294

Vulvovaginal ulceration/inflammation in other diseases

167

1302

1.30

2.68

4.4

2.9

1.23

mmol/l

0.26

143

1118

Hereditary corneal dystrophies

112

828

1.39

2.68

5.0

3.7

1.23

mmol/l

0.04

715

Postprocedural disorders of ear and mastoid process, not elsewhere classified

210

0.36

2.67

2.5

3.1

1.21

1.22

mmol/l

—

184

Dermatitis herpetiformis

435

1.55

2.67

4.4

3.8

1.25

1.23

mmol/l

1.42

375

Acute nasopharyngitis (common cold)

328

2733

1.20

2.67

4.7

3.9

1.22

mmol/l

1.16

298

2420

Dental caries 3 and operation codes, only avohilmo

1266

5799

1.10

2.65

3.7

4.4

1.23

mmol/l

0.54

1097

5155

Maternal care for known or suspected disproportion

885

0.66

2.64

3.2

3.3

1.23

mmol/l

0.20

790

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

133

1010

1.35

2.64

3.5

3.9

1.23

mmol/l

0.36

120

872

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

508

4420

1.16

2.62

3.6

3.2

1.23

mmol/l

0.81

431

3834

Benign neoplasm: Parotid gland

260

2142

1.23

2.61

4.4

3.9

1.21

1.23

mmol/l

3.33

230

1862

Anosmia

334

1.60

2.61

3.1

1.8

1.23

1.24

mmol/l

0.30

259

Disorders of tyrosine metabolism

4.43

2.61

8.0

3.4

1.23

1.22

mmol/l

—

Pterygium

103

756

1.40

2.58

4.9

4.0

1.22

mmol/l

0.10

651

Other and unspecified injuries of shoulder and upper arm

670

1.42

2.58

5.5

3.7

1.22

1.23

mmol/l

1.09

577

Acute posthaemorrhagic anaemia

113

841

1.38

2.57

6.6

3.2

1.21

1.22

mmol/l

1.25

104

712

Other congenital malformations of circulatory system

562

1.46

2.57

3.8

4.1

1.22

1.23

mmol/l

0.79

492

Benign neoplasm of urinary organs

135

1031

1.34

2.56

4.9

2.9

1.23

mmol/l

0.11

128

860

Behavioural disorders

349

1.58

2.55

3.7

1.23

mmol/l

0.08

301

Sequelae of infectious and parasitic diseases

237

1938

1.24

2.54

4.6

3.8

1.22

mmol/l

0.28

207

1683

malignant neoplasm of female genital organs

555

4880

1.15

2.54

3.4

3.6

1.24

mmol/l

0.22

480

4152

Combined immunodeficiency, unspecified

4.32

2.53

7.0

5.2

1.24

1.21

mmol/l

—

Other disorders affecting eyelid function

208

0.37

2.53

1.5

3.7

1.25

1.23

mmol/l

—

184

Unspecified dementia

363

2783

1.19

2.53

3.4

3.6

1.22

mmol/l

0.01

291

2399

Other and specified injuries of hip and thigh

507

1.48

2.51

4.5

3.7

1.22

1.23

mmol/l

0.78

438

Other or ill-defined heart diseases

152

1182

1.31

2.50

7.1

3.4

1.22

1.23

mmol/l

1.07

141

1017

Hemiplegia

159

1245

1.30

2.50

4.8

3.7

1.22

1.23

mmol/l

0.47

146

1069

Presbyopia

189

1512

1.27

2.50

3.8

4.0

1.23

mmol/l

0.10

162

1331

Scar conditions and fibrosis of skin

123

931

1.35

2.50

4.4

3.2

1.23

mmol/l

0.70

110

801

Melanocytic naevi of trunk

360

3066

1.19

2.50

6.0

3.7

1.23

mmol/l

0.15

316

2677

COPD, hospital admissions 3, with asthma pneumonia sepsis

980

7563

1.11

2.49

5.5

3.9

1.21

1.22

mmol/l

9.70

904

6525

Any dementia

1446

9403

1.09

2.49

3.5

3.9

1.23

mmol/l

0.17

1173

8132

Muscle strain

691

1.41

2.49

4.4

3.5

1.23

mmol/l

0.07

586

Anomalies of dental arch relationship, including avohilmo

548

4318

1.15

2.48

4.1

3.5

1.23

mmol/l

0.22

478

3764

Bicuspidal aortic valve syndrome

101

743

1.39

2.47

3.6

4.3

1.22

mmol/l

0.16

655

Burn and corrosion of hip and lower limb, except ankle and foot

483

1.49

2.47

3.6

3.8

1.22

1.23

mmol/l

0.47

418

Third [oculomotor] nerve palsy

427

1.53

2.47

6.8

3.7

1.22

1.23

mmol/l

0.16

372

Arterial embolism and thrombosis of lower extremity artery

116

873

1.36

2.46

9.4

3.6

1.21

1.22

mmol/l

1.24

108

757

Fracture at wrist and hand level

1090

9945

1.10

2.46

3.8

3.9

1.22

1.23

mmol/l

0.90

961

8757

Single spontaneous delivery

1504

7388

1.09

2.46

3.3

3.6

1.24

1.23

mmol/l

0.53

1267

6326

Vertical strabismus

106

788

1.38

2.45

3.5

3.6

1.23

mmol/l

0.13

690

Atherosclerosis, excluding cerebral and coronary sclerosis

1583

11731

1.09

2.45

7.4

3.7

1.21

1.23

mmol/l

17.27

1421

10096

Sequelae of intentional self-harm, assault and events of undetermined intent

104

2.12

2.44

3.1

3.4

1.24

1.22

mmol/l

0.83

Other disorders of bone density and structure

559

1.45

2.44

4.7

3.2

1.23

mmol/l

0.14

478

Pneumothorax

213

1732

1.25

2.44

5.6

3.5

1.22

mmol/l

0.92

204

1507

Benign neoplasm: Skin of lower limb, including hip

551

1.45

2.43

5.0

2.6

1.23

mmol/l

0.10

452

Benign neoplasm: Rectum

479

5474

0.87

2.42

4.3

4.0

1.23

mmol/l

0.83

425

4791

Thrombotic microangiopathy

119

2.05

2.41

11.0

3.8

1.22

mmol/l

0.25

101

Benign neoplasm of other and unspecified sites

670

1.40

2.41

3.8

2.6

1.22

mmol/l

0.05

553

Benign neoplasm: Conjunctiva

645

1.41

2.40

4.6

2.7

1.22

1.23

mmol/l

0.41

538

Benign neoplasm of mouth and pharynx

356

3043

1.18

2.40

4.3

3.9

1.22

1.23

mmol/l

0.44

319

2667

Other benign neoplasms of uterus

190

1533

1.27

2.39

3.2

2.8

1.24

mmol/l

0.10

154

1246

Injury of intra-abdominal organs

512

1.46

2.37

4.9

3.6

1.21

1.23

mmol/l

1.37

442

Ulcerative proctitis

178

1425

1.27

2.35

3.1

3.5

1.23

mmol/l

0.26

166

1237

Desensitization to allergens

1062

0.71

2.35

2.3

3.3

1.23

mmol/l

0.12

913

Benign neoplasm: Short bones of upper limb

278

1.63

2.34

2.4

2.3

1.25

1.23

mmol/l

0.99

230

Malignant neoplasm of oral cavity

112

848

1.35

2.33

5.6

4.0

1.25

1.22

mmol/l

1.17

104

744

Benign neoplasm: Nasopharynx

164

1.85

2.32

3.7

2.6

1.24

1.22

mmol/l

0.80

143

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

2.15

2.30

2.7

3.7

1.22

mmol/l

0.13

Olecranon bursitis

191

1547

1.25

2.30

4.2

4.4

1.21

1.22

mmol/l

1.69

173

1370

Benign neoplasm: Colon, unspecified

749

6709

1.12

2.30

5.0

3.0

1.23

mmol/l

0.21

683

5630

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

183

1473

1.26

2.30

3.1

1.22

1.23

mmol/l

1.77

167

1282

Corns and callosities

223

1837

1.23

2.29

7.7

3.5

1.22

1.23

mmol/l

0.70

203

1593

Other and unspecified disease of Bartholin gland

770

0.66

2.29

2.8

3.2

1.22

1.23

mmol/l

0.90

653

Pregnancy, childbirth and the puerperium

1156

5540

1.10

2.28

3.2

3.5

1.23

mmol/l

0.06

972

4710

Oral leukoplakia and related diseases

118

1530

0.76

2.28

4.2

3.8

1.23

mmol/l

0.01

106

1334

Graves ophthalmopathy

602

1.42

2.27

3.2

3.5

1.22

1.23

mmol/l

1.30

508

Benign neoplasm: Duodenum

654

1.40

2.27

3.6

3.7

1.22

1.23

mmol/l

0.10

571

Diaphragmatic hernia

1153

12524

0.91

2.27

4.0

3.8

1.23

mmol/l

0.23

1039

10833

Benign lipomatous neoplasm of other sites/unspecified

262

2193

1.21

2.26

3.8

2.9

1.22

1.23

mmol/l

0.52

226

1837

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

2.64

2.25

3.5

2.8

1.22

mmol/l

0.30

Use of levodopa decarboxylase inhibitor

453

3966

1.16

2.25

3.4

4.0

1.23

1.22

mmol/l

0.43

387

3454

Other epidermal thickening

137

1071

1.30

2.24

8.6

3.5

1.22

1.23

mmol/l

0.95

121

919

Other and unspecified disorders of adult personality and behaviour

101

2.08

2.24

2.3

2.7

1.23

mmol/l

0.08

Right hemicolectomy

197

1609

1.25

2.23

4.6

3.8

1.22

1.23

mmol/l

0.19

182

1388

Haemangioma and lymphangioma, any site

277

2335

1.20

2.22

3.6

3.9

1.23

mmol/l

0.36

254

2040

Allergic purpura

663

1.39

2.22

6.4

3.4

1.22

1.23

mmol/l

0.93

570

Other enthesopathy of foot (+metatarsalgia)

318

2713

1.19

2.21

4.1

3.7

1.22

1.23

mmol/l

1.64

286

2354

Injury of unspecified body region

229

1899

1.22

2.20

5.7

3.7

1.22

1.23

mmol/l

0.89

208

1639

Abnormal findings on antenatal screening of mother

180

1453

1.25

2.19

2.1

2.7

1.22

1.23

mmol/l

0.95

145

1260

Intrahepatic Cholestasis of Pregnancy (ICP)

183

1482

1.25

2.19

3.1

3.0

1.22

1.23

mmol/l

1.73

167

1286

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

132

1029

1.30

2.19

4.2

2.9

1.24

1.22

mmol/l

2.77

124

865

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

552

1.42

2.19

5.8

3.9

1.22

1.23

mmol/l

0.84

486

Progressive external ophthalmoplegia

5.98

2.18

3.2

7.1

1.23

1.21

mmol/l

—

Carcinoma in situ of skin of lower limb, including hip

541

1.44

2.18

6.8

3.9

1.24

1.22

mmol/l

0.83

469

Abnormalities of forces of labour

199

2423

0.81

2.18

2.8

3.2

1.24

1.23

mmol/l

0.44

178

2123

Hypertrophic cardiomyopathy

130

1015

1.31

2.17

6.8

4.2

1.22

mmol/l

0.23

122

885

Other puerperal infections

195

1592

1.24

2.16

2.4

2.6

1.22

1.23

mmol/l

3.08

163

1368

Artificial joint re-operation

240

2008

1.22

2.15

4.8

3.8

1.22

1.23

mmol/l

1.70

224

1754

Nonsuppurative otitis media

654

5062

1.12

2.15

4.9

3.5

1.22

mmol/l

0.22

582

4352

Other acquired deformities of musculoskeletal system and connective tissue

143

1131

1.29

2.14

3.3

3.9

1.22

1.23

mmol/l

0.19

127

990

Guttate psoriasis

293

1.59

2.14

3.8

3.7

1.21

1.23

mmol/l

0.62

252

Localized scleroderma [morphea]

342

1.54

2.14

3.3

3.4

1.24

1.23

mmol/l

0.51

297

Hirsutism in women

357

1.52

2.14

3.2

2.6

1.22

1.23

mmol/l

0.66

296

Use of amantadine

383

1.51

2.14

3.2

3.7

1.22

1.23

mmol/l

0.27

336

Hair colour and hair shaft abnormalities

104

2.08

2.13

2.8

4.4

1.22

mmol/l

0.10

Personality and behavioural disorders due to brain disease, damage and dysfunction

309

1.57

2.13

3.0

4.0

1.22

1.23

mmol/l

0.06

278

Delivery, wide proxy

1282

6298

1.09

2.12

3.0

3.5

1.24

1.23

mmol/l

0.66

1084

5347

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

592

1.40

2.11

2.9

3.6

1.22

1.23

mmol/l

0.33

519

Trigger finger

461

4057

1.15

2.11

4.5

3.8

1.23

mmol/l

0.22

397

3531

Chronic suppurative otitis media

136

1717

0.78

2.11

4.1

3.6

1.22

1.23

mmol/l

0.49

116

1468

Other specified disorders of muscle

653

1.38

2.10

3.8

4.0

1.23

mmol/l

0.00

555

Exposure to other and unspecified inanimate mechanical forces

124

1582

0.77

2.10

6.0

3.9

1.22

1.23

mmol/l

0.06

105

1379

595

1.40

2.09

5.4

3.8

1.21

1.22

mmol/l

1.32

511

Postzoster neuralgia

369

1.52

2.09

6.9

3.6

1.22

mmol/l

0.14

324

Malignant neoplasm of ovary

101

1318

0.75

2.09

2.8

3.5

1.24

mmol/l

0.06

1136

Flatulence and related conditions

216

1.68

2.09

3.5

3.6

1.21

1.23

mmol/l

0.89

190

Effects of other external causes

500

1.43

2.08

2.8

3.7

1.22

1.23

mmol/l

0.27

435

Intracerebral haemorrhage

416

3642

1.15

2.07

4.9

3.9

1.22

mmol/l

1.53

366

3115

Benign neoplasm: Scapula and long bones of upper limb

201

1.70

2.07

3.5

3.9

1.21

1.22

mmol/l

0.47

178

Other disorders of central nervous system

248

1.63

2.07

2.9

3.3

1.23

mmol/l

0.01

217

Beningn neoplasm: Meninges, unspecified

337

1.53

2.05

3.1

2.5

1.24

1.23

mmol/l

0.79

281

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS